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ABSTRACT 
This thesis presents work on two projects: the all cysteinyl coordinated D14C variant of the 
hyperthermostable Pyrococcus furiosus (Pf) ferredoxin (Fd) as well as wild-type (WT) and two 
variants of the bifunctional dCTP deaminase-dUTPase (DCD-DUT) from Mycobacterium 
tuberculosis (Mt). Furthermore, a program named MyCrystals has been developed to keep track 
of crystallization trials and results. The program combines pictures with crystallization conditions 
and is able to sort the pictures based on selected conditions. MyCrystals was used extensively 
throughout this work and allows for an overview of the crystallization results through the use of 
databases. 
Changing the cluster coordinating aspartate to cysteine in Pf Fd proved to impair the ease with 
which the [Fe4S4] cluster converted to the [Fe3S4] cluster. A disulfide bonded dimer was observed 
at pH 8.0, whereas only the monomer was present at pH 5.8. The crystal structure of D14C 
[Fe3S4] is the first structure with a [Fe3S4] cluster, in which a cysteine from a full cysteine binding 
motif is unprotected and facing away from the cluster. The structure is in close resemblance with 
the WT [Fe3S4] structure. Crystal packing in both D14C and WT [Fe3S4] Fd shows extended β-
sheet dimers. These dimers were not observed in solution and were likely a result of the high 
protein concentration in the crystals.  
WT, A115V and A115G Mt DCD-DUT were successfully purified, and the crystal structure of the 
A115V variant with dTTP bound was solved. The variants were created to investigate the 
importance of steric hindrance on a water molecule suggested to play a key role in 
dephosphorylation. However, this water molecule was present in the structure of A115V:dTTP 
and the variant did not dephosphorylate dTTP. The dTTP pyrimidine moiety in the WT and A115V 
structures is rotated compared with the pyrimidine moiety of dUMPNPP in the structure of 
Mehtanocaldococcus jannaschii (Mj) DCD-DUT. This causes changes in the hydrogen bonding 
pattern of conserved residues in the active site and may give rise to less stabilization of the 
negative charge formed on the oxygen bridging the α-β-phosphorous of the nucleotide in the 
course of the dephosphorylation reaction. The flexible region consisting of residues 110-118 in 
the structure of A115V:dTTP is in close resemblance with the active conformation seen in Mj 
DCD-DUT:dUMPNPP. A115V Mt DCD-DUT was unable to bind dTTP in the inactive conformation 
due to steric hindrance caused by the introduced valine side chain. In contrast to the 
A115V:dTTP structure, an increased number of hydrogen bonds in the WT:dTTP structure favors 
dTTP binding in the inactive conformation. The reduced number of hydrogen bonds in 
A115V:dTTP may explain its reduced thermal stability compared with WT:dTTP.  
dTTP inhibition of WT Mt DCD-DUT at pH 6.8 was confirmed, whereas the WT enzyme proved 
insensitive to dTTP at pH 8.0. The protonation state of the conserved His112 in the flexible loop 
is likely to play an important role herein. His112 is completely deprotonated at pH 8.0, where it 
is stabilized in the active conformation. The active conformation for the WT enzyme is likely to 
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be the same as seen in Mj DCD-DUT:dUMPNPP, and this conformation does not allow dTTP 
binding because of steric hindrance. Hyperbolic dCTP and dUTP saturation curves support that 
the WT enzyme was present solely in the active conformation at pH 8.0. 
The A115V variant was inhibited by dTTP at both pH 6.8 and 8.0, albeit with a stronger inhibition 
at pH 8.0. The flexible 110-118 loop in the A115V:dTTP structure is more loose compared with 
Mj DCD-DUT:dUMPNPP. This wider loop could allow dTTP binding even with protonated His112. 
dTTP binds more easily at pH 8.0 because completely deprotonated His112 takes up less space 
near the nucleotide binding site. 
The A115G variant showed an opposite pH effect of dTTP inhibition compared with the WT 
enzyme. A115G was very sensitive to dTTP at pH 8.0, while no substantial inhibition was 
observed at pH 6.8. Changing alanine to glycine, which has additional allowed backbone 
conformations, is likely to introduce additional flexibility to the already flexible 110-118 loop. 
Hence, dTTP binding at pH 8.0 could simply be explained by the less restrained structure. In 
contrast, the lack of inhibition at pH 6.8 for the A115G variant could be caused by the 
protonated histidine inducing stability by binding to Gly115 O and thereby structurally arranging 
the very flexible loop. At pH 8.0, the A115G variant shows sigmoidal dCTP saturation and 
hyperbolic dUTP saturation. This distinction between dCTP and dUTP as substrates could be 
related to Ala115 being involved in dCTP deamination in the WT enzyme. The flexible Gly115 
backbone of the A115G variant may require adjustment for the deamination to take place, 
whereas the conformation of this residue is indifferent for dephosphorylation. 
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DANSK RESUMÉ 
Denne afhandling omfatter arbejde på to projekter: D14C varianten af Pyrococcus furiosus (Pf) 
ferredoxin med fuldt cystein bindingsmønster samt vildtype (WT) og to varianter af den 
bifunktionelle dCTP deaminase-dUTPase (DCD-DUT) fra Mycobacterium tuberculosis (Mt). 
Endvidere blev programmet MyCrystals udviklet for at holde rede på krystallisationsforsøg og 
resultater. Programmet kombinerer billeder med krystallisationsbetingelser og er i stand til at 
sortere billederne ved valg af givne betingelser. MyCrystals blev brugt i vid udstrækning i dette 
arbejde og programmet giver et overblik over krystallisationsresultaterne ved hjælp af 
databaser. 
Udskiftning af en klyngekoordinerende aspartat til cystein i Pf ferredoxin gjorde det sværere at 
omdanne klyngen fra [Fe4S4] til [Fe3S4]. En dimer bundet sammen af en disulfidbro blev 
observeret ved pH 8.0, mens kun monomeren fandtes ved pH 5.8. Krystalstrukturen af D14C 
[Fe3S4] er den første struktur med en [Fe3S4] klynge, hvori en fri cystein fra et fuldt cystein 
bindingsmønster peger væk fra klyngen. Strukturen er meget lig WT [Fe3S4] strukturen. 
Krystalpakningen af både D14C og WT [Fe3S4] Fd er som β-sheet dimerer. Disse dimerer blev ikke 
observeret i opløsning og var sandsynligvis et resultat af den høje proteinkoncentration i 
krystallerne. 
WT, A115V og A115G Mt DCD-DUT blev oprenset og krystalstrukturen af A115V med dTTP 
bundet blev løst. Varianterne blev lavet for at undersøge betydningen af et vandmolekyle, der 
måske havde en vigtig rolle i defosforyleringsreaktionen. Dette vandmolekyle var dog til stede i 
A115V:dTTP strukturen og varianten var ikke i stand til at defosforylere dTTP. Pyrimidindelen af 
dTTP i WT og A115V strukturerne er roteret i forhold til pyrimidindelen af dUMPNPP i 
Methanocaldococcus jannaschii (Mj) DCD-DUT. Denne drejning forårsager ændringer i hydrogen-
bindingsmønsteret for konserverede rester i det aktive center og kan muligvis medføre mindre 
stabilisering af den negative ladning, som dannes på oxygenet, der forbinder α-β-fosfaterne i 
nukleotidet, i løbet af defosforyleringsreaktionen. Den fleksible region, der udgøres af 
aminosyreresterne 110-118, i strukturen af A115V Mt DCD-DUT med dTTP bundet er meget lig 
den aktive konformation af Mj DCD-DUT:UMPNPP. A115V varianten var ikke i stand til at binde 
dTTP i den inaktive konformation på grund af sterisk hindring fra valinsidekæden. Et højere antal 
hydrogenbindinger i WT:dTTP strukturen favoriserer dTTP binding i den inaktive konformation i 
modsætning til A115V:dTTP strukturen. Det reducerede antal hydrogenbindinger i A115V:dTTP 
kan forklare dennes lavere termostabilitet sammenlignet med WT:dTTP.  
dTTP inhibering af WT Mt DCD-DUT ved pH 6.8 blev påvist, hvorimod WT enzymet var upåvirket 
af dTTP ved pH 8.0. Protoneringen af den konserverede His112 i det fleksible loop har 
sandsynligvis en vigtig rolle heri. His112 er fuldstændigt deprotoneret ved pH 8.0, hvor den er 
stabiliseret i den aktive konformation. Den aktive konformation for WT enzymet er sandsynligvis 
magen til konformationen af Mj DCD-DUT:dUMPNPP, og denne konformation tillader ikke dTTP 
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binding på grund af sterisk hindring. Hyperbolske dCTP og dUTP mætningskurver underbygger at 
WT enzymet udelukkende findes i den aktive konformation ved pH 8.0.  
A115V varianten var inhiberet af dTTP både ved pH 6.8 og ved 8.0, om end stærkest inhiberet 
ved pH 8.0. Det fleksible 110-118 loop er løsere i A115V:dTTP strukturen end i Mj 
DCD-DUT:dUMPNPP. Dette bredere loop kan tillade dTTP binding selvom His112 er protoneret. 
dTTP har lettere ved at binde ved pH 8.0, idet en fuldstændig deprotoneret His112 optager 
mindre plads nær nukleotidbindingssitet.  
A115G varianten viste en modsat pH effekt af dTTP inhibering i forhold til WT enzymet. A115G 
var meget sensitiv overfor dTTP ved pH 8.0 og overvejende upåvirket ved pH 6.8. Udskiftning af 
alanin til glycin, der har flere tilladte hovedkædekonformationer, vil sandsynligvis tilføje yder-
ligere fleksibilitet til det i forvejen fleksible 110-118 loop. En simpel forklaring på dTTP binding 
ved pH 8.0 er, at der er mere plads i strukturen. Den modsatte mangel på dTTP inhibering ved pH 
6.8 for A115G er muligvis forårsaget af den protonerede histidin, der kan give mere stabilitet i 
strukturen ved at binde til Gly115 O og derved skabe en strukturel begrænsning i det meget 
fleksible loop. Ved pH 8.0 udviser A115G varianten sigmoid dCTP mætning og hyperbolsk dUTP 
mætning. Denne skelnen mellem dCTP og dUTP som substrater kan skyldes, at Ala115 i WT 
enzymet er involveret i dCTP deaminering. Det er muligvis nødvendigt strukturelt at tilpasse 
positionen af det fleksible Gly115 backbone i A115G varianten for at deaminering kan finde sted, 
hvorimod konformationen af denne rest ikke er vigtig for defosforylering. 
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A115G A115G variant of Mycobacterium tuberculosis dCTP deaminase-dUTPase 
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Ec  Escherichia coli 
EPR Electron paramagnetic resonance 
ESRF European Synchrotron Radiation Facility (Grenoble, France) 
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FeS  Iron-Sulfur 
HEPES N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid 
HPLC High-pressure liquid chromatography 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
LB media 1 % tryptone, 0.5 % yeast extract, 0.5 % NaCl 
MAX-lab National electron accelerator laboratory for synchrotron radiation research, 
nuclear physics and accelerator physics (Lund University, Sweden) 
MIB Buffer system containing malonic acid, imadizole and boric acid 
Milli-q 18.2 MΩ cm water, Milli-Q Synthesis system by Millipore 
MPD 2-Methyl-2,4-pentanediol 
Mj Methanocaldococcus jannaschii 
MPEG Polyethylene glycol monomethyl ether 
Mt Mycobacterium tuberculosis 
NCS Non-crystallographic symmetry 
NDK Nucleoside diphosphate kinase 
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viii 
NMR Nuclear magnetic resonance 
NMWL  Normal molecular weight limit 
OD Optical density; wavelength given as subscript 
Pdb Protein Data Bank: www.pdb.org 
PEG Polyethylene glycol 
Pf Pyrococcus furiosus 
QTOF Quadrupole Time of Flight 
RMS Root mean square 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Ss Sulfolobus solfataricus 
TB/carb  Terrific Broth with 0.5 % (w/w) glycerol and 50 µg/mL carbenicillin 
TLS Translation Libration Screw-motion 
Tris 2-amino-2-(hydroxymethyl)-1,3-propandiol 
UV-vis Ultraviolet-visible 
WT Wild-type  
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Chapter One 
1 INTRODUCTION AND OUTLINE 
Proteins participate in virtually every process within cells and are an essential part of life, as they 
are required for structure, function and regulatory purposes. Enzymes are proteins that catalyze 
biochemical reactions. They are also of vital importance, as they catalyze the majority of the 
reactions involved in metabolism and are also involved in transcription, DNA-replication 
and -repair. The three-dimensional structure of proteins and enzymes is absolutely essential for 
the function, and structure determination is thus a valuable method for discovering shared 
features among members of molecular families. Detailed three-dimensional protein structures 
can be determined using NMR spectroscopy and X-ray crystallography, the latter of which was 
used throughout this work.  
Successful protein crystallization is required in order to solve the crystal structure by X-ray 
diffraction. This can be an immense task involving numerous crystallization conditions, and 
meticulous bookkeeping of the results is important in order to optimize the conditions. Chapter 
2 presents a database program named MyCrystals that was developed for managing and storage 
of such information. The unique feature of MyCrystals is the option to sort crystallization 
conditions coupled with a picture. MyCrystals is available online and is also enclosed in Appendix 
A along with databases containing crystallization conditions and pictures of protein 
crystallization results throughout this work. 
Metalloproteins are crucial for many essential processes and exist extensively throughout 
nature. Ferredoxin (Fd) from Pyrococcus furiosus (Pf) is hyperthermostable and contains a single 
[Fe4S4] cluster with incomplete cysteinyl coordination [1,2]. Studies of the D14C variant 
ferredoxin, in which the cluster coordinating aspartate has been changed to cysteine, may 
contribute to the understanding of cysteine ligation and its effects on protein function and 
stability. The D14C variant of Pf Fd is introduced in Chapter 3 along with a brief introduction to 
iron-sulfur proteins. Conversion of [Fe4S4] to [Fe3S4] is a preceding step in the formation of 
heterometallic clusters, in which an externally imposed metal ion is part of the cluster [MFe3S4]. 
Formation of novel metalloproteins presents an opportunity to engineer new or improve existing 
functional properties with relevance for a wide range of applications within the pharmaceutical- 
and biotechnological industries [3]. Structural studies of metalloproteins are important because 
the structure-function relationship is vital for protein design. Expression and purification of D14C 
[Fe4S4] Pf Fd as well as cluster conversion to [Fe3S4] and subsequent purification are described in 
Chapter 4. Crystallization and crystal structures of D14C Pf Fd are described in Chapter 5. 
 
1 INTRODUCTION AND OUTLINE 
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Building blocks for DNA and RNA are in continuous demand, and (deoxy)ribonucleotide synthesis 
is thus vital for cell growth. During evolution, the base pairing in DNA changed from including the 
uracil base (found in RNA) to include the thymine base. Studying the synthesis of 
deoxythymidine triphosphate (dTTP) may provide clues as to how this evolution transpired. The 
bifunctional enzyme dCTP deaminase-dUTPase (DCD-DUT) is involved in the biosynthesis of dTTP 
and is described in Chapter 6. Kinetic and inhibition studies can be used to characterize enzymes 
in order to gain an understanding of the function. In this work, the bifunctional DCD-DUT from 
Mycobacterium tuberculosis (Mt) has been studied. The infectious bacterial disease tuberculosis 
caused by Mt killed an estimated 1.7 million people in 2009 [4], and enzymes involved in 
deoxyribonucleotide synthesis provide potential drug targets. Structures and inhibition 
mechanisms of these enzymes are important in the design of specific inhibitors that leave the 
human host unaffected. Wild-type (WT) and two variants of the bifunctional Mt DCD-DUT have 
been studied in this work. An introduction to the variants and the applied equations for kinetic 
analyses is given in Chapter 7. Purification of the enzymes is described in Chapter 8, followed by 
structural and kinetic studies of the enzymes in Chapter 9.  
Numerous figures of protein structures are shown throughout this thesis, both in chapters 
outlining the literature and in experimental chapters describing the obtained results. All these 
figures have been made using PyMol [5], occasionally in combination with other programs, 
which will be stated explicitly in the figure legends.  
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Chapter Two 
2 MYCRYSTALS – A SIMPLE VISUAL DATA 
MANAGEMENT PROGRAM FOR LABORATORY 
SCALE CRYSTALLIZATION EXPERIMENTS 
2.1 Introduction 
Macromolecular structure determination by X-ray diffraction requires successful crystallization. 
This can be a difficult task where numerous crystallization experiments lead to a large amount of 
data. Crystallization projects can be worked on by several people over longer periods of time and 
keeping track of, as well as sharing, results can be made much easier by the use of a database. A 
program named MyCrystals has been developed with the main purpose of managing and storing 
pictures and crystallization conditions, as well as sorting them to give an overview of the results. 
A program description is available in this chapter and a descriptive note of the program has been 
published [6]. 
There are many other available programs and applications to store crystallization data. 
Crystallization robots usually include commercial software that is able to handle large amount of 
data. Some of the available free programs are XtalBase [7], XAct [8], Xtrack [9], CLIMS [10] and 
LISA [11]. Images combined with scores present a simple way to assess crystallization results and 
also simplifies the optimization procedure because of the transparency of the results. XtalBase 
[7] is a comprehensive system that amongst many other features can manage and display 
pictures of the results, and CLIMS [10] is able to store visual observations of the drops. 
Laboratory Information Management Systems like PiMS [12] are designed to manage various 
kinds of data such as target, construct and experiment data through a web interface.  
MyCrystals is simple to use, easy to navigate, and requires minimal time investment by the 
researcher to utilize the software. The unique feature of MyCrystals is its ability to display and 
sort crystallization pictures. The pictures are stored locally or on external media, and the 
program creates a database with file paths to identify the pictures. MyCrystals is also able to sort 
pictures by the entered data to view the effect of e.g. changing the pH or precipitant. This makes 
it easier to establish the best conditions and to assess how they can be optimized. MyCrystals 
can also be used as a notebook program to keep track of attempted crystallization conditions 
without necessarily using the picture viewing part. Furthermore, MyCrystals may be useful in 
other experimental optimization procedures, such as purification, where a lot of slightly different 
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procedures are usually tested. These may be stored in the database and linked to an image file 
containing the resulting chromatogram. 
 
2.2 Program Description and Use 
MyCrystals is primarily designed for viewing and sorting pictures in a simple and intuitive user 
interface. The File menu is used for creating new databases and loading or saving existing 
databases. Creating a new database in the file menu will auto-generate a standard set of 
conditions. The user interface of MyCrystals is divided into three simple main tabs: Edit Data, 
Filter Data and Data Table. Data entry and edit are carried out in the Edit Data tab as described 
in section 2.2.2. Picture display and selection based on conditions are carried out in Filter Data as 
described in section 2.2.3. Data Table lists all entered data in a table to give an overview of the 
contents of the database. 
 
2.2.1 Data Structure 
The data consist of two parts. The first part is an XML-database that contains all entered 
conditions including the appropriate image path for each set of conditions (data entries). The 
second part is the images, which are placed in a directory on the hard drive. MyCrystals 
recognizes graphics file formats JPEG, GIF, PNG and TIFF. 
The full path to each image consists of two paths, a Project Directory and a relative Image Path. 
The Image Path is unique for each data entry while the Project Directory is shared. This 
arrangement facilitates the moving of all images to another location, as only the Project 
Directory needs to be changed. 
 
2.2.2 Edit Data 
In the Edit Data tab, the database can be edited by adding new data entries or editing already 
existing data entries. The tab consists of three parts: Project Directory, Column Properties and 
Data Entry. 
The Project Directory is the path to a directory where all the images used in the database are 
placed. The rest of the path is stored as a property (Image Path) for each data entry. The Column 
Properties makes it possible to change the data columns of the database. It is possible to delete 
or add columns, change the names and types, and switch the positions of two columns. An 
intuitive user interface renders this possible, see Figure 2.1.  
The Data Entry area is used to add, change or remove data entries in the database. The Selected 
Data Entry operates on an existing data entry. To add a new data entry into the database, use 
the Add Data Entry button, which creates a new data entry with a consecutive index number. 
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The data entry fields are empty when the first data are typed in, and after Add Data Entry has 
been used, the entry fields will contain the information of the latest data entry. Drop down 
menus of previously entered data are available when entering or correcting database entries. 
The Selected Data Entry can advantageously be used when entering data, as an entire set of 
previously entered conditions can be loaded by giving the index number. Minor changes can be 
applied to the set of conditions and Add Data Entry will generate a new data entry in the 
database. 
 
Figure 2.1: A screenshot showing how the Edit Data tab of MyCrystals can appear. Checking the 
Lock Properties option will simplify the Column Properties by only showing the name. 
 
2.2.3 Filter Data 
The Filter Data tab is used for viewing and sorting pictures entered into a database. The sorting 
options are available in a drop down menu and consist of all entered data. First, a condition is 
selected and then a filter option is applied. Text strings can be sorted as absolutes, while 
numerical strings also can be sorted using >, <, ≤, ≥, ≠. It is possible to apply 15 filters 
simultaneously. A list of entries that match the criteria will be generated and displayed in the 
tab, see Figure 2.2. 
 The information shown for each data entry in the list can be customized using the field Filter 
text. Writing '[1]' will list the data entered in the first field in the Data Entry area of the Edit Data 
tab, '[2]' will list the data in the second field and so forth. Selecting one of the listed entries will 
display the matching picture to the right of the tab as shown in Figure 2.2. 
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Figure 2.2: A screenshot showing how the Filter Data tab of MyCrystals can appear. Data with 
the following conditions have been sorted: Enzyme: A115V, pH = 7.5, Additives Drop: 5 mM 
dTTP, 20 mM MgCl2 and Precipitant concentration ≤ 8 (w/w%). In the displayed image: 5 % 
PEG8000. The scale-bar is part of the depicted image. 
 
2.3 Platforms and Availability 
The program is written in C# as a Windows form in Microsoft Visual Studio. The program consists 
of a single executable file, and no installation is needed. MyCrystals runs under Windows and 
has no special hardware requirements. MyCrystals is available free of charge for download from 
http://xray.kemi.dtu.dk/mycrystals/ and is enclosed on DVD in Appendix A. Furthermore, the 
DVD includes three databases and matching pictures of crystallization results carried out as 
described in Chapters 5 and 9, and in Appendix F. 
 
2.4 Conclusion 
The unique main feature of the program MyCrystals, presented here, is the displaying and 
sorting of crystallization pictures based on the entered crystallization conditions. This enables 
the user to view the effect of changing conditions, which helps to identify parameters for 
optimization. 
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Chapter Three 
3 IRON-SULFUR PROTEINS IN BRIEF 
3.1 Introduction to Iron-Sulfur Proteins 
Iron-sulfur (FeS) proteins are present in all kinds of organisms and cellular compartments. They 
are predominantly involved in electron transfer, but also in substrate binding, catalysis, 
regulatory and sensing functions [13-15]. FeS proteins are proposed to be ancient structures that 
may have played a role during the emergence of life on this planet [16,17]. The formation of FeS 
clusters in a living cell is catalyzed by various complex biosynthetic machineries and a range of 
diseases are associated with defects in FeS proteins in humans [15]. 
The predominant product in autoassembly involving iron, sulfide and thiolates is the [Fe4S4] 
cluster [18]. The stability of FeS clusters in proteins depends on the protein surroundings. The 
preferred organic ligands of FeS are cysteines, but also histidine, glutamine or arginine can be 
used as ligands. FeS proteins are in general present in a single protein domain and have a 
reasonably rigid ligand framework. Exposed FeS clusters are uncommon and very unstable. 
Examples of large and specialized FeS clusters are the [Fe8S7] (P cluster) and [MoFe7S9] (FeMoco) 
clusters of nitrogenase, the Fe2-[Fe4S4] active site of [FeFe] hydrogenases and the Ni2-[Fe4S4] (A 
cluster) and NiFe4S5 (C cluster) clusters of CO dehydrogenase/acetylcoenzyme A synthase 
[13,19]. Figure 3.1 shows simple and more complex FeS cluster structures. 
 
Figure 3.1: Four examples of iron-sulfur clusters: [Fe2S2] (pdb 1RFK). [Fe3S4] (pdb 1SJ1). [Fe4S4] 
(pdb 2Z8Q). [MoFe7S9] (pdb 1M1N).  
The redox potentials of FeS proteins have a very large span of about 1 V. The [Fe4S4] ferredoxin 
cluster changes oxidation state from +2 to +1 during reduction, while the [Fe3S4] cluster changes 
from +1 to 0 during reduction [14]. High-potential iron-sulfur proteins (HiPIPs) are small globular 
proteins (6-10 kDa) that act as electron donors. They contain a [Fe4S4]
2+/3+ cluster bound to four 
conserved cysteine residues and are distinguished by high reduction potentials [13,20]. 
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The electrochemical properties of ferredoxins are sensitive to changes in the cluster environ-
ment. More positive reduction potentials are expected for less buried clusters because the 
reduced cluster including ligands is more charged than the oxidized cluster, [Fe4S4(Cys
-)4]
3-/2-. 
Increased solvent accessibility of the cluster thus increases the reduction potential [21-23]. More 
and stronger hydrogen bonds to cluster coordinating cysteine Sγ increase the reduction 
potential, most likely by stabilizing the reduced, more charged cluster by attenuating the charge 
density [22,24]. Other effects discussed to influence the reduction potential include ligand 
conformation, hydration effects and volume of the cavity hosting the cluster [22,25,26]. 
 
3.2  [Fe4S4] ↔ [Fe3S4] Cluster Interconversions 
Aconitase is a widely used example of incomplete cysteinyl coordination in which the cluster 
conversion plays a crucial role for the enzyme activity. The inactive enzyme contains a [Fe3S4]
+ 
cluster coordinated to the protein by three cysteines. The enzyme is active when a fourth iron 
coordinated by hydroxyl is incorporated to complete the cubane [Fe4S4]
2+ cluster [27-29]. 
The [Fe4S4] cluster is a common cluster in bacterial ferredoxins and is bound to the polypeptide 
chain with a typical binding motif: -Cys-X2-Cys-X2-Cys-Xn-Cys-.  Common single cluster ferredoxins 
have two additional cysteines forming an intramolecular disulfide bond, which replace a second 
cluster in more ancient ferredoxins [30]. Incomplete cysteine coordination of a [Fe4S4] cluster is 
seen in Pf ferredoxin and in one of two [Fe4S4] clusters in Desulfovibrio africanus (Da) ferredoxin 
III, which both readily convert to [Fe3S4] clusters [2,31]. Site-directed change of a cluster 
coordination aspartate to cysteine has been reported to impair the ease with which [Fe4S4] 
converts to [Fe3S4] [31]. 
Formation of a [Fe3S4] cluster is a preceding step to the formation of heterometallic clusters in 
which a fourth exogenous metal (M) is incorporated into the cluster [MFe3S4]. Protein templates 
used for this type of cluster redesign include ferredoxins from Pf, Da and Desulfovibrio gigas 
[32,33]. [MFe3S4] Pf Fd has been studied with M = Cr
2+, Mn2+, Zn2+, Ni2+, Co2+, Cd2+, Cu+ and Tl+ 
[34-38]. Design or modification of metal binding sites in proteins opens for the possibility to 
engineer new or improve existing functional properties. This can contribute to the under-
standing of structure-function relationships and result in new enzymes for a wide range of 
applications [3].  
 
3.3 Pyrococcus furiosus Ferredoxin and the D14C variant 
Ferredoxin from the strict anaerobic hyperthermophilic archaeon Pyrococcus furiosus functions 
as an electron carrier [1]. The 7.5 kDa ferredoxin consists of 66 amino acids and includes a single 
[Fe4S4] cluster coordinated to the protein by three cysteine residues (residues 11, 17, 56) and 
one aspartate (residue 14) [2,39]. The iron coordinated to Asp14 is lost during a reversible 
cluster conversion to [Fe3S4]. Reassembly of the [Fe4S4] cluster occurs during incubation with Fe
2+ 
under reducing conditions [2]. Two additional cysteine residues (21, 48) form a redox active 
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disulfide bond [40]. The disulfide bond exists in a double conformation with a left-handed spiral 
conformation destabilized compared to the right-handed spiral conformation [39,41,42].  
The crystal structure of [Fe3S4] Pf Fd was solved by Nielsen et al. [41,43] (pdb 1SJ1). In the crystal 
structure, the ferredoxin forms an extended β-sheet dimer. The dimer has been proposed to be 
present at low ionic strength, while monomers are present at high ionic strength [44,45]; a 
behavior, which has been reported for Pyrococcus woesei ferredoxin [46]. 
Structural, electronic and functional characteristics of incomplete cysteinyl coordination have 
been studied extensively in Pf Fd by replacing Asp14 with cysteine [47-52]. D14C [Fe4S4] Pf Fd 
show the same extreme thermostability as WT Pf Fd with no observed denaturation after 12 h at 
95 °C [1,50]. Differences between D14C and WT Pf Fd are seen as an increase in the absorbance 
ratio, A390/A280 = 0.73 for D14C compared with 0.56 for WT (UV-vis spectra are shown in Figure 
3.2) and an increase in the extinction coefficient, ε390 = 20.2 mM
-1cm-1 for D14C compared with 
17.0 mM-1cm-1 for WT [48,49]. Also, D14C [Fe4S4] Pf Fd has a more negative redox potential (-427 
mV) compared with WT [Fe4S4] Pf Fd (-368 mV) [50]. The efficiency of electron acceptance is also 
affected by the mutation, as the D14C variant has a decreased Vmax compared with WT Pf Fd 
[50]. A detailed description of expression, purification and properties of WT, WT-recombinant 
and several mutants of Pf Fd is given by Kim et al. [53]. 
 
 
Figure 3.2: UV-vis spectra of Pf ferredoxins: WT and D14C [4Fe-4S] and WT [3Fe-4S]. Adapted 
with permission from [50]. Copyright 2011 American Chemical Society. 
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Chapter Four 
4 OXIDATION AND PURIFICATION OF THE D14C 
VARIANT OF PYROCOCCUS FURIOSUS FERREDOXIN 
4.1 Introduction 
Oxidation of [Fe4S4] ferredoxins to [Fe3S4] ferredoxins is a preceding step to the formation of 
heterometallic clusters [MFe3S4]. D14C Pf Fd contains a [Fe4S4] cluster and the difference in 
oxidation to [Fe3S4] compared with the WT Fd may provide information on the effects of 
complete cysteinyl coordination. Aerobic purification of WT Pf Fd produces two peaks with 2 
mS/cm elution difference during anion exchange on a Source 30Q column; first the Fd with a 
[Fe4S4] cluster followed by the Fd with a [Fe3S4] cluster [54]. Differences are seen in the 
characteristics of the UV-vis spectra of WT [Fe4S4] and [Fe3S4] Pf Fd shown in Figure 3.2. The 
absorbance maximum moves from 390 nm to 408 nm and a shoulder around 340 nm becomes 
more pronounced when the cluster in WT Pf Fd is converted from [Fe4S4] to [Fe3S4] [50]. 
Prior to this project1, oxidation of purified D14C [Fe4S4] Pf Fd was attempted, but proved 
unsuccessful (section 4.1.1) and several experiments were made to oxidize the Fd (section 4.2.3). 
Cultivation and purification of D14C Pf Fd are also described in this chapter.  
All solutions were prepared with 18.2 MΩ cm water from a Milli-Q Synthesis system by Millipore 
(milli-q water). Protein purifications were carried out on an ÄKTATM Purifier 100 HPLC system. 
Ultrafiltration was carried out at 4 °C in a stirred Amicon cell with a PLBC NMWL 3 kDa 
membrane. 
 
4.1.1 Initial Oxidation Procedure and Results 
The initial oxidation procedure presented in this section was carried out prior to this project, 
following the procedure described in reference [47] with minor modifications.  
In experiment A, 15x molar excess of K3[Fe(CN)6]3 was used. The solution with ferricyanide and 
10 mg D14C Pf Fd in 20 mM Tris/HCl pH 8.0 was incubated at room temperature for 15 minutes 
with gentle stirring. The protein solution was exchanged into 20 mM Tris/HCl pH 8.0 by 
ultrafiltration and then loaded onto a 16 mm/10 cm Source 30Q column equilibrated with 20 
                                                           
1 Monika Nøhr Johannessen (Løvgreen) Master's Thesis, Department of Chemistry, Technical University of 
Denmark, October 2007 
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mM Tris/HCl pH 8.0. The column was washed with 2 column volumes (CV) 20 mM Tris/HCl pH 
8.0 and elution was carried out using a linear salt gradient of 0.15 M to 0.4 M NaCl in 20 mM 
Tris/HCl pH 8.0 over 17 CV. The chromatogram is shown in Figure 4.1 along with the UV-vis 
spectra of protein in the main peak a and D14C [Fe4S4] Pf Fd for comparison. Protein from the 
main peak a was collected and crystallized. The structure proved to contain a [Fe4S4] cluster. 
 
 
Figure 4.1: Left: chromatogram from purification of oxidized D14C Pf Fd. Collected fractions of 
peak a are marked with a black line. Right: UV-vis spectrum of peak a from the chromatogram 
and D14C [Fe4S4] Pf Fd. 
 
4.2 Experimental 
4.2.1 Expression of D14C Pf Fd  
The expression strain was an E. coli strain over expressing the D14C variant of Pf Fd. Cultivation 
of the cells was carried out in Terrific Broth with carbenicillin as selection marker. Sterilization 
was applied to all instruments that came in contact with the cells to avoid contamination. The 
cultivation procedure is based on a previously developed method in the Metalloprotein 
Chemistry and Engineering Research Group for expressing native Pf Fd [54]. 
The bacteria cells expressing D14C Pf Fd from a glycerol stock were streaked on an agar plate 
containing Luria Broth, 100 µg/mL ampicillin. A single colony was selected and added to 50 mL 
Terrific Broth with 0.5 % (w/w) glycerol and 50 µg/mL carbenicillin (TB/carb) in a 300 mL triple 
baffled shake flask. Two 50 mL cultures were prepared per 6 x 650 mL large-scale cultures. The 
two cultures were incubated at 37 °C with shaking until the optical density at 600 nm (OD600) was 
0.6-1.0. The cultures were incubated at 4 °C overnight. Each culture was then transferred to a 50 
mL sterile plastic tube and centrifuged at 4 °C. The clear supernatants were decanted off and 
discarded, and each of the two pellets was resuspended in 23 mL TB/carb. 6.5 mL culture was 
transferred into 650 mL TB/carb in a 2 L triple baffled shake flask to give a total of six 650 mL 
large-scale cultures. The cultures were incubated at 30 °C with shaking until OD600 was 2.4. IPTG 
was added to a final concentration of 0.1 mM and incubation continued at 30 °C for 16 hours. 
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Each of the 650 mL cells were transferred to a Beckmann centrifuge tube and centrifuged at 4 °C. 
The clear supernatants were decanted off and discarded. The cells in each centrifuge tube were 
resuspended in 25 mL ice-cold 20 mM Tris/HCl pH 8.0 and poured into 50 mL sterile plastic 
centrifuge tubes. The six 50 mL tubes were centrifuged at 4 °C. The clear supernatants were then 
decanted off and discarded. Cell pellets were stored at -80 °C. 
 
4.2.2 Purification of D14C Pf Fd 
Six tubes, each containing cells from 650 mL culture (section 4.2.1), were slowly defrosted on 
ice. Each tube was added approximately 30 mL 20 mM Tris/HCl pH 8.0 buffer and the cells 
resuspended. 80 µL 1 M sodium dithionite was then added to each tube. The cells were lysed by 
sonication three times for 40 seconds. The suspension was kept on ice during and in between 
sonications. After sonication, the suspensions were incubated for 10 minutes in a 70 °C water 
bath, and then centrifuged at 4 °C and the clear supernatants decanted off. The pooled 
supernatants were diluted four times with 20 mM Tris/HCl pH 8.0, 2 mM sodium dithionite. 
The protein solution was loaded onto a 50 mm/7 cm Q Sepharose Fast Flow column equilibrated 
with 20 mM Tris/HCl pH 8.0. The column was washed with 2 CV 20 mM Tris/HCl pH 8.0 and 2 CV 
0.15 M NaCl in 20 mM Tris/HCl pH 8.0. The protein was eluted isocratically using 0.4 M NaCl in 
20 mM Tris/HCl pH 8.0. The volume was reduced by ultrafiltration. Less than 30 mg protein 
reduced to a maximum volume of 9 mL was then loaded onto a HiLoad 26 mm/60 cm Superdex 
75 column equilibrated with 0.15 M NaCl in 20 mM Tris/HCl pH 8.0 and eluted using the same 
buffer. Fractions containing the protein were pooled and exchanged into a 20 mM Tris/HCl pH 
8.0 buffer by ultrafiltration. A maximum of 15 mg protein was loaded onto a 16 mm/10 cm 
Source 30Q column equilibrated with 20 mM Tris/HCl pH 8.0. The column was washed with 2 CV 
20 mM Tris/HCl pH 8.0 and elution was carried out using a linear salt gradient of 0.15 M to 0.4 M 
NaCl in 20 mM Tris/HCl pH 8.0 over 17 CV. The protein was exchanged into 20 mM Tris/HCl pH 
8.0 by ultrafiltration. UV-vis spectrophotometry was used to determine the protein 
concentration and yield. 
 
4.2.3 Oxidation and Purification 
Different parameters were varied during the oxidation process. The experimental details are 
given in Appendix B and summarized in Table 4.1. In brief, purified D14C [Fe4S4] Pf Fd was mixed 
with ferricyanide and left with mild stirring for a variable amount of time and then exchanged 
into 20 mM Tris/HCl pH 8.0 and purified by anion exchange on a 16 mm/10 cm Source 30Q 
column equilibrated with the same buffer unless otherwise specified. In addition to these 
experiments (A to N), three other types of experiments (O, P and Q) were attempted. CoCl2 was 
added in experiment O in order to investigate whether the [Fe3S4] cluster was unstable and 
would allow for a heterometal to replace the fourth iron of the cluster. In experiment P, it 
attempted to break the cluster by adding a large excess of dithionite as suggested by Moura et 
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al. [55]. In experiment Q, ferricyanide was substituted by [Fe(phen)3]
3+ that has a potential of 
+1127 mV compared with +360 mV of ferricyanide and -426 mV D14C [Fe4S4] Pf Fd [50,56,57]. 
 
Table 4.1: Overview of the experimental procedures for oxidation of D14C Pf Fd. K3[Fe(CN)6]3 
was present in 15x molar excess, except in experiments P and Q. Subsequent purification was 
performed by anion exchange at pH 8.0 unless otherwise stated.  
ID Buffer pH Time Notes 
A 20 mM Tris/HCl 8.0 15 min - 
B 20 mM Tris/HCl+0.3 M NaCl 8.0 15 min - 
C 100 mM Tris/HCl 7.8 15 min - 
D 100 mM Tris/HCl 7.8 45 min - 
E 100 mM Tris/HCl 7.8 3 hrs - 
F 100 mM BisTrisPropane/HCl 6.5 15 min Anaerobic purification 
G 20 mM Tris/HCl 8.0 45 min 1.5x molar excess EDTA 
H 50 mM Na Acetate/Acetic Acid 4.5 45 min 1.5x molar excess EDTA 
I 20 mM BisTris/HCl 5.8 3 hrs 
+overnight at 4 °C 
1.5x molar excess EDTA 
J 20 mM BisTris/HCl 5.8 overnight 1.5x molar excess EDTA 
K 20 mM BisTris/HCl 5.8 3 hrs 1.5x molar excess EDTA 
Ion exchange at pH 5.8 
L 20 mM BisTris/HCl 5.8 3 hrs 1.5x molar excess EDTA 
Ion exchange at pH 5.8 
M 20 mM BisTris/HCl 5.8 overnight 1.5x molar excess EDTA 
Ion exchange at pH 5.8 
N 100 mM Tris/HCl 7.8 15 min Ion exchange pH 7.8 
O 20 mM Tris/HCl 8.0 45 min CoCl2 present 
P 0.8 M Tris/HCl 
0.1 M Tris/HCl+0.8 M NaCl 
7.6 
7.6 
2.5 hrs 
2.5 hrs 
Excess dithionite 
Excess dithionite 
Q 20 mM Tris/HCl 8.0 20 min Excess [Fe(phen)3]
3+ 
 
 
4.2.4 Molecular Weight Determination and EPR 
Three protein samples from experiment G were sent to molecular weight determination by mass 
spectrometry at Alphalyse A/S. The mass spectra were obtained using a Micromass QTOF mass 
spectrometer in positive ion mode and deconvoluted with MassLynx software, MaxEnt1 [58]. A 
detailed description of the selected samples from the purification is given with the results in 
section 4.3.3. The samples were in 5 mM Tris/HCl pH 8.0 with a concentration of 0.1 mg/mL. 
Two additional samples of were also sent: 0.6 mg/mL in 5 mM Tris/HCl pH 8.0 and 0.4 mg/mL in 
milli-q water. 
Protein from experiment J (EPR peak a sample) and a mix of protein from experiments K and L 
(EPR peaks c sample) were concentrated to 500 µM in 20 mM Tris/HCl pH 8.0 by ultrafiltration. 
Oxidized EPR samples were prepared by transferring 350 µL of each sample directly to an EPR 
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sample tube. Reduced EPR samples were prepared in a glove-box by adding dithionite to a final 
concentration of 10 mM and then transferring 350 µL to EPR sample tubes, which were 
subsequently sealed with Suba-Seal silicon rubber septas. All samples were frozen in liquid 
nitrogen. EPR spectra were obtained by Hanne Nørgaard2 under the following conditions: 
temperature 10 K, field modulation amplitude: 10 G, receiver gain 50, microwave frequency: 
9.63GHz, microwave power: 14 mW and corrected by withdrawing the spectrum of an empty 
EPR tube. 
 
4.2.5 Resource Anion Exchange 
Some of the collected fractions of oxidized D14C Pf Fd after anion exchange (section 4.2.3, 
experiments A, J and L) were run on a 16 mm/3 cm ResourceQ anion exchange column to 
improve the resolution. Also, purified D14C [Fe4S4] Pf Fd was run twice. The oxidized samples 
were loaded onto a 16 mm/3 cm ResourceQ column equilibrated with 20 mM Tris/HCl pH 8.0. 
The column was washed with 2 CV 20 mM Tris/HCl pH 8.0 and elution was carried out using a 
linear salt gradient of 0.15 M to 0.4 M NaCl in 20 mM Tris/HCl pH 8.0 over 17 CV. 
 
4.2.6 Gel Filtration 
Selected fractions of oxidized D14C Pf Fd after anion exchange (section 4.2.3, experiments J, K 
and L) were run on a 10 mm/30 cm Superdex75 column to estimate if protein from different 
fractions differed in size. Purified D14C [Fe4S4] Pf Fd was run twice. The oxidized samples were 
loaded using a 250 µL superloop onto a 10 mm/30 cm Superdex75 column equilibrated with 0.15 
M NaCl in 20 mM Tris/HCl pH 8.0 and eluted using the same buffer. 
 
4.3 Results 
4.3.1 Expression and Purification of D14C Pf Fd 
The cells (section 4.2.1) had a light brown color. The yield was 5-10 mL cells per 650 mL culture.  
The experimental purification procedure for D14C Pf Fd is given in section 4.2.2 and summarized 
in Figure 4.2. During the HPLC operated steps, protein elution was monitored with a UV-detector 
at three wavelengths: 280 nm, 390 nm and 408 nm. 
Resuspension of the cells in buffer followed by cell lysis and centrifugation produced a brown 
supernatant. The initial anion exchange purification was not performed using HPLC and the 
brown colored protein was collected based on a visual estimation of its elution. Gel filtration of 
the protein solution on a HiLoad 26 mm/60 cm Superdex 75 column was carried out in several 
                                                           
2 Metalloprotein Chemistry and Engineering, Department of Chemistry, Technical University of Denmark. 
Current address: Dept. of Chemistry, The Pennsylvania University, University Park, PA 
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Figure 4.3: Chromatograms from purification of D14C Pf Fd on HiLoad 26 mm/60 cm Superdex 
75 column and on 16 mm/10 cm Source 30Q column. The collected fractions are marked with a 
black line. To the right is shown a UV-vis spectrum of purified D14C [Fe4S4] Pf Fd, the vertical line 
marks 390 nm. 
Addition of salt during the oxidation (experiment B) does not affect the chromatogram 
(Appendix C, Figure C.1) compared to Figure 4.1. Increasing the incubation time leads to an 
increase in the amount of protein in peak c and produces more irregular peaks. Chromatograms 
and UV-vis spectra from experiments C (15 min), D (45 min) and E (3 hours) are shown in 
Appendix C, Figure C.5. The UV-vis spectra show that after oxidation, the absorption maximum 
at 390 nm had moved towards 408 nm, while the curve was slightly flattened. 
Oxidation at pH 6.5 followed by anaerobic purification at pH 8.0 (experiment F, chromatogram 
shown in Appendix C, Figure C.6) increases the amounts of protein in peaks b and c. Oxidation at 
pH 7.8 as described by Duderstadt et al. [47] followed by ion exchange at pH 7.8 (experiment N) 
produces peak a and a broad, irregular peak c (Appendix C, Figure C.7). 
An increased amount of protein in peaks b and c is observed after EDTA addition (experiment G). 
Lowering the pH during the oxidation (experiment H) reduces peak b. The chromatograms and 
UV-vis spectra from experiments G and H are shown in Appendix C, Figure C.8. The UV-vis 
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spectra show the absorption maximum had a tendency to move towards 408 nm, but the curve 
was slightly flattened.  
Overnight incubation (experiments I and J) produces peak a and an irregular peak c. Experiment 
M is identical to experiment J, but the purification was performed at pH 5.8. A single peak at 
23.7 mS/cm is observed at pH 5.8. Chromatograms and UV-vis spectra are shown in Figure 4.4. 
The UV-vis spectra from experiments J and M show a more pronounced peak at 408 nm. In 
comparison, D14C [Fe4S4] Fd elutes at 25.6 mS/cm at pH 5.8. 
 
 
Figure 4.4: Oxidation of D14C Pf Fd; chromatograms and UV-vis spectra from experiment I, J and 
M. UV-vis spectra corresponding to the chromatograms are shown to the right. 
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The single peak at pH 5.8 from experiment M is also seen in experiments K at 25.1 mS/cm and 
25.6 mS/cm in a re-run (Figure 4.5), as well as in experiment L at 24.8 mS/cm (Appendix C, Figure 
C.9). Exchanging the protein from this peak into 20 mM Tris/HCl pH 8.0 and running the 
purification at pH 8.0 produces even amounts of protein in peak a and c, see Figure 4.5. In 
contrast, performing the purification at pH 8.0 under anaerobic conditions produces more 
protein in peak a compared with peak c. Experiment L shows that a re-run of the protein from 
pH 5.8 anaerobically at pH 8.0 increases the amount of protein in peak a compared with peak c 
(Appendix C, Figure C.9 bottom chromatogram). Experiment L also shows that mixing protein 
purified at pH 5.8 with [Fe4S4] protein increases the amount of protein in peak a compared with 
peak c (Appendix C, Figure C.9 second to bottom chromatogram). The UV-vis spectra show a 
tendency of the absorption maximum to move towards 408 nm after oxidation, except in the 
case where D14C [Fe4S4] Fd was added (Figure C.9, UV-vis second to bottom red spectrum). 
 
4.3.3 Molecular Weight Determination and EPR 
Samples of protein in peaks a, b and c from experiment G (chromatogram shown in Appendix C 
Figure C.8) were sent to molecular weight determination by mass spectrometry at Alphalyse A/S. 
Two additional samples of protein from peak c were also sent. The molecular weights of the 
protein in peaks a and b were 7503 Da and 7425 Da, respectively. No mass was determined for 
an intact metalloprotein in peak c because the samples were very heterogenous. The molecular 
weight determination by Alphalyse A/S of protein in peak b does not correspond to a calculated 
mass of D14C Pf Fd with an intact cluster. The calculated mass of D14C [Fe4S4]
2+ Pf Fd with an 
intramolecular disulfide bond is 7503 Da, which corresponds very well with the molecular weight 
determination by Alphalyse A/S of protein in peak a from experiment G (spectra shown in 
Appendix C, Figure C.10). 
A total of four samples were prepared for EPR analysis: EPR peak a sample contained protein 
from peak a (experiment J, Figure 4.4), while EPR peaks c sample contained protein from four c 
peaks: a mix from experiments K (re-run at pH 8.0 Figure 4.5 bottom chromatogram) and L (pH 
8.0 re-runs, three bottom chromatograms in Figure C.9, Appendix C). Both oxidized and reduced 
samples of protein in peak a and peaks c were measured. The spin of [Fe4S4]
+,2+ is 0 and ½ for the 
oxidized and reduced cluster, respectively, and the spin of [Fe3S4]
0,+ is ½ and 2 for the oxidized 
and reduced cluster, respectively. Thus, only the reduced [Fe4S4]
+ and the oxidized [Fe3S4]
+ 
clusters produce an EPR signal. EPR spectra are shown in Figure 4.6. The signal for both peaks c 
samples and the oxidized peak a sample are at g = 2.01, which is characteristic for [Fe3S4]
+ 
clusters [2]. The observed signal in the reduced peaks c sample could be caused by a residual 
amount of oxidized protein in the sample or by the sample being re-oxidized. The reduced peak 
a sample show no signal, which supports the presence of a [Fe3S4]
0 cluster. 
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Figure 4.5: Oxidation of D14C Pf Fd; chromatograms and UV-vis spectra from experiments K. 
Top: chromatogram from first purification at pH 5.8. Mid: aliquot of collected fractions from the 
top chromatogram re-run at pH 5.8. Bottom: aliquot of collected fractions from top 
chromatogram re-run at pH 8.0. 
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Figure 4.6: EPR spectra of EPR peak a sample and EPR peaks c sample; oxidized or reduced. 
Figure made by Hanne Nørgaard3, reprinted with permission. 
 
4.3.4 Resource Anion Exchange 
Purified D14C [Fe4S4] Pf Fd elute at 26.7 mS/cm from the 16 mm/3 cm ResourceQ column 
(chromatograms not shown). In comparison, protein from peak a from experiment A (Figure 4.1) 
elute at 27.7 mS/cm (Figure 4.7 top left); a difference of 1 mS/cm. A general trend is observed in 
the Resource chromatograms in Figure 4.7: one peak around the elution of D14C [Fe4S4] Fd and a 
peak eluting at a later point. Conductivities suggest these peaks are equivalent to peak a and c 
observed in Source 30Q runs. 
During experiment J, the oxidation process was left for incubation overnight followed by 
purification at pH 8.0 (Figure 4.4), peak a was collected and the protein re-run on the Resource 
column, top right chromatogram in Figure 4.7. It is seen, that the protein has rearranged and 
now elute significantly later. The oxidation process of experiment L had an incubation time of 3 
hours and was purified at pH 5.8. An aliquot was purified at pH 8.0 and protein from peak a 
(Appendix C, Figure C.9 second to the top) was loaded onto the ResourceQ column and re-run, 
bottom left chromatogram in Figure 4.7, which shows two peaks equivalent to peak a and c in 
even amounts. Another aliquot from the 5.8 purification was mixed with purified D14C [Fe4S4] 
Fdx and purified at pH 8.0 (Appendix C, Figure C.9 second to the bottom) and protein from peak 
a was re-run on the Resource column, bottom right chromatogram in Figure 4.7, which shows a 
major peak a and also peak c. 
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Figure 4.7: Chromatograms from re-runs on 16 mm/3 cm ResourceQ column. Top left: peak a 
from experiment A (Figure 4.1). Top right: peak a from experiment J (Figure 4.4). Bottom left: 
peak a from experiment L purified first at pH 5.8 and then at pH 8.0 (Appendix C, Figure C.9 
second to the top). Bottom right: peak a from experiment L purified first at pH 5.8 and then 
mixed with D14C [Fe4S4] Fd and re-run at pH 8.0 (Appendix C, Figure C.9 second to the bottom). 
 
4.3.5 Gel Filtration 
Protein from peaks a and c were run on a 10 mm/30 cm Superdex 75 gel filtration column in 
order to estimate if the proteins differ in size. Purified D14C [Fe4S4] Pf Fd was run for comparison 
(top left chromatogram in Figure 4.8), it elutes at 12.4 mL. Protein from peak a (experiment J) 
elutes at the same volume (bottom left chromatogram in Figure 4.8). Protein from four c peaks 
was mixed: experiments K (re-run at pH 8.0, Figure 4.5 bottom chromatogram) and L (pH 8.0 re-
runs, three bottom chromatograms in Appendix C, Figure C.9), the chromatogram from gel 
filtration is the top right part of Figure 4.8. Protein in these peaks c elute at 11.0 mL, which is 
earlier than protein from peak a and D14C [Fe4S4] Fd, indicating a larger protein size. The bottom 
right part of Figure 4.8 is protein from a peak that eluted later than peak c in experiment J 
(Figure 4.4) and it contains proteins with different sizes. 
The ratios of the absorbance at 390 nm and 408 nm are given for each peak in Figure 4.8. A ratio 
slightly greater than one is observed for D14C [Fe4S4] Fd, which is consistent with the UV-vis 
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spectrum (Figure 4.1). Ratios slightly below one is observed for protein in peak a and c, which is 
consistent with the tendency of the absorption maximum to move towards 408 nm upon 
oxidation. 
 
 
Figure 4.8: Chromatograms from gel filtration on a 10 mm/30 cm Superdex 75 column. Elution 
volumes in mL and the ratio A390/A408 are given for each peak. Top left: elution of D14C [Fe4S4] 
Fd. Top right: a mix of peaks c from experiments K and L (Figure 4.5 bottom chromatogram and 
Appendix C, Figure C.9 three bottom chromatograms). Bottom left: peak a from experiment J 
(Figure 4.4). Bottom right: late elution peak at 35.2 mS/cm from experiment J (Figure 4.4). 
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4.4 Discussion 
The objective of the experiments was to obtain D14C [Fe3S4] Pf Fd. The first attempt (section 
4.1.1) proved to contain D14C [Fe4S4] Fd as determined by X-ray diffraction. Purification of WT Pf 
Fd on a Source 30Q column produces two Fd peaks with an elution difference of 2 mS/cm; 
[Fe4S4] Fd elutes first followed by [Fe3S4] Fd [54]. D14C [Fe4S4] Pf Fd eluted at 25-26 mS/cm and 
the collected fractions of peak a, experiment A (Figure 4.1), eluted at 25.6 mS/cm. During the 
oxidation experiments, section 4.2.3, it was attempted to produce D14C [Fe3S4] Pf Fd with a UV-
vis spectrum with distinct [Fe3S4] cluster containing characteristics. 
EPR supports that protein in peak a from experiment J contained a [Fe3S4] cluster. This is in 
agreement with the UV-vis spectrum (Figure 4.4), which shows a significant peak at 408 nm. A 
more flattened UV-vis spectrum around wavelengths 390-408 nm is observed in experiment G 
(Appendix C, Figure C.8). Mass spectrometric analysis by Alphalyse supports the presence of 
D14C [Fe4S4] Pf Fd in experiment G peak a. The differences between preparations in experiment 
G and J is pH and incubation time; experiment G was carried out at pH 8.0 with 45 minutes 
incubation, while experiment J was carried out at pH 5.8 with overnight incubation. Low pH is 
thus preferable during oxidation. 
Purification at pH 5.8 produced a single peak in experiment M (Figure 4.4), experiments K (Figure 
4.5) and experiment L (Appendix C, Figure C.9). Elution of protein in these peaks were at the 
same conductivity as elution of purified D14C [Fe4S4] Pf Fd. UV-vis spectra at pH 5.8 strongly 
resembled a protein with a [Fe3S4] cluster with an absorption maximum at 408 nm and a 
shoulder around 340 nm. Collecting the protein at pH 5.8 and running it on a Source 30Q at pH 
8.0 produced two peaks in even amounts (peaks a and c, Figure 4.5). Protein from peak a 
rearranged to produce protein in peak c, since collecting protein from peak a and running it on a 
ResourceQ column produced both peaks (Figure 4.7 bottom left). Experiments L (Appendix C, 
Figure C.9) showed that anaerobic purification at pH 8.0 of an aliquot of protein oxidized and 
purified at pH 5.8 increased the amount of protein in peak a compared with peak c. Mixing D14C 
[Fe4S4] Fd with an aliquot oxidized and purified at pH 5.8 and purifying it at pH 8.0 also increased 
the amount of protein in peak a. In summary, [Fe4S4] and oxidized Fd (assumed [Fe3S4]) elute at 
the same conductivity at pH 5.8 in a single peak, and at pH 8.0 in peak a with an additional peak 
c. Anaerobic conditions favor protein elution in peak a, and the conversion of protein from peak 
a to peak c (Figure 4.7) appears to be an oxidative process. 
Oxidizing D14C [Fe4S4] Fd to D14C [Fe3S4] Pf Fd produces a free cysteine. In WT [Fe3S4] Pf Fd, the 
free residue is Asp14 [41], which corresponds to Cys14 in D14C Fd. The pKa of Cys14 was 
estimated using PROPKA [59,60] with structure coordinates of WT [Fe3S4] Pf Fd [41], where 
Asp14 was mutated to Cys using WinCoot [61,62]. pKa was estimated to 8.8, which is an increase 
compared with the normal Cys pKa of 8.3. At pH 5.8, the free cysteine is fully protonated and a 
single peak is observed during anion exchange. Protonation of the free cysteine can explain why 
the [Fe4S4] Fd and [Fe3S4] Fd elute at the same conductivity. The charges including ligands are 
identical: [Fe4S4(Cys-S
-)4]
2- and [Fe3S4(Cys-S
-)3(Cys-SH)]
2-. At pH 8.0, D14C [Fe3S4] Fd is only partly 
protonated and protein in peak a can thus be Fd with protonated Cys (elution at the same 
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conductivity as [Fe4S4] Fd), while protein in peak c can be related to the deprotonated Cys 
portion of [Fe3S4] Fd. This explains why re-running protein in peak a on a ResourceQ column 
produces two peaks: a and c (Figure 4.7). Gel filtration experiments support that protein in peak 
c is larger than protein in peak a (Figure 4.8). Protein in peak c can thus contain dimers, where a 
disulfide bond has formed between two deprotonated monomers. Such a dimer will be very 
flexible, as the two monomers have many possible orientations. This is consistent with peak c 
often appearing very irregular. The pH dependent equilibrium is illustrated in Figure 4.9. 
 
 
Figure 4.9: Bjerrum diagram illustrating the pH dependent equilibrium (pKa=8.8) of D14C [Fe3S4] 
Pf Fd between protonated and deprotonated monomers and formation of a disulfide bonded 
dimer. Two ferredoxin monomers were graphically connected to illustrate the dimer. The curve 
is an illustration, it does not reflect stability of the Fd in the given pH range. 
 
Mass spectrometric analysis by Maja Martic [63] verified the presence of D14C [Fe3S4]
+ Pf Fd as 
the protein in the single peak from purification at pH 5.8 from an experiment prepared in the 
same way as experiment M (Figure 4.4). Re-running the protein purified at pH 5.8 at pH 8.0 
produced two peaks (Figure 4.5) and mass spectrometric analysis on protein from a repetition of 
this experiment verified that the first peak contains D14C [Fe3S4]
+ Pf Fd, while the second peak 
contains a disulfide bonded dimer: D14C [Fe3S4 (Cys-S)-(S'-Cys') Fe'3S'4]
2+ Pf Fd. The apparent 
mass of the monomer was 7447.6 Da compared to a calculated mass of 7447.9 Da of D14C 
[Fe3S4]
+ Pf Fd with one intramolecular disulfide bond. The apparent mass of the disulfide bonded 
dimer was 14893.1 Da compared to a calculated mass of 14893.7 Da. For experimental details, 
see the article by Løvgreen et al. (2011) [64] (Appendix G). 
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4.5 Conclusion 
Cells expressing D14C [Fe4S4] Pf Fd were successfully cultivated and the Fd was purified. The 
yield of pure D14C [Fe4S4] Pf Fd was 14 mg/L cell culture. 
Purified D14C [Fe4S4] Pf Fd was oxidized with several variations in the experimental conditions. It 
proved difficult to separate D14C [Fe4S4] Fd from the oxidized D14C [Fe3S4] Fd as they have the 
same charge at low pH: [Fe4S4(Cys-S
-)4]
2- and [Fe3S4(Cys-S
-)3(Cys-SH)]
2-. The pKa value of the 
protonated cysteine, Cys14, is 8.8 and purifying the oxidized Fd at pH 5.8 is advantageous 
because the free cysteine is fully protonated. At pH 8.0, the free cysteine is partly deprotonated 
and able to form a disulfide bonded dimer.  
In summary, in order to obtain D14C [Fe3S4] Pf Fd, it is advisable to oxidize purified D14C [Fe4S4] 
Pf Fd at pH 5.8 and leave it overnight with ferricyanide at room temperature with gentle stirring. 
Purifying and storing the protein at pH 5.8 is preferred in order to avoid formation of a disulfide 
bonded dimer. D14C [Fe3S4] Pf Fd was formed by incubation of purified D14C [Fe4S4] Pf Fd 
overnight with 15x molar excess ferricyanide in 20 mM BisTris/HCl pH 5.8 and purification by 
anion exchange on a Source 30Q column at pH 5.8. 
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Chapter Five 
5 CRYSTAL STRUCTURES OF D14C PYROCOCCUS 
FURIOSUS FERREDOXIN 
5.1 Introduction 
Crystallization of D14C [Fe3S4] Pf Fd was very difficult due to solution inhomogeneity and results 
are described in section 5.3.1. The structure of D14C [Fe4S4] Pf Fd was solved prior to this 
project4. A structural description and discussions regarding the Fd electrochemical properties are 
included in results and discussion (section 5.3) and can be found in the article by Løvgreen et al. 
(2011) [64] (Appendix G). 
There are currently two reported crystal structures of [Fe3S4] ferredoxins with complete cysteine 
binding motifs (-Cys-X2-Cys-X2-Cys-Xn-Cys-): Desulfovibrio gigas (pdb 1FXD [65]) and Bacillus 
thermoproteolyticus (pdb 1WFT [66]). However, these structures both have additional chemical 
groups bound to protect the free cysteine, and the structure of D14C [Fe3S4] Pf Fd reported here 
is the first crystal structure of a ferredoxin in which a cysteine from a complete cysteine binding 
motif is unprotected and facing away from the cluster. 
 
5.2 Experimental 
5.2.1 Crystallization and X-Ray Data Collection 
The starting point of the crystallization trials of oxidized D14C Pf Fd was similar to the 
crystallization conditions of WT [Fe3S4] Pf Fd [43]. Several factors were varied during 
crystallization: protein concentration, buffer and pH, precipitant type and concentration, 
additives and protein:reservoir volume ratio. The crystal used for data collection was produced 
with protein collected from peak a in experiment J (Figure 4.4, page 18). The UV-vis spectrum is 
characteristic for a [Fe3S4] cluster containing Fd and EPR measurements strongly support the 
presence of a [Fe3S4] cluster (section 4.3.3). A total of 12 trays with up to 24 different reservoirs 
per tray and up to 3 drops per reservoir were set up. A complete set of all tested conditions is 
not provided here. Instead, a variety of crystallization conditions are available for picture entries 
in the enclosed database (Appendix A, Ferredoxin.xml, see Chapter 2 for a program description). 
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Crystals to be tested for diffraction were mounted in a loop and cryo-cooled directly in liquid 
nitrogen. Around 50 crystals were tested at MAX-lab in Lund, Sweden, at a number of visits, and 
data were collected to 2.8 Å at ESRF in Grenoble, France. Data collection statistics are shown in 
Table 5.1. Data collection and processing were performed by Pernille Harris with MOSFLM [67] 
and space group determination and averaging with Pointless and SCALA [68]. Indexing was only 
successful once and could not be reproduced. 
Table 5.1: Data collection statisticsa for D14C [Fe3S4] Pf Fd. 
Beamline ESRF, ID14-3 
Detector ADSC Quantum Q315r 
Wavelength (Å) 0.9765 
Temperature (K) 100 
Crystal space group P212121 
Unit cell parameters  
a (Å) 47.4 
b (Å) 49.8 
c (Å) 51.2 
Resolution (Å) 35.7-2.8 (2.95-2.8) 
No. of reflections 17,078 (2504) 
No. of unique reflections 3,254 (456) 
Redundancy 5.2 (5.5) 
Mosaicity (°) Fixed 0.8 
Completeness (%) 99.9 (99.9) 
I/σ(I) 3.6 (1.9) 
Rmerge 0.252 (0.755) 
a Values for the outermost resolution shell are given in parenthesis. 
Rmerge = Σi Ii – 〈Ii〉/ Σi Ii 
 
 
5.2.2 Structure Determination and Refinement 
The CCP4 [69] suite was used for structure determination and refinement. MOLREP [70] was 
used to solve the structure with molecular replacement. The search model was the peptide 
chain of molecule A D14C [Fe4S4] Pf Fd (pdb ID: 2Z8Q). Two molecules were found in the 
asymmetric unit. Molecular replacement was also carried out with the search model of molecule 
B D14C [Fe4S4] Pf Fd. The R factor and score after molecular replacement with molecule B were 
0.622 and 0.455, respectively, compared to 0.592 and 0.534 for molecule A, respectively. An 
increase in Rfree was observed during refinement when using molecule B compared with 
molecule A for molecular replacement. Molecule A of D14C [Fe4S4] Pf Fd is thus a considerably 
better model for molecular replacement than molecule B. Refinement was performed with 
REFMAC5 [71]. Inspection of the 2Fobs - Fcalc and the Fobs - Fcalc sigma-A weighted difference maps 
was done using winCoot [61,62]. Electron density appeared clearly from the [Fe3S4] cluster in 
each of the two molecules. Four Co atoms were added. Refinement statistics are given in Table 
5.2. The structure is available in the protein data bank with pdb entry code 1PNI. 
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Table 5.2: Refinement statistics. 
R 0.279 
Rfree 0.318 
No. of atoms in model  
Protein 988 
FeS clusters 14 
Cobalt atoms 4 
Mean temperature (B) factors (Å2)  
Protein chain A 39 
Protein chain B 39 
FeS cluster chain A 34 
FeS cluster chain B 28 
Ramachandran plot [72]  
No. of residues in favored region 116 
No. of residues in allowed region 12 
No. of residues in outlier region 0 
 
 
5.3 Results 
5.3.1 Crystallization and X-Ray Data Collection 
Crystals were difficult to grow and drops were generally inhomogeneous with a mixture of 
several combinations of phase separation, precipitation, protein films and crystalline clusters 
with very high mosaicity. Figure 5.1 shows some typical crystal clusters and phase separations of 
D14C [Fe3S4] Pf Fd. At pH below 7, where a homogeneous solution of monomers is expected, 
grey precipitation generally occurred indicating that the ferredoxin had lost its iron-sulfur 
cluster. An elaborate summary of crystallization results can be found in the enclosed database 
(Appendix A, Ferredoxin.xml, see Chapter 2 for a program description) that includes 461 picture 
entries with matching crystallization conditions. 
Diffraction patterns revealed several crystals with poor diffraction to around 7 Å as well as 
several salt crystals when ammonium dihydrogen phosphate was used as an additive. Data were 
collected to 2.8 Å on ESRF in Grenoble on one of the crystals shown in Figure 5.2. Crystallization 
conditions were 35 % PEG1500 in 100 mM Tris/HCl pH 8.5. The drop contained 2 µL protein with 
a concentration of 6.4 mg/mL, 2 µL reservoir solution and 0.3 µL 100 mM [Co(NH3)6]Cl3.  
 
5.3.2 Structure of D14C [Fe4S4] Pf Fd 
This section briefly outlines significant differences between two molecules, type A and B, in the 
asymmetric unit of D14C [Fe4S4] Pf Fd (pdb 2Z8Q). A more detailed description of the structure is 
part of the article by Løvgreen et al. (2011) [64] (Appendix G).  
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Figure 5.1: Crystal clusters of D14C [Fe3S4] Pf Fd. Grid spacing is 0.125 mm on the top three 
pictures and 0.089 mm on the bottom two pictures. 
 
 
Figure 5.2: Crystal clusters of D14C [Fe3S4] Pf Fd. The small brown spheres are phase separations 
and the light brown background is a film that crackles when touched. Grid spacing is 0.125 mm. 
 
Differences between molecules A and B of D14C [Fe4S4] Pf Fd can be related to the crystal 
packing and the conformation of the intramolecular disulfide bond. Molecule A packs as an 
extended β-sheet dimer with an adjacent A molecule, see Figure 5.3A, while molecule B packs as 
monomers in a less rigid position, see Figure 5.3B. Also, molecule B shows significantly larger B 
factors (18Å2) compared with molecule A (7.5 Å2), which may be related to the much more 
flexible position of the molecules in the crystal packing.  
D14C [Fe4S4] Pf Fd has an intramolecular disulfide bond connecting Cys21 and Cys48. This 
disulfide bond is found in a double conformation in molecule A and in a single conformation in 
molecule B. WT [Fe3S4] Pf Fd also displays a double conformation of the disulfide bond [41], 
albeit with a shift in occupancy compared with molecule A of D14C [Fe4S4] Pf Fd. The single 
conformation of the disulfide bond in molecule B is possible due to an approximately 1 Å shift of 
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α-helix 2 accompanied by a displacement of the backbone at Asp42, Glu43 and Glu44, see Figure 
5.3C.  
In general, molecule A shows greater resemblance to WT [Fe3S4] Pf Fd than to molecule B from 
the same asymmetric unit when comparing molecule packing, hydrogen bonds and 
intramolecular disulfide bond conformation. Superposing the A and B molecules of D14C [Fe4S4] 
Pf Fd gives an RMS deviation of 0.8 Å, while superposing molecule A and B onto WT [Fe3S4] Pf Fd 
gives RMS deviations of 0.3 Å and 0.8 Å, respectively. RMS deviations were calculated using the 
program superpose [73].  
 
 
Figure 5.3: D14C [Fe4S4] Pf Fd molecule A shown in cyan, molecule B shown in red. A: crystal 
packing of two molecules A as an extended β-sheet dimer. B: crystal packing of molecules A and 
B. C: overlay of molecule A and B of D14C [Fe4S4] Pf Fd, disulfide bonds and clusters are shown in 
ball and stick. 
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5.3.3 Structure-reduction potential relationship 
A sequence alignment of Pf Fd with related ferredoxins is given in Figure 5.4. Related ferredoxins 
were selected based on similarity and availability of crystal structures with an intact [Fe4S4] 
cluster. The cluster environment show a high degree of structural integrity, see Figure 5.5, even 
though there are different residues between the cysteines in the binding motif -Cys-X2-Cys-X2-
Cys-X2-Cys-Xn-Cys-. 
Sγ of the second cysteine in the coordination motif (Cys14 in Pf Fd) is the least buried atom of 
the [Fe4S4] cluster including ligands [22] and solvent accessibilities of these atoms are given in 
Table 5.3 for [Fe4S4] ferredoxins from D14C Pf, Thermotoga maritima, Desulfovibrio africanus I 
and Bacillus thermoproteolyticus along with reduction potentials of the ferredoxins. In 
agreement with the literature [21-23], a correlation is seen where less buried [Fe4S4] clusters 
have higher reduction potentials. Table 5.3 also lists the N-H···S bonds of Sγ of cluster 
coordinating cysteines, which has been discussed in the literature to have an influence on the 
reduction potential of [Fe4S4] clusters [22,24]. The ferredoxins have equal numbers of bonds 
with comparable distances. A shift is seen in the reduction potential of D14C versus WT Pf Fd as 
the D14C Fd has a more negative reduction potential in its [Fe4S4] form and a more positive 
reduction potential in its [Fe3S4] form when it is compared with WT Pf Fd, see Table 5.3. 
Changing a cluster coordinating aspartate to cysteine in ferredoxin III from D. africanus also 
results in a more negative reduction potential in the [Fe4S4] form and a more positive reduction 
potential in the [Fe3S4] form [31]. For the [Fe4S4] cluster containing ferredoxins this can be 
explained by aspartate being a better electron withdrawing group than cysteine [50]. For the 
[Fe3S4] cluster containing ferredoxins it can be explained by the pKa difference between 
aspartate and cysteine; aspartate is completely deprotonated while cysteine is partly protonated 
and the increased charge density of the WT ferredoxin with a free aspartate results in a lower 
reduction potential in the [Fe3S4] form compared with the D14C ferredoxin with a free (partly 
protonated) cysteine near the cluster.  
 
D14C P.furiosus  MAWKVSVDQDTCIGCAICASLCPDVFEMNDEGKAQP----KVEVIEDE-ELYNCAKEAME 
T.maritima       --MKVRVDADACIGCGVCENLCPDVFQLGDDG--------KAKVLQPE-TDLPCAKDAAD 
D.africanus I    MARKFYVDQDECIACESCVEIAPGAFAMDPEIE-------KAYVKDVEGASQEEVEEAMD 
B.thermoprot.    -PKYTIVDKETCIACGACGAAAPDIYDYDEDGIAYVTLDDNQGIVEVPDILIDDMMDAFE 
 
D14C P.furiosus  ACPVSAITIEEA---------- 
T. maritima      SCPTGAISVEE----------- 
D. africanus I   TCPVQCIHWEDE---------- 
B.thermoprot.    GCPTDSIKVADEPFDGDPNKFE 
 
Figure 5.4: Sequence alignment of ferredoxins from D14C Pf, T. maritima, D. africanus I and B. 
thermoproteolyticus. All cysteines are highlighted in yellow, cluster coordinating cysteines are 
shown in black and cysteines forming an intramolecular disulfide bond are shown in green. 
Conserved residues are shown in red. Sequence alignment was made using ClustalW [74] with 
sequence information from UniProt [75,76]. 
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Figure 5.5: Structural overlay of ferredoxins with a [Fe4S4] cluster. D14C Pf molecule A (pink, pdb 
2Z8Q), D. africanus I (yellow, pdb 1FXR), T. maritima (blue, pdb 1VJW) and B. 
thermoproteolyticus (green, pdb 1IQZ). The cluster and cysteines from the -Cys-X2-Cys-X2-Cys- 
segment are shown. 
 
Table 5.3 Solvent accessibility of Sγ of the second cluster coordinating cysteine, number of N-
H···S bonds to Sγ of cluster coordinating cysteines and their average distances (Å) and reduction 
potentials of ferredoxins.  
 PDB 
code 
Reduction 
potential 
Solvent 
accessibility of 
second Cys Sγ 
No. of N-H···S 
(average 
distance Å) 
[Fe4S4] ferredoxin:     
P. furiosus * -368 mV [50]   
D14C P. furiosus  2Z8Q [64] -427 mV [50] A/B: 0/0 A/B: 10/10 
(3.40/3.44) 
T. maritima 1VJW [77] -388 mV [78] 0.6 10 (3.47) 
D. africanus I 1FXR [79] -385 mV [80] 0.1 10 (3.58) 
B. thermoproteolyticus 1IQZ [81] -280 mV** [82] 3.9 10 (3.49) 
 
[Fe3S4] ferredoxin: 
    
P. furiosus 1SJ1 [41] -203 [50]   
D14C P. furiosus 3PNI [64] -155 mV [63]   
* No structure is available for Pf [Fe4S4] Fd 
** Reduction potential is for the very closely related Bacillus stearothermophilus ferredoxin 
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5.3.4 Structure of D14C [Fe3S4] Pf Fd 
The resolution of the solved structure of D14C [Fe3S4] Pf Fd is inadequate to make detailed 
comparisons. However, the overall structure of D14C [Fe3S4] Pf Fd is very similar to both WT 
[Fe3S4] Pf Fd and molecule A of D14C [Fe4S4] Pf Fd, with RMS deviations of 0.4 Å and 0.5 Å, 
respectively. Less similarity is seen with molecule B of D14C [Fe4S4] Pf Fd, which shows an RMS 
deviation of 0.8 Å. RMS deviations were calculated using the program superpose [73]. 
Electron density clearly shows the presence of a [Fe3S4] cluster, in agreement with UV-vis (Figure 
4.4, page 18) and EPR (section 4.3.3). Figure 5.6 shows two views of the cluster environment of 
D14C [Fe3S4] Pf Fd with a 2Fobs – Fcalc σ = 1.3 electron density map. 
Crystal packing is seen as extended β-sheet dimers in the structures of D14C [Fe3S4] Pf Fd, WT 
[Fe3S4] Pf Fd and in molecule A of D14C [Fe4S4] Pf Fd. The overall crystal packing is very similar for 
D14C [Fe3S4] Pf Fd and WT [Fe3S4] Pf Fd, see Figure 5.7, even though the space groups differ. 
Dimerization of WT Pf Fd has been proposed to occur depending on ionic strength [44,45]. 
Although extended β-sheet dimers are observed in the crystal structures, these dimers have not 
been observed in solution (Chapter 4) and could be an artifact of the high protein concentration 
in the crystal. 
Crystals of D14C [Fe3S4] Pf Fd were grown at pH 8.5 (section 5.3.1) and although both monomers 
and disulfide bonded dimers should be present at this pH (Chapter 4), no disulfide bonded 
dimers are seen in the crystal structure. Crystallization of monomers is likely to be favored 
because of the large flexibility expected around the intermolecular disulfide bond in the dimer. 
 
 
Figure 5.6: Two views of D14C [Fe3S4] Pf Fd with 2Fobs – Fcalc σ = 1.3 electron density map.  
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Figure 5.7: A: Two views of WT [Fe3S4] Pf Fd crystal packing including hexaaminecobalt(III) 
complexes. B: two views of D14C [Fe3S4] Pf Fd crystal packing including cobalt atoms. 
 
5.4 Conclusion 
Crystallization of D14C [Fe3S4] Pf Fd was very difficult and numerous crystallization conditions 
were tested. Small crystals or crystalline clusters only formed at pH 8.5 where the protein 
solution is very inhomogeneous (Chapter 4). Data were collected to 2.8 Å resolution and the 
crystal structure of D14C [Fe3S4] Pf Fd was solved. Close resemblance is seen between monomers 
of WT [Fe3S4], D14C [Fe3S4] and D14C [Fe4S4] molecule A, whereas D14C [Fe4S4] molecule B show 
some differences that can be related to the differences seen in the intramolecular disulfide bond 
conformation and crystal packing. Crystal packing as extended β-sheet dimers is seen for WT 
[Fe3S4], D14C [Fe3S4] and for adjacent A molecules of D14C [Fe4S4] Pf Fd. In contrast, D14C [Fe4S4] 
molecule B packs as monomers next to the extended β-sheet dimers formed between adjacent A 
molecules. The conformations of the highly conserved cysteines in the [Fe4S4] binding motif (-
Cys-X2-Cys-X2-Cys-Xn-Cys-) are in close resemblance. 
The crystal structure of D14C [Fe3S4] Pf Fd is the first structure in which a [Fe3S4] containing 
ferredoxin with a complete cysteine binding motif has an unprotected cysteine facing away from 
the cluster. 
 37 
Chapter Six 
6 SELECTED ENZYMES INVOLVED IN 
DEOXYRIBONUCLEOTIDE SYNTHESIS 
6.1 Introduction to deoxyribonucleotide synthesis 
Nucleotides are essential for cell growth because they are necessary for replication and 
transcription of the genome. The building blocks for RNA are ribonucleotides, while the building 
blocks for DNA are deoxyribonucleotides. The building blocks consist of a purine or pyrimidine 
base linked to a sugar (RNA: β-D-ribose, DNA: β-D-deoxyribose) and a phosphate group. 
Nucleotides are able to interconvert between mono-, di- and triphosphates. In RNA, the base 
can be adenine, guanine, uracil or cytosine, whereas in DNA, thymine replaces uracil. This 
replacement in DNA prevents mutagenesis as a result of spontaneous deamination of cytosine to 
uracil, which pairs with adenine instead of guanine. A DNA repair system recognizes uracil to be 
foreign in DNA [83]. 
Deoxyribonucleotides are all, except dTTP, synthesized from their corresponding ribonucleotide, 
a reaction catalyzed by ribonucleotide reductase. Instead, dTTP is synthesized from dUMP, see 
Figure 6.1 for a schematic overview. dUMP is first methylated to form dTMP, which is then 
phosphorylated forming dTDP and phosphorylated again forming dTTP. dUMP is thus an 
important precursor in the formation of dTTP to be used for DNA synthesis. Different pathways 
exist for synthesis of dUMP: it can originate from a uracil base or it can be formed by 
deamination of a cytosine base as illustrated in Figure 6.1.  The majority of dUMP is formed 
through deamination of the cytosine base either by deamination of dCTP followed by 
dephosphorylation or by deamination of dCMP [84].  
Recently, a bifunctional enzyme was discovered that catalyzes both the deamination and 
dephosphorylation of dCTP thereby forming dUMP directly; Figure 6.2 shows the reaction. The 
bifunctional enzyme dCTP deaminase-dUTPase (DCD-DUT) has been found in the bacterium 
Mycobacterium tuberculosis (Mt) [85] and in the archaea Methanocaldococcus jannaschii (Mj) 
[86,87]. dTTP inhibition is observed for enzymes with dCTP deaminase activity as illustrated in 
Figure 6.1 and Figure 6.2. This chapter presents structures, inhibition, catalytic mechanisms and 
details on important residues for activity of the bifunctional enzymes as well as the 
monofunctional enzymes dCTP deaminase (DCD) and dUTPase (DUT). For keeping track of the 
numbering of key residues across organisms discussed in the remaining sections of this chapter, 
refer to Table 6.1 for an overview. 
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Figure 6.1: Schematic view of pathways for deoxyribonucleotide synthesis. Annotations: 
enzymes in italic, DNA building blocks in blue, dTTP inhibition as red arrows, dTTP activation as 
green arrow. 
 
 
Figure 6.2: Schematic view of reactions catalyzed by dCTP deaminase, dUTPase and the 
bifunctional enzyme dCTP deaminase-dUTPase. dTTP is shown and dotted arrows illustrate the 
inhibition by dTTP on dCTP deaminase and dCTP deaminase-dUTPase. Differences between 
nucleotides are highlighted in red. 
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Table 6.1: Numbering of key residues in dCTP deaminase-dUTPase (DCD-DUT) from M. 
tuberculosis (Mt), M. jannaschii (Mj), monofunctional dCTP deaminase (DCD) from E. coli (Ec) 
and monofunctional dUTPase (DUT) from Mt and Ec. Residues involved in the DCD and DUT 
reactions are colored green and red, respectively, and the absolutely conserved serine is shown 
in blue. 
Mt 
DCD-DUT 
Mj 
DCD-DUT 
Ec 
DCD 
Mt 
DUT 
Ec 
DUT 
His112 His128 His121 Val76 Gly83 
Gly116 Gly132 His125 Gly80 Gly87 
Ser102 Ser118 Ser111 Ser65 Ser72 
Arg106 Arg122 Arg115 Thr69 His76 
Ala115 Ala131 Ala124 Pro79 Val86 
Glu129 Glu145 Glu138 Ala93 Ser100 
Asp119 Asp135 Asp128 Asp83 Asp90 
Gln148 Gln163 Ala157 Gln113 Gln119 
 
6.2 dCTP deaminase  
dCTP deaminase catalyzes the deamination of dCTP thereby forming dUTP, see Figure 6.2. The 
structure of dCTP deaminase is a trimer with three active sites, each of which is composed of 
residues from two subunits of the trimer [88]. 
Kinetic studies show that the true substrate is dCTP⋅Mg2+ [89]. This is in agreement with the 
structure of dCTP deaminase from E. coli with bound reaction product, dUTP (pdb 1XS1), as well 
as with the structures of the E138A enzyme with bound substrate, dCTP (pdb 1XS4), or product, 
dUTP (pdb 1XS6). The structures all have a magnesium ion octahedrally coordinated to the α-, β- 
and γ-phosphate of the nucleotide and three water molecules. The magnesium ion does not play 
a catalytic role, but it is important for structurally arranging the nucleotide phosphates and for 
shielding their negative charge, thereby allowing the C-terminal to close over the active site 
nucleotide-Mg2+ complex [88]. 
Two suggestions regarding the catalytic mechanism of dCTP deaminase have been made, both of 
which involve a nucleophilic attack on the pyrimidine ring of dUTP by an activated water 
molecule [88]. The starting point of the reaction is based on the crystal structure of Ec DCD with 
dUTP bound (pdb 1XS1). Two hydrogen bonds (from Val136 and Gln182 to the pyrimidine ring of 
dUTP) anchor and orient the nucleotide pyrimidine ring upon binding to the active site. One 
water molecule in the active site is held in place by hydrogen bonds to Glu138, Ala124 and 
Ser111 and is activated by Glu138, see Figure 6.3A. Also, both mechanisms involve the release of 
ammonia and the completely conserved residues Glu138, Ala124 and Ser111, which are crucial 
for activity based on mutational studies [88,90].  
dCTP deaminase can exist in two conformations: an active stabilized by substrate binding and an 
inactive stabilized by dTTP binding to the active site [91]. In the structure of E138A Ec DCD in 
complex with dTTP (pdb 2J4Q), amino acid residues 120-125 rearrange in the dTTP complex 
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compared with the dCTP and dUTP complexes. Furthermore, the entrance to the active site in 
the dTTP complex site is partly collapsed, as the region of α-helix 2 and β-strand 5 moves 
towards the active site in the absence of an ordered C-terminal fold. The nucleophilic water 
molecule, positioned between Glu138 and Ala124 in the dCTP and dUTP structure [88], appears 
to be expelled in the dTTP structure by the side chain of His121. Additionally, the side chains of 
Val122 and Thr123 in the dTTP structure move to new positions. The side chains of Val122 from 
one subunit and Thr123 from a neighboring molecule are likely to clash in the center of the 
trimer unless the subunits all are in the same conformation. Changing His121 to alanine results 
in a loss of activity, and the structure of H121A:dCTP almost superimposes with the E138A:dTTP 
complex in the region of residues 120-125. Both structures also have disordered C-terminals. 
These structural agreements support that the enzyme is inhibited through a change to an 
inactive conformation [91].  
 
6.3 dUTPase 
dUTPase catalyzes the hydrolysis of dUTP to dUMP. Depletion of toxic concentrations of dUTP in 
the cell is crucial to keep uracil out of DNA [92]. dUTPases have been well studied, since drugs 
designed for specific inhibition of dUTPase can be used for treatment of e.g. cancers, retroviral 
infections and tuberculosis [93,94]. Consequently, several structures of dUTPases from different 
organisms are available. Human dUTPase [95], bacterial (Ec [96] and Mt [93]) dUTPases and viral 
dUTPases (feline immunodeficiency [97] and equine infectious anaemia virus [98]) are trimeric 
enzymes with three active sites at the subunit interfaces. All subunits contribute to each binding 
site as the C-terminal extends to cover the opposite binding site. The C-terminal loop is essential 
for catalysis, as removal or point mutation of important residues in the motif results in a loss of 
activity [99,100]. dUTPase requires Mg2+ for the reaction to take place [99]. Mg2+ is octahedrally 
coordinated to the α-, β- and γ-phosphate of the nucleotide and three water molecules, which 
are held in place in the active site by hydrogen bonds to conserved active site residues Asp24, 
Asp28 and Arg140 in Mt dUTPase [93]. It has been proposed that Mg2+ plays a key role in 
ordering the C-terminal loop, both by direct coordination to the γ-phosphate and through a 
bifurcated hydrogen bond between the γ-phosphate and Arg140 [93]. 
In Mt dUTPase, a water molecule is positioned for a direct in-line nucleophilic attack and held in 
place by hydrogen bonds to the conserved residues Asp83 and Gln113. Asp83 can act as a 
general base for the water molecule by abstracting a proton, which results in a nucleophilic 
hydroxide ion. A hydrogen bond from Gln113 to the remaining hydrogen helps direct the 
electron lone pair of the water oxygen toward the α-phosphorous, see Figure 6.3B. The 
pyrophosphate leaving group is stabilized by hydrogen bonds to Gly66 and Arg64 as well as by a 
bifurcated hydrogen bond to Arg140. Negative charge on the α-β bridging oxygen can be 
stabilized by a hydrogen bond to a strictly conserved hydroxyl side group of Ser65 [93,101]. Point 
mutations of the conserved aspartate, acting as a general base (Asp84) in human endogenous 
retrovirus, and of the conserved serine in E. coli (Ser72), cause complete loss or great reduction 
of activity and thus emphasize the importance of these residues [94,102]. 
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Figure 6.3: Schematic reaction starting points of: A: dCTP deaminase reaction based on the 
structure of Ec DCD [88], shown in red are the catalytic water oxygen and the amine group, 
which is replaced to expel ammonia. B: dUTPase reaction based on the structure of Mt dUTPase 
[93], shown in red are the nucleophilic hydroxide ion and the oxygen bridging the α-β-
phosphorous, on which negative charge is formed during the course of the reaction.  
 
6.4 dCTP deaminase-dUTPase 
The bifunctional dCTP deaminase-dUTPase catalyzes deamination of dCTP and hydrolysis of 
dUTP to form dUMP and is inhibited by dTTP. The bifunctional enzyme is found in M. jannaschii 
[86,87,103] and in M. tuberculosis [85]. The two reactions are tightly coupled in the bifunctional 
enzymes and no dUTP is released during the course of the reaction. The enzymes are 
homotrimeric with three active sites consisting of residues from two subunits and require Mg2+ 
for activity. Residues important for dCTP deamination (section 6.2) are Ser102, Arg106, Ala115 
and Glu129 in Mt DCD-DUT, which are conserved amongst enzymes with dCTP deamination 
activity. Residues important for dUTPase activity (section 6.3) in Mt DCD-DUT are Ser102, 
Asp119 and Gln148, which are conserved amongst enzymes with dUTPase activity. Glu129 
corresponds to Glu145 in Mj DCD-DUT and changing this residue to Gln causes a complete lack 
of deaminase activity, while retaining 25 % dUTPase activity. Asp119 corresponds to Asp135 in 
Mj DCD-DUT and changing this residue to Asn causes a complete loss of activity [87]. DCD-DUT 
from Mt shows a higher affinity for dUTP compared with DCD-DUT from Mj [85], albeit the 
activity is still between 10- and 100-fold less than monofunctional dUTPases [99,104]. The 
reaction rate (kcat) of the DUT reaction of Mt DCD-DUT is twice that of the bifunctional reaction, 
i.e. with dCTP as substrate, indicating deamination is rate limiting in the DCD-DUT reaction [85].  
The crystal structure of Mt DCD-DUT:dTTP (pdb 2QXX) shows the pyrimidine moiety of dTTP 
forming hydrogen bonds with Arg106, Gln174, Thr127 and two water molecules. A magnesium 
ion is coordinated to the α-, β- and γ-phosphate of the nucleotide and three water molecules in 
an octahedral coordination sphere. The triphosphoryl is hydrogen bonded to Lys101, Ser102, 
Ser103, and Gln148 as well as to Tyr162 and Lys170 from the C-terminal lid covering the binding 
site. This lid is disordered in the apo structure of Mt DCD-DUT (pdb 2QLP). Another difference 
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between the apo and dTTP structures is a rearrangement of residues 109
of these residues determines whether the enzyme is in its active or inactive conformation. 
Binding the inhibitor dTTP causes the enzyme to adopt the i
conformation of the key residues for catalytic activity is unchanged in the two conformations 
and the inability to cleave dTTP has been attributed to the lack of a key water molecule near 
Ala115 in the structure of Mt DCD
The crystal structure of DCD-DUT from 
variant, pdb 2HXD) shows the same conformation of the flexible region near the nucleotide 
binding side as Ec DCD with dUT
interacts with the nucleotide phosphate moiety, which is held in place by coordination to Mg
whereas the C-terminal is disordered in the structure of apo 
conformational change is observed when substrate binds to the enzyme, which is in agreement 
with a mechanism where the enzyme exists in an active and inactive form and substrate binds to 
the active form of the enzyme [105]
 
6.5 Structural Comparison of the Enzymes
There is a high sequence and structural similarity between DCD, DCD
structures are trimeric with active sites placed on the interfaces between molecules. 
DUT shows a greater similarity w
Figure 6.4 shows a structural overlay of monomers from the three enzymes illustrating the
structural similarities and differences. A main structural diff
DUT is the C-terminal lid. In the DUT enzyme, the lid reaches across the monomer to form active 
sites composed of residues from all three subunits, whereas the active site in the bifunctional 
enzyme consists of residues from two neighboring subunits.
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Figure 6.4: Ribbon view of structural overlay of 
DUT:dUMPNPP (blue, pdb 1SIX), Mt
(red, pdb 2QXX) and Ec DCD:dUTP (green, pdb 1XS1) 
with nucleotides shown in respectively colored sticks. 
The view is perpendicular to the 3-fold rotation axis. 
Arrows point to the close resemblance of the DCD 
(green) and DCD-DUT (red) structures, while the DUT 
(blue) structure shows some more variation.
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Alignment based on structure and sequence is given in Figure 6.5 for the two bifunctional 
enzymes from Mj and Mt and the monofunctional Ec DCD and DUT from various sources.  The 
two bifunctional enzymes include conserved residues important for both dCTP deaminase and 
dUTPase activity as described in section 6.4 and the monofunctional Ec DCD shows a key 
mutation at Ala157, which is a Gln in the structures with DUT function. Gly116 in Mt DCD-DUT 
has been suggested to be important in bifunctional enzymes [85] and is seen to be conserved 
also in enzymes with DUT activity.  
 
2QXX     1 MLLSDRDLRAEISSGRLGIDP.....FDD.T..LVQ..PSSIDVRLDCLFRVFNNTRYTHID  
2HXD     1 MILSDKDIIDYVTSKRIIIKP.....FNK.D..FVG..PCSYDVTLGDEFIIYD...DEVYD  
1XS1     1 MRLCDRDIEAWLDEGRLSINP.....RPPVE..RIN..GATVDVRLGNKFRTFRGHTAAFID  
1SIX     1 MSTT............LAIVRLDPGLPLP.S..RAHDGDAGVDLYSAE..............  
3P48     1   KV............LKIQLRSASATVP.T..KGSATAAGYDIYASQ..............  
3EHW     1   MQ............LRFARLSEHATAP.T..RGSARAAGYDLYSAY..............  
2XCE     1 T.MQ............IKIKYLDETQTRI.SKIE...QGDWIDLRAAE..............  
2OKE     1    P............VRFVKETNRAKSP.T..RQSPGAAGYDLYSAY..............  
1F7N     1                 MIIEG.....DGI.L..DKRSEDAGYDLLAAK..............  
 
2QXX    53 PA.....KQ..QDELTS.LVQPVDGEPFVLHPG.......................EFVLGS  
2HXD    50 LS.....KE..L..NYK.RIKIK..NSILVCPLNYNLTEEKINYFKEKYNVDYVVEGGVLGT  
1XS1    54 LSGPKDEVSAALDRVMSDEIVLDEGEAFYLHPG.......................ELALAV  
1SIX    34 ..........................DVELAPG.......................RRALVR  
3P48    32 ..........................DITIPAM.......................GQGMVS  
3EHW    32 ..........................DYTIPPM.......................EKAVVK  
2XCE    32 ..........................DVTIKKD.......................EFKLVP  
2OKE    31 ..........................DYTIPPG.......................ERQLIK  
1F7N    25 ..........................EIHLLPG.......................EVKVIP  
 
                             U                 U  
                             C   C         C                C  
2QXX    84 TLELFTLPDNLAGRLEGKSSLGR.LGLLTHSTAGFIDPGFS...GHITLELSNVA.NLPITL  
2HXD   100 TNEYIELPNDISAQYQGRSSLGR.VFLTSHQTAGWIDAGFK...GKITLEIVAFD.K.PVIL  
1XS1    93 TLESVTLPADLVGWLDGRSSLAR.LGLMVHVTAHRIDPGWS...GCIVLEFYNSG.KLPLAL  
1SIX    47 TGVAVAVPFGMVGLVHPRSGLATRVGLSIVNSPGTIDAGYR...GEIKVALINLDPAAPIVV  
3P48    45 TDISFTVPVGTYGRIAPRSGLAVKNGIQTGA..GVVDRDYT...GEVKVVLFNHS.QRDFAI  
3EHW    45 TDIQIALPSGCYGRVAPRSGLAAKHFIDVGA..GVIDEDYR...GNVGVVLFNFG.KEKFEV  
2XCE    45 LGVAMELPEGYEAHVVPRSSTYKNFGVIQTNSMGVIDESYKGDNDFWFFPAYAL...RDTEI  
2OKE    44 TDISMSMPKFCYGRIAPRSGLSL.KGIDIGG..GVIDEDYR...GNIGVILINNG.KCTFNV  
1F7N    38 TGVKLMLPKGYWGLIIGKSSIGS.KGLDVLG..GVIDEGYR...GEIGVIMINVS.RKSITL  
 
                  U  
2QXX   141 WPGMKIGQLCMLRLTSPSEHPYGSSRAGSKYQGQRGPTPSRSYQNFIRS  
2HXD   156 YKNQRIGQLIFSKLLSPADVGYSERK.TSKYAYQKSVMPSLIHLD      
1XS1   150 RPGMLIGALSFEPLSGPAVRPYNRRE.DAKYRNQQGAVASRIDKD      
1SIX   106 HRGDRIAQLLVQRVEL.VELVEVSSFDEAGLASTSRGDGG           
3P48   101 KKGDRVAQLILEKIVDDAQIVVVDSLE                        
3EHW   101 KKGDRIAQLICERIFY.PEIEEVQAL.....DDTERGSGGFGSTGKN    
2XCE   104 KKGDRICQFRIMKKMPAVELVEVEHL                         
2OKE    99 NTGDRIAQLIYQRIYY.PELEEVQSL                         
1F7N    93 MERQKIAQLIILPCKH.EVLEQGKVV                         
 
Figure 6.5: Alignment based on sequence and structure using STRAP [106,107] on DCD-DUT from 
Mt (pdb 2QXX) and Mj (pdb 2HXD excl. mutation), Ec DCD (pdb 1XS1) and DUT from Mt (pdb 
1SIX), Saccharomyces cerevisiae (pdb 3P48), human (pdb 3EHW), Bacillus subtilis (pdb 2XCE), 
Vaccina virus (pdb 2OKE) and feline immonodeficiency virus (pdb 1F7N). C marks residues 
important for deamination and U marks residues important for dephosphorylation. 
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Chapter Seven 
7 MYCOBACTERIUM TUBERCULOSIS DCTP DEAMINASE-
DUTPASE: MUTATIONAL BACKGROUND AND 
EQUATIONS FOR KINETIC STUDIES 
7.1 Structural reasoning behind the mutational study 
The bifunctional Mt DCD-DUT enzymes are inhibited by dTTP, which is structurally very similar to 
the substrates and binds to the active site of the enzyme. The additional 5-methyl group of dTTP 
induces a structural reorganization near the active site of the enzyme. The inhibition is not fully 
relieved by an increase in substrate concentration suggesting a noncompetitive mechanism [85]. 
The residues involved directly in catalysis do not, however, rearrange in the active and inactive 
forms of the enzyme. Helt et al. ascribed the lack of dTTP hydrolysis to a water molecule, which 
was expelled from the WT structure with dTTP bound (pdb 2QXX) because of the Ala115 side 
chain [85]. This forms the basis of the mutational study presented here. The reasoning behind 
the A115V variant is that an increase in size of the side chain will prevent dTTP from binding 
because of a steric clash of V115 with the 5-methyl group of dTTP thereby leaving the enzyme 
unaffected by the presence of dTTP. The reasoning behind the A115G variant is an attempt to 
dephosphorylate dTTP. With dTTP bound, Gly115 would allow enough space for the water 
molecule suggested to be crucial for activity. 
 
7.2 Steady state kinetics 
Equations important for data treatment of steady state kinetic experiments are listed in this 
section. The Michaelis-Menten equation (7.1) is a central expression for steady state enzyme 
kinetics and is applied when the reaction rate, v, has a hyperbolic dependence of the substrate 
concentration, [S]. 
      	
  	
  (7.1) 
 
Km is the substrate concentration that results in half maximal reaction rate, Vmax (at [S] = KM, v = 
Vmax/2). The rate constant, kcat, reflects summation of multiple chemical steps and provides the 
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maximal rate of an enzymatic reaction at given enzyme concentration, [E], and infinite 
availability of substrate S, equation (7.2). 
     	 (7.2) 
 
Oligomeric enzymes, in which substrate binding at one active site influences the substrate 
binding affinity of the other active sites in the oligomer deviate from the hyperbolic dependence 
of the reaction rate on the substrate concentration. This cooperativity can be either positive or 
negative, reflecting an increase or a decrease, respectively, in the affinity of substrate binding to 
other active sites subsequent to substrate binding to one active site. Cooperativity influences the 
measured value of the reaction rate as described by the Hill equation (7.3). The Hill coefficient, 
h, describes cooperativity, while K´ is related to the dissociation constant of the enzyme-
substrate complex and factors describing the influence of substrate binding at one site on the 
affinity of the other sites. The Hill equation is also described by equation (7.4), but with kcat and 
S0.5 (the substrate concentration at half maximal reaction rate).  
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Equation (7.5) was used to describe ligand binding to an enzyme. N is the degree of ligand 
binding with dissociation constant Kd to an enzyme with a maximal number of binding sites Nmax 
at a given concentration of the ligand, [L]. 
     	  	  (7.5) 
 
Inhibition studies with constant substrate concentration and varying inhibitor concentration are 
described using equation (7.6) or (7.7) for a hyperbolic or sigmoidal dependence, respectively, of 
the reaction rate on the inhibitor concentration. 
   
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  (7.7) 
 
where v0 is the reaction rate in the absence of the inhibitor, I, and Ki is the inhibitor 
concentration resulting in half reaction rate (at [I] = Ki, v = v0/2). 
Radioactive nucleotide labeling and liquid scintillation counting were used experimentally. 
Equation (7.8) was used to calculate reaction rates (s-1) from the experimentally obtained 
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counts-per-minute (CPM) for dCTP and was used equivalently for experiments with dUTP as 
substrate. 
 !"#$%  
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[dCTP]0 is the initial concentration of dCTP in mM, MP is monophosphate nucleotide, TP is 
triphosphate nucleotide, F is the factor corresponding to the total enzyme dilution, t is the 
reaction time in seconds and cenzyme is the enzyme concentration in mM.  
Equation (7.9) was used to calculate the degree of dTTP binding (NdTTP) to the enzyme. 
 --,  	&(() 
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[dTTP]0 is the initial concentration of dTTP in mM, CPM0 is the initial counts-per-minute, while 
CPMfree is counts-per-minute for unbound ligand. 
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Chapter Eight 
8 PURIFICATION OF WT AND TWO VARIANTS OF 
MYCOBACTERIUM TUBERCULOSIS DCTP DEAMINASE-
DUTPASE 
8.1 Introduction 
A prerequisite to protein characterization is acquiring purified protein and this chapter describes 
purification procedures of WT, A115G and A115V Mt DCD-DUT. All solutions were prepared with 
milli-q water. Protein solutions were kept on ice at all times and centrifugations were at 4 °C in a 
Sorvall R5C centrifuge with a SS-34 rotor unless otherwise stated. During the purifications, 
problems with protein precipitation were encountered several times, and a more suitable buffer 
was found through solubility experiments (results are given in section 8.3.5). 
 
8.2 Experimental 
8.2.1 Expression of the A115G variant 
All instruments that came in contact with the cells were sterilized to avoid contamination. A 
glass pipette was used to transfer BL21 (DE3) E. coli cells over-expressing A115G Mt DCD-DUT 
into 5 mL LB media (containing 1 % tryptone, 0.5 % yeast extract, 0.5 % NaCl) with 100 µg/mL 
ampicillin, and the cells were incubated overnight at 37 °C. 2 mL of the overnight culture was 
added to approximately 250 mL media consisting of 225 mL LB media with 2.2 mM MgCl2·6H2O, 
0.11 mM CaCl2·2H2O, 3.3 µM FeCl3·6H2O) and 25 mL A media (containing 2 % (NH4)2SO4, 7.5 % 
Na2HPO4·2H2O, 3 % KH2PO4, 3 % NaCl) and 2.5 mL 20 % glucose (or 0.25 mL 20 % glucose in a 
different expression) and 25 mg ampicillin (100 µg/mL final concentration) in a 1 L conically 
shaped flask. The culture was incubated with shaking at 37 °C and 250 µL 500 mM IPTG was 
added around OD436=6. The culture was left overnight with shaking at 37 °C. The cells were 
transferred to a large centrifuge tube on ice and centrifuged for 15 minutes at 9,000 rpm using a 
Sorvall R5C centrifuge with a GSA rotor. The supernatant was discarded, and the cells were 
resuspended in 30 mL 0.9 % NaCl and transferred to two small centrifuge tubes. The cells were 
centrifuged for 15 minutes at 9,000 rpm. The supernatant was discarded and the cells were 
frozen at -20 °C. 
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8.2.2 Purifications of WT and the variants
A number of purifications were carried out on dCTP deaminase
and A115V variants. A combination of techniques was used with some variations due
precipitation and degradation issues. A standard purification is described below and detailed 
descriptions of purifications along with specifications of SDS
D. An overview of the purifications is shown in 
 
 
Figure 8.1: Diagram of the steps involved in purification of WT, A115G and A115V 
 
8.2.2.1 Standard Purification
Cell pellet from 250 mL culture was defrosted on ice. 20 mL 50 mM KH
added and the cells resuspended. The cells were lysed by sonication twelve times for 30 seconds 
while kept on ice. The suspension was allowed to cool down for 30
sonications. The suspension was centrifuged for 20 minutes at 10,000 rpm. The supernatant was 
decanted off and kept on ice. While stirred on ice, 10 (w/w)% streptomycin was slowly added to 
a final concentration of 1 %. The solution was 
then centrifuged for 20 minutes at 14,000 rpm. The supernatant was decanted off and kept on 
ice. The solution was gently stirred on ice and solid (NH
saturation. The solution was stirred for 5 minutes and then centrifuged for 20 minutes at 14,000 
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rpm. The supernatant was discarded and the pellet was dissolved in 10 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8. The solution was dialyzed against 500 mL 50 mM KH2PO4/K2HPO4 pH 6.8.  
The protein solution was loaded onto a 14 mm/30 cm DE52 anion exchange column equilibrated 
with 50 mM KH2PO4/K2HPO4 pH 6.8 and eluted using a linear salt gradient of 50 mM 
KH2PO4/K2HPO4 pH 6.8 to 0.4 M NaCl in 50 mM KH2PO4/K2HPO4 pH 6.8 over 4 CV. The 
absorbance at 280 nm and SDS-PAGE was used to determine the protein content and purity of 
the collected fractions. Selected fractions were pooled and solid (NH4)2SO4 was added to 40 % 
saturation while stirring the solution on ice. The solution was stirred for 5 minutes and then 
centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the pellet was 
dissolved in 10 mL 20 mM HEPES pH 8.0 (the choice of buffer was based on solubility 
experiments on the A115V variant, results are given in section 8.3.5) and dialyzed against the 
same buffer. 
 
8.2.3 SDS-PAGE 
Samples for SDS-PAGE were mixed with equal volumes of sample buffer (80 mM Tris/HCl pH 6.8, 
2 % Sodium Dodecyl Sulfate, 10 % Glycerol, 5 % Dithiothreitol, 0.02 % Bromophenol blue). Solid 
samples were dissolved in 95 µL sample buffer. Biorad Broad Range Marker was used on all gels 
and prepared by mixing 10 µL marker with 10 µL sample buffer. All samples were heated 5 
minutes at 95 °C prior to loading onto the gel. Gel casting is described in Appendix D.6.  
The mounted gel was placed in running buffer (25 mM Tris, 1.4 % Glycine, 0.1 % Sodium Dodecyl 
Sulfate) and the samples were loaded. An electric current of 25 mA was applied for 
approximately 1 hour until the samples had traveled an appropriate distance on the gel. The gel 
was stained with Coomassie Brilliant Blue R and then bleached with a bleaching solution (10 % 
Acetic Acid, 24 % Ethanol) for at least 2 hours prior to drying the gel under vacuum. 
 
8.2.4 Solubility Experiments  
Purified A115V Mt DCD-DUT (in 20 mM HEPES/NaOH pH 6.8 that initially was used as buffer) was 
defrosted on ice and centrifuged for 10 minutes at 20,000 rpm (Ole Dich centrifuge). The 
supernatant was decanted off and the solubility of the pellet was tested. 
The pellet was dissolved in 300 µL 0.5 M KCl in 20 mM HEPES/NaOH pH 6.8. The absorbance at 
280 nm was used to determine the protein content of the dissolved pellet and of the 
supernatant in 20 mM HEPES/NaOH pH 6.8. 
80 µL 1 M KCl in 20 mM HEPES/NaOH pH 6.8 was gradually added to 200 µL protein in 20 mM 
HEPES/NaOH pH 6.8 to a final concentration of 0.3 M KCl in 20 mM HEPES/NaOH pH 6.8. To test 
if the dilution alone could dissolve the protein, 80 µL 20 mM HEPES/NaOH pH 6.8 was added to 
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200 µL protein in 20 mM HEPES/NaOH pH 6.8. Additionally 120 µL 20 mM HEPES/NaOH pH 6.8 
was added to this tube. 
The solubility of additional protein pellets were tested in 20 mM Tris/HCl pH 7.4, 200 mM 
HEPES/NaOH pH 8.0 and 20 mM HEPES/NaOH pH 8.0. 
 
8.3 Results and Discussion 
8.3.1 Expression of the A115G variant 
E. coli (BL21) cells over-expressing A115G Mt DCD-DUT were grown twice with two different 
glucose concentrations, see Figure 8.2. IPTG was added at the final point on the curve and the 
cells were left overnight. OD436 was 11.9 at cell harvest when the cells were grown in media 
containing 0.02 % glucose, while OD436 was 17.8 at cell harvest when the cells were grown in 0.2 
% glucose. 
 
 
Figure 8.2: Growth of E. coli over-expressing A115G Mt DCD-DUT at two different glucose 
concentrations. 
 
8.3.2 Purification of WT 
The steps involved in the purification of WT Mt DCD-DUT are shown in Figure 8.1. No ammonium 
sulfate precipitation was carried out prior to the two anion exchange steps. SDS-PAGE and the 
absorbance at 280 nm of the fractions from both anion exchange steps are shown in Figure 8.3. 
Fractions 6-8 were collected during the first run, and fractions 10-12 were collected during the 
second run. The final ammonium sulfate precipitation was carried out to 45 % saturation and the 
precipitate dissolved in 2.5 mL 20 mM HEPES pH 8.0 and dialyzed against the same buffer. 
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Protein with a concentration of 2.5 mg/mL was apportioned into aliquots and stored at -20 °C. 
SDS-PAGE of purified WT Mt DCD-DUT is shown in Figure 8.6A. 
 
 
 
Figure 8.3: Purification of WT Mt DCD-DUT: SDS-PAGE with collected fractions marked and the 
absorbance at 280 nm (the connecting line serves as guide to the eye). A: fractions from the first 
anion exchange. B: fractions from the second anion exchange.  
 
8.3.3 Purification of the A115V variant 
The purification of A115V Mt DCD-DUT was followed using SDS-PAGE samples, and the results 
are shown in Figure 8.4A. The figure shows the presence of the protein in the supernatant after 
centrifuging the sample subsequent to sonication (V2). A slight loss of protein is seen in the 
pellet (V3). The protein is present in the supernatant after centrifuging the sample subsequent 
to streptomycin precipitation (V4) and in the dissolved pellets of the ammonium sulfate 
precipitations (V7 and V9). Solution V9 was quite pure, but because of a slight yellow 
discoloration of the solution, an anion exchange step was incorporated. The sample (V9) was 
loaded onto the DE52 anion exchange column, and SDS-PAGE and the absorbance at 280 nm of 
the fractions are shown in Figure 8.4B. Fractions 9-13 were collected and pooled. The solution 
was precipitated with ammonium sulfate and the pellet was readily dissolved in 5 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8. The solution was dialyzed twice, during which it precipitated. The 
solution was centrifuged and the supernatant apportioned into aliquots. The aliquots had a 
tendency to precipitate during transfer on ice. Therefore, solubility experiments were made to 
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find a more suitable buffer (see section 8.3.5). These experiments showed that the solubility of 
the protein was enhanced at pH 8.0 compared with pH 6.8. Consequently, the A115V variant 
aliquots were pooled and precipitated with ammonium sulfate, and the precipitate was readily 
dissolved in 3 mL 20 mM HEPES/NaOH pH 8.0. The solution was dialyzed against the same buffer 
and the solution was apportioned into aliquots and stored at -20 °C. The final protein 
concentration was 4 mg/mL. SDS-PAGE of the purified protein is shown in Figure 8.6B. 
 
 
 
Figure 8.4: Purification of A115V Mt DCD-DUT. A: SDS-PAGE samples: V1: cell resuspension, V2: 
sonication supernatant, V3: sonication pellet, V4: streptomycin precipitation supernatant, V5: 
streptomycin pellet, V6: first ammonium sulfate precipitation supernatant, V7: first ammonium 
sulfate precipitation dissolved pellet, V8: second ammonium sulfate precipitation supernatant, 
V9: second ammonium sulfate precipitation dissolved pellet (see Appendix D.2 for additional 
details on the samples). B: SDS-PAGE of fractions from the anion exchange with collected 
fractions marked and the absorbance at 280 nm shown above (the connecting line serves as 
guide to the eye). 
 
8.3.4 Purification of the A115G variant 
Several problems with precipitation and degradation were encountered during work with A115G 
Mt DCD-DUT. This section describes the successful purification of A115G, while Appendix E.1 
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describes two additional purifications of the A115G variant, in which the protein degraded and 
was discarded. 
The A115G variant protein was expressed (section 8.2.1) and purified with a modified procedure, 
see Figure 8.1. Pellet from the first ammonium sulfate precipitation proved difficult to dissolve 
(purification 2, Appendix E.1) and the volume of 50 mM KH2PO4/K2HPO4 was therefore doubled 
to 20 mL, in which the protein completely dissolved (G2). SDS-PAGE results of the supernatant 
after centrifuging the sample subsequent to sonication (G1) and of solution G2 are shown in 
Figure 8.5. Figure 8.5 also shows SDS-PAGE and the absorbance at 280 nm of fractions from the 
anion exchange. Fractions 5-9 were collected and pooled. The solution was precipitated with 
ammonium sulfate and the pellet was readily dissolved in 2 mL HEPES/NaOH pH 8.0. The 
solution was dialyzed against the same buffer, and the solution was apportioned into aliquots 
and stored at -20 °C. The final protein concentration was 3 mg/mL SDS-PAGE of the purified 
protein is shown in Figure 8.6B. 
 
Figure 8.5: Purification of A115G Mt DCD-DUT. SDS-PAGE of: G1: sonication supernatant, G2: 
dissolved pellet from the first ammonium sulfate precipitation. Fractions 5-14 from anion 
exchange are shown. The collected fractions are marked, and the absorbance at 280 nm is 
shown to the right (the connecting line serves as guide to the eye). See Appendix D.3 for more 
details on the samples. 
 
 
Figure 8.6: SDS-PAGE of the purified proteins. A: WT Mt DCD-DUT, B: A115V and A115G diluted 
four times. 
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8.3.5 Solubility Experiments 
Solubility experiments were carried out to find more suitable conditions where the proteins 
were soluble. Increasing ion strength and changing pH were tested. However, the proteins were 
going to be used for crystallization and addition of salt should preferably be avoided. 
Solubility experiments were performed on A115V Mt DCD-DUT that had precipitated during 
dialysis against 20 mM HEPES/NaOH pH 6.8 (Figure 8.1, A115V second to last dialysis). 
Supernatant and pellet were separated by centrifugation, and the total protein content was 
determined to be 3.8 mg/mL in the precipitated protein solution. 
The protein was soluble in 0.3 M KCl in 20 mM HEPES/NaOH pH 6.8 at a protein concentration of 
2.7 mg/mL. With a protein concentration of 2.7 mg/mL, the protein was not soluble in 20 mM 
HEPES/NaOH pH 6.8. Further dilution to a protein concentration of 1.9 mg/mL in 20 mM 
HEPES/NaOH pH 6.8 did not dissolve the protein. At the same protein concentrations, the 
protein was not soluble in 20 mM Tris/HCl pH 7.4. 
The protein pellet proved easily soluble in both 200 mM HEPES/NaOH pH 8.0 and 20 mM 
HEPES/NaOH pH 8.0 up to concentrations of approximately 6 mg/mL. The preferred buffer was 
thus 20 mM HEPES/NaOH pH 8.0 and protein solutions were stored in this buffer at -20 °C. 
Defrosting the A115V variant enzyme and leaving it on ice for more than 20-30 minutes 
sometimes caused precipitation. This precipitation could be dissolved by diluting the protein to 2 
mg/mL with 20 mM HEPES pH 8.0. 
 
8.3.6 Comments on Stability 
The successful purification of the intact A115G variant is distinguished from the two unsuccessful 
purifications of the A115G variant given in Appendix E.1 by being carried out in 3 days instead of 
9 days, and precipitation issues were solved by changing pH during the final dialysis step. During 
purification 3 described in Appendix D.5, degradation was not observed until the protein was 
frozen at -20 °C prior to the final ammonium sulfate precipitation. Protein degradation was 
evident from the final SDS-PAGE shown in Figure E.3B. 
Successful purification of the A115V variant was carried out in 9 days and no degradation was 
observed. Purified A115V protein used in the solubility experiments (section 8.2.4) was left 
refrigerated for an additional 9 days and the SDS-PAGE results are shown in Figure 8.7. SDS-
PAGE lanes A, B, C, D refer to the protein in 0.3 M KCl in 20 mM HEPES pH 6.8, 20 mM HEPES pH 
8.0, 20 mM HEPES pH 6.8 with precipitation and 20 mM HEPES pH 6.8 centrifuged supernatant 
without precipitation, respectively. It is seen that especially C shows degradation. The C solution 
was left with precipitation for the additional 9 days.  
To avoid degradation, it is advantageous to minimize the time a solution is left with 
precipitation, and to carry out the purification quickly and without freezing the protein until the 
purification is complete – in particular when working with A115G Mt DCD-DUT. 
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Figure 8.7: Purified A115V Mt DCD-DUT after 9 days storage at 4 °C (section 8.3.6). A: protein in 
0.3 M KCl in 20 mM HEPES pH 6.8, B: protein in 20 mM HEPES pH 8.0, C: protein in 20 mM HEPES 
pH 6.8 with precipitation, D: protein in 20 mM HEPES pH 6.8 without precipitation. 
 
8.4 Conclusion 
WT Mt DCD-DUT and two variants (A115V and A115G) were successfully purified with yields of 
35 mg/L, 45 mg/L and 77 mg/L cell culture, respectively. Problems with precipitation of A115G 
and A115V Mt DCD-DUT during purification were encountered and changing pH from 6.8 to 8.0 
increased the solubility of the proteins. Purified WT, A115G and A115V Mt DCD-DUT were stored 
at -20 °C in 20 mM HEPES/NaOH pH 8.0 with concentrations of 2.5 mg/mL, 3 mg/mL and 4 
mg/mL, respectively. SDS-PAGE results of the final product of purified WT, A115V and A115G Mt 
DCD-DUT are shown in Figure 8.6.  
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Chapter Nine 
9 CHARACTERIZATION OF WT AND TWO 
VARIANTS OF MYCOBACTERIUM TUBERCULOSIS 
DCTP DEAMINASE-DUTPASE 
9.1 Introduction 
As described in section 7.1, the two variants (A115V and A115G) of Mt DCD-DUT were produced 
to investigate the importance of steric hindrance by the side chain of Ala115 on a water 
molecule suggested to be crucial for activity [85]. The solubility of A115V Mt DCD-DUT was 
enhanced at pH 8.0 (section 8.3.5). In the kinetic studies, pH was therefore initially changed to 
8.0 instead of pH 6.8, which was used in previous WT enzyme studies [85]. Kinetic studies were 
expanded to include pH 6.8. 
This chapter includes characterization of WT, A115V and A115G Mt DCD-DUT and covers kinetic 
studies of all three enzymes as well as dTTP binding and inhibition experiments. Crystallization 
experiments and the crystal structure of A115V Mt DCD-DUT to 2.8 Å are also included in this 
chapter.  
 
9.2 Experimental 
9.2.1 Turnover Numbers 
Experiments used to calculate the turnover numbers of WT, A115V and A115G Mt DCD-DUT 
were all carried out at 37 °C. 80 µL assay mix containing 2 mM MgCl2 and 20 mM HEPES/NaOH 
pH 6.8 or 8.0 and a minor amount of 3H labeled nucleotide (dCTP or dUTP) with a temperature of 
37 °C was added 10 µL nucleotide and allowed to warm to 37 °C again. Initial assay 
concentrations of dCTP or dUTP were 1 mM. 10 µL appropriately diluted enzyme was added and 
samples were taken from the mixture at specific times and loaded directly onto a TLC PEI 
Cellulose F chromatogram. 1 µL 5 mM dUMP was added to each sample on the chromatogram as 
a marker. Chromatograms were treated and samples measured as described in section 9.2.5. 
WT assays were carried out in duplicate with 91 µM enzyme with in-assay dilution factors of 100 
and 200. A115V assays were carried out in duplicate with 191 µM enzyme with in-assay dilution 
factors of 30 and 60. A115G assays were carried out in duplicate with 144 µM enzyme with in-
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assay dilution factors of 10 and 20. Samples were taken after 2, 5, 10 and 20 minutes in all assays 
with the exception of A115G and A115V dCTP pH 8.0 assays, which were carried out in duplicate 
with enzyme dilution factors of 20 and 40 and sampling after 2, 5 and 10 minutes. 
 
9.2.2 Nucleotide Saturation 
All nucleotide saturation experiments were carried out at 37 °C. Numerous nucleotide saturation 
assays with variations in nucleotide concentrations were carried out for WT, A115V and A115G 
Mt DCD-DUT with dCTP and dUTP at pH 8.0, as well as with dUTP at pH 6.8. The assay contents 
varied depending on pH and nucleotide type and concentration; specifications and 
corresponding in-assay nucleotide concentrations and enzyme dilutions are given in Appendix D, 
Table D.1. 10 µL nucleotide was added to 80 µL assay mix including a minor amount of 3H labeled 
nucleotide (dCTP or dUTP) with a temperature of 37 °C and allowed to warm to 37 °C again. 10 
µL appropriately diluted enzyme with a temperature of 37 °C was added to each assay and after 
a reaction time of 6 minutes, 10 µL samples were loaded directly onto a TLC PEI Cellulose F 
chromatogram. 1 µL 5 mM dUMP was added to each sample on the chromatogram as a marker. 
Chromatograms were treated and samples measured as described in section 9.2.5. 
 
9.2.3 dTTP inhibition 
All dTTP inhibition experiments were carried out at 37 °C. dTTP inhibition experiments were 
carried out with WT, A115V and A115G Mt DCD-DUT at pH 6.8 and pH 8.0 with fixed 
concentrations of dCTP or dUTP. Assays were made with variations in both initial substrate 
concentration and type, and also with variation in dTTP concentration. Details on assay mix 
contents are given in Appendix D, Table D.2 along with dTTP concentration range, total enzyme 
dilution in-assay and the applied nucleotide concentrations. 10 µL dTTP was added to 80 µL 
assay mix including a minor amount of 3H labeled nucleotide (dCTP or dUTP) with a temperature 
of 37 °C and allowed to warm to 37 °C again. 10 µL appropriately diluted enzyme with a 
temperature of 37 °C was added to the assay and after a reaction time of 6 minutes, 10 µL 
samples were loaded directly onto a TLC PEI Cellulose F chromatogram. 1 µL 5 mM dUMP was 
added to each sample on the chromatogram as a marker. Chromatograms were treated and 
samples measured as described in section 9.2.5. 
 
9.2.3.1 dTTP inhibition at three pH values 
The activity of WT Mt DCD-DUT with dCTP or dUTP as substrate was tested at pH 6.8, 7.4 and 8.0 
in 20 mM HEPES in the presence (500 µM) or absence of dTTP. 20 µL assay component (pH and 
dTTP steering) were added to 70 µL assay mix (2 mM MgCl2, 300 µM dCTP or 300 µM dUTP and a 
minor amount of 3H dCTP or 3H dUTP) and allowed to reach 37 °C. Assays were carried out in 
duplicates. 10 µL appropriately diluted enzyme (100x or 200x total in-assay dilutions) with a 
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temperature of 37 °C was added to the mixture and after a reaction time of 6 minutes, a 10 µL 
sample was loaded directly onto a TLC PEI Cellulose F chromatogram. 1 µL 5 mM dUMP was 
added to each sample on the chromatogram as a marker. Chromatograms were treated and 
samples measured as described in section 9.2.5. 
 
9.2.4 dTTP Binding 
Ligand binding experiments were performed at ambient temperature. The experiments 
contained 2 mM MgCl2, 20 mM HEPES/NaOH, dTTP at different concentrations including a small 
amount of 3H dTTP (concentration in nM scale) and enzyme. Mixing WT Mt DCD-DUT enzyme in 
20 mM HEPES/NaOH pH 8.0 with buffer at pH 6.8 caused a pH shift, and WT experiments were 
thus carried out at pH 7.1 with a total enzyme concentration of 33 µM. A115V and A115G Mt 
DCD-DUT experiments were carried out at pH 8.0 with total enzyme concentrations of 54 µM 
and 40-80 µM, respectively. The components were mixed in an eppendorf tube with a Microcon 
ultracel YM-30 membrane. A 5 µL sample was taken from each tube and added to a TLC PEI 
Cellulose F chromatogram. The tubes were centrifuged at 10,000 rpm (Ole Dich centrifuge) for 5 
minutes and a 5 µL sample of the flow-through was added to the chromatogram. 
Chromatograms were treated and samples measured as described in section 9.2.5. 
 
9.2.5 Liquid Scintillation Counting 
Chromatograms were placed in a jar containing a shallow layer of 0.9 M CH3COOH and 0.3 M 
LiCl, and the solvent was allowed to travel to the top of the chromatograms. The chromatograms 
were dried and placed under 254 nm UV light, and the samples were framed with a soft pencil. 
The framed pencil markings were cut out, placed in small plastic containers, added 2 mL 2 M 
ammonia and left to dissolve for one hour. 5 mL Optiphase HiSafe2 Liquid Scintillation Cocktail 
was added, the solutions were gently mixed and left to stand for an additional hour. The samples 
were measured using a 2200CA TRI-CARB Liquid scintillation analyzer by United Technologies 
Packard. 
 
9.2.6 Differential Scanning Calorimetry 
Differential scanning calorimetry experiments were performed using a Microcal VP-DSC with 
scan rates of 0.5 °C/min. Experiments were carried out with WT Mt DCD-DUT at pH 8.0 and pH 
6.8 with apo enzyme, as well as at pH 6.8 in the presence of 500 µM dTTP. Experiments with 
A115V Mt DCD-DUT were carried out at pH 8.0 in the presence (500 µM) and absence of dTTP. 
Experiments with apo A115G Mt DCD-DUT were carried out at pH 8.0 and pH 6.8 as well as at pH 
8.0 in the presence of 500 µM dTTP. Background measurements were carried out using the same 
buffer that was used in the reference cell during the subsequent measurements. Experimental 
details are given in Appendix D.3, Table D.3. 
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9.2.7 Crystallization  
The initial crystallization conditions were based on crystallization of WT Mt DCD-DUT [85]. The 
crystallization conditions for apo WT Mt DCD-DUT were 20 % PEG 8000, 50 mM MgCl2 and 100 
mM HEPES pH 7.5, while the crystallization conditions for the enzyme in complex with dTTP 
were 45 % PEG 400, 200 mM MgCl2 and 100 mM HEPES pH 7.5. The hanging-drop vapor-
diffusion method was applied in 24 well plates during all crystallization experiments.  
Substrate analogues used during crystallization were dUMPNPP or dUMPCPP, which are 
analogues to dUTP, but with the oxygen bridging the α-β phosphorous replaced by nitrogen or 
carbon, respectively. Crystallization trials were carried out with A115V Mt DCD-DUT in the apo 
form or in complex with dTTP, dUMPCPP or dUMPNPP. Crystallization trials of WT Mt DCD-DUT 
were carried out with apo enzyme or enzyme in complex with dUMPNPP or dUMPCPP. 
Crystallization trials of A115G Mt DCD-DUT were carried out with apo enzyme or enzyme in 
complex with dUMPCPP. A complete set of all tested conditions is not provided here. Instead, a 
variety of crystallization conditions are available for picture entries in the enclosed database 
(Appendix A, DCDDUT.xml, see Chapter 2 for a program description). 
 
9.2.8 Data Collection and Processing 
Data were collected to 2.8 Å resolution on A115V Mt DCD-DUT in complex with dTTP. Diffraction 
data were collected at ID14-4 on ESRF. Integration and scaling of the data were performed with 
XDS/XSCALE [108,109]. Data collection statistics are presented in Table 9.1.  
Table 9.1: X-ray data-collection and refinement statistics.  
Values in parentheses are for the outermost resolution shell. 
Beamline ESRF, ID14-4 
Detector ADSC Quantum Q315r 
Wavelength (Å) 0.9765 
Temperature (K) 100 
Space group  P21 
Sample-to-detector distance (mm) 377 
No.  of images 360 
Oscillation angle (°) 0.5 
Unit-cell parameters (Å, °) a=56.07 (7), b=179.4 (2), 
c=96.22 (5), α=γ=90.0, β=96.4 
Resolution range (Å) 99.724-2.900 (3.00-2.90) 
No. of observed reflections 161,875 (15,832) 
No. of unique reflections 43,288 (4,216) 
Mosaicity (°) 0.3-0.7 
Multiplicity 3.74 (3.76) 
Completeness (%) 98.7 (99.1) 
Rmerge 0.177 (0.976) 
I/9(I) 7.01 (1.44) 
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9.2.9 Structure Determination and Refinement 
Molecular replacement using MOLREP [70] was applied to solve the structure. Different search 
models were tested: monomer, dimer or trimer of WT Mt DCD-DUT (pdb 2QXX). The structure 
was solved with the peptide chains of two trimers of WT Mt DCD-DUT with dTTP bound as 
search model. 12 molecules were found in the asymmetric unit. Refinement was performed with 
REFMAC5 [71]: first a rigid body refinement with rigid domains in all chains (residues 1-189), 
then a restrained refinement with tight NCS restraints on residues 1-189 in all chains. Structural 
refinements with REFMAC5 and winCoot [61,62] were performed. 12 dTTP molecules and 12 
Mg2+ were added to the structure. Two additional Mg2+ were added on interfaces between the 
molecules. Residue 189 was removed in five chains (B, D, E, J, K). NCS restraints were removed 
on resides 110-118 and kept tight on the remainder of the peptide chain and on dTTP during 
refinement. TLS refinement was used and the peptide chains were used as TLS groups [110]. 
Refinement using phenix.refine [111] with restraints on Ramachandran angles or with simulated 
annealing had no effect on R/Rfree. Refinement statistics are given in Table 9.2. The 
Ramachandran plot [72] shows 8 residues in the outlier region (0.4 %). All these residues are 
placed in the flexible region at the nucleotide binding site and are probably outliers because of 
the strain in the structure from binding dTTP.  
Table 9.2: Refinement statistics. 
R factor 0.2530 
Rfree 0.2899 
No. of subunits in asymmetric unit 12 
No. of atoms in model 17912 
No. of water molecules 12 
Average B factors (Å2) 
     Main chain 
     Side chain 
     dTTP 
 
31.23 
29.85 
25.01 
Ramachandran plot [72] 
     Favored (%) 
     Allowed (%) 
     Outliers (%) 
 
96.8 
2.8 
0.4 
 
 
9.3 Results 
Modeling curves to data points was performed in GraphPad Prism [112], using the equations 
given in Chapter 7. Throughout this section, data points for rates (s-1) were calculated using 
equation (7.8) and data points for the degree of dTTP binding were calculated using equation 
(7.9). 
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9.3.1 Turnover numbers 
Turnover numbers for WT, A115V and A115G were determined for 1 mM dCTP and 1 mM dUTP 
at pH 8.0 and pH 6.8. Experiments were carried out as described in section 9.2.1. No detectable 
activity was measured for A115V and A115G at pH 6.8 with dCTP. Turnover numbers are given in 
Table 9.3 and the plots showing the turnover number vs. time are shown in Appendix E.1, Figure 
E.4. Both variant enzymes had reduced activities compared with the WT enzyme. 
Table 9.3: Turnover numbers (s-1) for WT, A115V and A115G Mt DCD-DUT with 1 mM dCTP or 
dUTP at pH 6.8 or 8.0. Plots of turnover number vs. time are shown in Appendix E.1, Figure E.4. 
 dCTP pH 8.0 dUTP pH 8.0 dCTP pH 6.8 dUTP pH 6.8 
WT 0.239 ± 0.007 0.29 ± 0.01 0.044 ± 0.002 0.195 ± 0.007 
A115V 0.068 ± 0.007 0.016 ± 0.001 - 0.0215 ± 0.0009 
A115G 0.014 ± 0.001 0.0120 ± 0.0006 - 0.0015 ± 0.0002 
 
9.3.2 Substrate saturation  
Substrate saturation experiments were carried out with dCTP and dUTP at pH 8.0 as well as with 
dUTP at pH 6.8, as described in section 9.2.2. Neither of the variant enzymes had any detectable 
activity with dCTP at pH 6.8. The determined kinetic constants are given in Table 9.4 and data 
points with the modeled curves are shown in Figure 9.1 for the WT enzyme, Figure 9.2 for the 
A115V variant and Figure 9.3 for the A115G variant. 
Table 9.4: Kinetic constants calculated for substrate saturation with dCTP at pH 8.0 and dUTP at 
pH 8.0 as well as pH 6.8 for WT, A115V and A115G Mt DCD-DUT. 
 Michaelis-Menten equation (7.1) Hill equation (7.4) 
 kcat Km kcat S0.5 h 
WT      
dCTP pH 8.0 0.35 ± 0.01 s-1 40 ± 6 µM    
dUTP pH 8.0 0.29 ± 0.01 s-1 57 ± 10 µM    
dUTP pH 6.8   
0.188 
± 0.007 s-1 
118 
± 12 µM 
1.7 
± 0.2 
 
A115V 
     
dCTP pH 8.0 0.22 ± 0.02 s-1 1.3 ± 0.2 mM    
dUTP pH 8.0 0.015 ± 0.001 s-1 0.6 ± 0.2 µM    
dUTP pH 6.8 0.0204 ± 0.0008 s-1 15 ± 3 µM    
 
A115G 
     
dCTP pH 8.0   
0.020 
± 0.001 s-1 
171  
± 16 µM 
2.5 
± 0.5 
dUTP pH 8.0 0.0157 ± 0.0007 s-1 24 ± 5 µM    
dUTP pH 6.8 0.010 ± 0.003 s-1 1.4 ± 0.7 mM    
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Cooperativity was observed for the WT enzyme at pH 6.8 (Figure 9.1B) with kinetic constants 
similar to what has been observed previously [85]. In contrast, no significant cooperativity was 
observed at pH 8.0 with dCTP or dUTP as substrates (Figure 9.1C). 
In comparison with the WT enzyme, A115V showed some major differences in dCTP and dUTP 
saturation kinetics. Contrary to WT, A115V displayed hyperbolic saturation kinetics at pH 6.8 
with dUTP, as shown in Figure 9.2B. Hyperbolic saturation was also observed at pH 8.0 with both 
dCTP and dUTP (Figure 9.2C+D), albeit with large differences in the kinetic constants compared 
with the WT enzyme. kcat was about 1.5 and 20 fold lower for dCTP and dUTP, respectively, for 
A115V compared with the WT enzyme. KM was about 25 fold higher and 100 fold lower for dCTP 
and dUTP, respectively, for A115V compared with the WT enzyme. 
The A115G enzyme also showed major differences compared with the WT enzyme. Hyperbolic 
dUTP saturation was observed at both pH 6.8 and 8.0 (Figure 9.3), whereas cooperativity was 
observed with dCTP at pH 8.0 (Figure 9.3C). kcat and Km were about 20 and 2.5 fold lower, 
respectively, for dUTP at pH 8.0 for the A115G enzyme compared with the WT enzyme. 
 
Figure 9.1: Substrate saturation curves fitted to data points of WT Mt DCD-DUT. A: curves and 
data points. B: zoomed plot of curve and data points at pH 6.8. C: zoomed plot of curves and 
data points at pH 8.0. Calculated kinetic constants and references to the applied equations can 
be found in Table 9.4. Each point was determined at least twice at different enzyme 
concentrations. 
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Figure 9.2: Substrate saturation curves fitted to data points of A115V Mt DCD-DUT. A: curves 
and data points. B: zoomed plot of curve and data points at pH 6.8. C+D: zoomed plot of curves 
and data points at pH 8.0. Calculated kinetic constants and references to the applied equations 
can be found in Table 9.4. Each point was determined at least twice at different enzyme 
concentrations. 
The full range of measured rates at different nucleotide concentrations is available in Appendix 
E.3, Figure E.5. It should be noted that some of the data points at high nucleotide concentrations 
(typically above 2 mM) were omitted during modeling of the curves to the data points, as seen in 
Figure 9.1, Figure 9.3 and in particular for the A115V variant shown in Figure 9.2. The observed 
behavior of a slow increase (seen for A115V dUTP pH 6.8 and pH 8.0) or a decrease (seen for 
A115V dCTP pH 8.0) could not be modeled satisfactorily using the equations given in section 7.2 
and data were therefore cut off to yield reasonable fits. 
 
9.3.3 dTTP Inhibition 
Inhibition by dTTP of WT, A115V and A115G Mt DCD-DUT was examined at pH 6.8 and pH 8.0. 
Experiments were carried out as described in section 9.2.3 and the calculated kinetic constants, 
as well as references to the applied equations, are presented in Table 9.5. Modeling of curves to 
the data points are shown in Figure 9.4.  
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Figure 9.3: Substrate saturation curves fitted to data points of A115G Mt DCD-DUT. A: curves 
and data points. B: zoomed plot of curves and data points at pH 6.8. C: zoomed plot of curves 
and data points at pH 8.0. Calculated kinetic constants and references to the applied equations 
can be found in Table 9.4. Each point was determined at least twice at different enzyme 
concentrations. 
Table 9.5: Kinetic constants calculated for dTTP inhibition of WT Mt DCD-DUT at pH 6.8, A115V 
Mt DCD-DUT at pH 6.8 and pH 8.0, and A115G Mt DCD-DUT at pH 8.0. 
 Inhibition (hyperbolic) 
equation (7.6) 
Inhibition (sigmoidal, cooperative) 
equation (7.7) 
 Ki Ki h 
WT    
300 µM dCTP pH 6.8  125 ± 9 µM 1.6 ± 0.1 
300 µM dUTP pH 6.8  183 ± 14 µM 1.4 ± 0.1 
 
A115V 
   
2.4 mM dCTP pH 8.0 323 ± 44 µM   
300 µM dCTP pH 8.0 72 ± 9 µM   
300 µM dUTP pH 6.8 1.4 ± 0.3 mM   
 
A115G 
   
300 µM dCTP pH 8.0  4.9 ± 0.9 µM 2.2 ± 0.8 
800 µM dCTP pH 8.0  11.2 ± 0.6 µM 2.2 ± 0.2 
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Unexpectedly, the WT enzyme was insensitive to the presence of dTTP at pH 8.0 even at dCTP 
concentrations around KM (Figure 9.4A). The inhibition by dTTP at pH 6.8 [85] was verified with 
dCTP and dUTP as substrates (Figure 9.4D). The apparent pH effect of dTTP inhibition was 
further examined by measuring activity with dCTP or dUTP at pH 6.8, 7.4 and 8.0 in the presence 
or absence of dTTP for the WT enzyme. A clear tendency of attenuation of dTTP inhibition at pH 
above 6.8 is observed, results are shown in Figure 9.5. 
 
 
Figure 9.4: Inhibition by dTTP at constant substrate concentration at pH 8.0 of A: WT, B: A115V 
(zoomed insert: 300 µM dCTP pH 8.0) and C: A115G. dTTP inhibition at pH 6.8 of D: WT, E: A115V 
and F: A115G. Each point was determined twice at different enzyme concentrations. Calculated 
kinetic constants and references to the applied equations can be found in Table 9.5.  
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The A115V and A115G enzymes were constructed to evaluate the importance of steric hindrance 
by the side chain of Ala115 on a water molecule suggested to be crucial for activity [85] as 
described in section 7.1. Neither of the variants displayed the expected properties (discussed in 
section 9.4). In contrast to WT, the A115V enzyme was inhibited by dTTP at both pH 8.0 and 6.8 
as shown in Figure 9.4B+E. A115V showed increased sensitivity to dTTP at pH 8.0 compared with 
pH 6.8 (Ki was about 20 times lower at pH 8.0 compared with pH 6.8). The A115G enzyme 
showed dTTP inhibition with pH effects contrary to the WT enzyme. A115G showed a high 
sensitivity to dTTP at pH 8.0 with a complete loss of activity at 0.1 mM dTTP (Figure 9.4C). Ki was 
25 fold lower for A115G at pH 8.0 compared with WT at pH 6.8. In contrast, no significant 
inhibition was observed at pH 6.8 (Figure 9.4F). 
  
Figure 9.5: Reaction rates for WT Mt DCD-DUT at pH 6.8, 7.4 and 8.0 with A: 300 µM dCTP and B: 
300 µM dUTP as substrates. Black and orange data points are for assays in the presence (500 
µM) and absence of dTTP, respectively. Straight lines were drawn between the data points as 
guides to the eye. 
 
9.3.4 dTTP Binding 
dTTP equilibrium binding experiments were carried out with WT, A115V and A115G Mt DCD-DUT 
as described in section 9.2.4. The WT dTTP binding experiments were designed to be carried out 
at pH 6.8. However, the shift in pH from mixing a substantial amount of protein at pH 8.0 with 
the buffer at pH 6.8 caused the final pH to be 7.1. At pH 7.1, WT does not bind dTTP, as shown in 
Figure 9.6A. pH of the WT binding experiments was changed compared with the variant dTTP 
binding experiments (carried out at pH 8.0) because the WT enzyme had proven insensitive to 
the presence of dTTP at pH 8.0 (Figure 9.4A). dTTP binding to the enzyme was therefore not 
expected at pH 8.0. 
A115V binds dTTP at pH 8.0 as shown in Figure 9.6B. dTTP binding was modeled using equation 
(7.5) resulting in a dissociation constant Kd = 7 ± 2 µM. dTTP binding to A115V at pH 8.0 is 
stronger than dTTP binding to the monofunctional dCTP deaminase from E. coli at pH 6.8. Kd was 
around 7 for A115V:dTTP compared with Kd around 35 for Ec DCD:dTTP [91]. A115G shows a 
very unusual dependence of the degree of dTTP binding on the concentration of dTTP. Initially, 
the degree of binding increases with the concentration of dTTP, but the enzyme never reaches 
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full occupation (N=1) and it appears that the dTTP binding site occupation decreases at dTTP 
concentrations above approximately 100 mM. 
 
 
Figure 9.6: Degree of dTTP binding (N) to A: WT at pH 7.1, B: A115V at pH 8.0, curve was 
modeled using equation (7.5) and C: A115G Mt DCD-DUT at pH 8.0.  
 
9.3.5 Differential Scanning Calorimetry 
Weak signals for irreversible transitions were observed for DSC experiments, and transition 
temperatures should therefore be considered as approximates. Transition temperatures are 
listed in Table 9.6 and DSC measurements are given in Appendix E.4. 
A115V Mt DCD-DUT is destabilized compared with the WT enzyme. The transition temperature 
for the A115V variant enzyme is 20 °C lower than for the WT enzyme (67 °C vs. 87 °C) in the 
presence of dTTP at pH 8.0. 
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Table 9.6: Transition temperatures for DSC experiments with WT, A115V or A115G Mt DCD-DUT. 
 pH cenzyme Apo 500 µM 
dTTP 
WT 8.0 20 µM 77 °C  
 6.8 20 µM 84 °C 87 °C 
     
A115V 8.0 24 µM inconclusive 67 °C 
     
A115G 8.0 12 µM 81 °C 83 °C 
 8.0 24 µM 83 °C 85 °C 
 6.8 24 µM inconclusive  
 
 
9.3.6 Crystallization and Diffraction Tests 
9.3.6.1 WT enzyme 
Crystallization of WT Mt DCD-DUT was carried out mainly in the presence of substrate analogues 
in an attempt to get a structure of WT Mt DCD-DUT in its active conformation. Selected 
crystallization results are given in Figure 9.7 and a range of crystallization pictures and conditions 
are available in the enclosed database (Appendix A, DCDDUT.xml, see Chapter 2 for a program 
description). dUMPNPP spontaneously hydrolyzes at the same rate whether or not WT Mt DUT is 
present [102]. A crystal of WT Mt DCD-DUT that had grown in the presence of dUMPNPP over a 
period of 4 months proved to contain enzyme in complex with monophosphate or diphosphate 
[113]. The crystals in Figure 9.7C+D had grown after 7-8 months at 15 °C and were therefore 
probably formed without an intact nucleotide. 
 
 
Figure 9.7: Crystallization of 2 mg/mL WT Mt DCD-DUT with specified reservoir conditions. For 
dUMPNPP: the enzyme used for crystallization setup was in solution with 2 mM dUMPNPP and 
14 mM MgCl2. 
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9.3.6.2 A115V variant enzyme 
Crystallization of A115V Mt DCD-DUT was carried out with enzyme in its apo form or in complex 
with dTTP, dUMPNPP or dUMPCPP. Selected crystallization results are given in Figure 9.8 and 
additional pictures and conditions can be found in the enclosed database (Appendix A, 
DCDDUT.xml). Data were collected to 2.8 Å resolution (section 9.2.8) on a crystal from Figure 
9.8C: A115V in complex with dTTP. 
 
 
Figure 9.8: Crystallization of 2-4 mg/mL A115V Mt DCD-DUT with specified reservoir conditions. 
For dTTP: the enzyme used for crystallization setup was in solution with 5 mM dTTP and 20 mM 
MgCl2. For dUMPCPP: the enzyme was in solution with 2 mM dUMPCPP and 10 mM MgCl2. 
 
9.3.6.3 A115G variant enzyme 
Crystallization of A115G Mt DCD-DUT was carried out mainly with enzyme in its apo form 
because the enzyme showed unusual dTTP binding (section 9.3.4). Selected crystallization results 
are given in Figure 9.9 and additional pictures and conditions can be found in the enclosed 
database (Appendix A, DCDDUT.xml). Diffraction properties were tested on the largest of the 
apo crystals (Figure 9.9D), but no diffraction was observed at ESRF. The morphology of these 
crystals was similar to apo WT enzyme [113]. 
 
 
Figure 9.9: Crystallization of 2 mg/mL A115G Mt DCD-DUT with specified reservoir conditions.  
 
9.3.7 Crystal structure of A115V:dTTP
The structure of A115V with 12 molecules in the asymmetric unit was refined using tight NCS 
restraints except for residues 110
binding pocket. dTTP is bound in all 12 active sites with clear electron density, 
Hydrogen bonds from the peptide chain to dTTP in A115V 
generally the same as observed in the WT structure 
protein hydrogen bonds are observed in the 110
with the WT structure. 
Figure 9.10: A115V Mt DCD-
the HJL trimer with 2Fobs – Fcalc
 
Figure 9.11: Schematic view of hydrogen bonds to dTTP in the structure of A115V 
* denote residues from a neighboring monomer.
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-118 region of the A115V structure compared 
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 σ = 1.0 electron density map are shown. 
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The structure of the flexible loop of residues 110
WT and the bifunctional enzyme from 
WT:dTTP (Figure 9.12A). The flexible loop in the A115V:dTTP structure is
active conformation, whereas the WT:dTTP structure is in the inactive conformation. However, 
some differences are observed between A115V:dTTP and 
In order to accommodate the 5-
which furthermore results in a 1 Å wider loop measured from His112 CA to Val115 CA. 
 
Figure 9.12: Superposed structures of
(red, pdb 2QXX), B: Mj DCD-DUT:dUMPNPP (blue, pdb 2HXD
 
Figure 9.13: Differences between t
DUT:dUMPNPP (blue, pdb 2HXD
along with 1.45 Å movement of N
backbone of Gly116 in A115V:dTTP has moved 2 Å.
                                                          
5 His128 was flipped because it faced the wrong way based on hydrogen bonds
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-118 in A115V:dTTP more closely resembles apo 
Mj with a substrate analogue bound (Figure 
 thus very similar to the 
Mj DCD-DUT:dUMPNPP (
methyl group of dTTP, Gly116 in A115V:dTTP has moved 2.4 Å, 
 A115V Mt DCD-DUT (green) and A: WT Mt
5).  
he structures of A115V:dTTP (green) and 
5). A: the 1 Å wider loop from His CA to Ala/Val CA is observed 
π. B: to accommodate the 5-methyl group o
 
 
9.12B) than 
Figure 9.13). 
 
 
 DCD-DUT:dTTP 
 
Mj DCD-
f dTTP, the 
The A115V enzyme is unable to exist in the inactive conformation with dTTP bound because of 
the larger size of the valine side chain compared with alanine. In the inactive conformation, the 
valine side chain would clash with the 5
movement of V115 is observed in order for A115V to bind dTTP, see 
structural overlay of WT:dTTP and A115V:dTT
Thr114, and a rearrangement of Thr111 and His112 in a neighboring molecule is necessary to 
avoid clashing of the residues (
the A115V structure is placed in the active conformation and hydrogen bonds of this residue are 
shown in Figure 9.15 for the structures of A115V:dTTP and WT:dTTP and for the corresponding 
His128 in Mj DCD-DUT:dUMPNPP. 
 
Figure 9.14: Overlay of A115V:dTTP (green) and WT:dTTP (red, pdb 2QXX). A shift in the 
backbone causes the valine to take up less space in the nucleotide binding pocket and allows 
room for dTTP binding. A rearrangement of the backbone at Thr111 and His112 prevents the 
side chain of Thr114 from clashing with Thr111 of a neighboring monomer.
The water molecule suggested to be important for dephosphorylation 
in the structure of A115V:dTTP even with the larger side chain of valine compared with alanine, 
see Figure 9.16.  
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Figure 9.15: Schematic and structural views of the hydrogen bonding network of a conserved 
histidine in A: His112 in A115V 
2HXD5) and C: His112 in WT Mt DCD
 
Figure 9.16: A115V:dTTP bound (chain H) shown with 2F
Electron density clearly shows the pr
dephosphorylation [85]. 
A rotation of the nucleotide pyrimidine moiety is observed between the substrate analogue in 
Mj DCD-DUT (pdb 2HXD) and dTTP in A115V and
seen between the pyrimidine planes of superposed nucleotide structures of dTTP in A115V and 
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Mt DCD-DUT:dTTP, B: His128 in Mj DCD-DUT:dUMPNPP (pdb 
-DUT:dTTP (pdb 2QXX). 
 
obs – Fcalc σ = 1.0 electron density map. 
esence of the water molecule suggested to be important for 
 WT (this work and pdb 2QXX). A 23
 
° angle is 
dUMPNPP in Mj DCD-DUT, see 
would apparently clash with Val115 and Ser102 if the pyrimidine moiety attained the same 
conformation as dUMPNPP in 
are shown in Figure 9.18. This
bond present between O4 of the nucleotide pyrimidine moiety and Gly116 in the structure of 
DCD-DUT:dUMPNPP, is not observed in the structures of A115V and WT with dTTP bound. 
Instead, the structures with dTTP bound have an additional hydrogen bond from O2 of the dTTP 
pyrimidine moiety to Nη1 of the conserved Arg106, see 
 
Figure 9.17: Stereo view of nucleotide structures from A115V 
DCD-DUT:dUMPNPP (blue, pdb 2HXD) showing a 23
the two structures. 
 
Figure 9.18: Structure of the A115V:dTTP complex shown in green with the surface of the 
nucleotide binding pocket shown in grey. dTTP shown in red was forced to obtain the same 
conformation as seen for dUMPNPP in 
PDB2PQR [114] and the APBS plugin 
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 rotation causes changes in the hydrogen bond pattern; a hydrogen 
Figure 9.19.  
Mt DCD-DUT:dTTP (green) and 
° turn of the nucleotide pyrimidine ring in 
Mj DCD-DUT (pdb 2HXD). The figure was made using 
[115] to PyMol [5]. 
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Figure 9.19: Schematic view of the hydrogen bonding network of A: Arg106 in A115V:dTTP, B: 
Arg122 in Mj DCD-DUT:dUMPNPP (pdb 2HXD) and C: Arg106 in WT:dTTP (pdb 2QXX). 
A different conformation of the Arg97 side chain is seen in A115V:dTTP (Figure 9.20A)  compared 
with WT:dTTP (Figure 9.20B). In two of the four trimers in the A115V structure, a Mg2+ ion has 
been modeled at the center of the trimer. The distance from Mg2+ to Glu99 Oε is 3-3.2 Å and 
water molecules are likely to occupy some of the space in the center of the trimer. However, the 
resolution is insufficient for modeling of these. Also, it is likely that Mg2+ is present in the other 
trimers, but that the resolution is insufficient for modeling these. The positive charge of Mg2+ 
stabilizes the side chains of Glu99. The conformation of the nearby His112 also does not affect 
the different conformation of Arg97, since apo WT shows the same conformation of His112 as 
A115V, but with Arg97 facing the center of the trimer similarly to WT:dTTP, see Figure 9.20C.  
 
 
Figure 9.20. Center of trimers from A: A115V:dTTP (orange, trimer HJL, Mg2+ grey), B: WT:dTTP 
(red, pdb 2QXX), C: apo WT (green, pdb 2QLP) with Glu99 and Arg97 shown in ball and stick. 
 
9.4 Discussion 
As described in section 7.1, A115V and A115G variants of Mt DCD-DUT were created to 
investigate the importance of steric hindrance by the side chain of Ala115 on a water molecule 
suggested to be crucial for activity [85]. Both variants proved to have some unexpected 
properties. 
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9.4.1 Properties of WT and A115V enzymes 
The flexible region consisting of residues 110-118 in the A115V variant with dTTP bound does 
not have the same conformation as the WT enzyme with dTTP bound. Instead, the conformation 
of the A115V variant is very similar to the active conformation found in Mj DCD-DUT:dUMPNPP. 
The water molecule suggested to be important for dephosphorylation [85] is present in chain H 
in the structure of A115V:dTTP, see Figure 9.16. The A115V variant does not dephosphorylate 
dTTP even though the water molecule is present in the structure and it can therefore not be the 
missing piece in explaining why dTTP is not dephosphorylated.  
Steric hindrance forces a rotation of the nucleotide pyrimidine moiety between dUMPNPP in Mj 
DCD-DUT (pdb 2HXD) and dTTP in A115V and WT (pdb 2QXX), see Figure 9.17. This rotation 
causes changes in the hydrogen bond pattern of a conserved arginine as shown in Figure 9.19. 
Changes in the hydrogen bonds of this conserved arginine (Mt DCD-DUT Arg106, Mj DCD-DUT 
Arg122) also affect a conserved serine (Mt DCD-DUT Ser102, Mj DCD-DUT Ser118) because of 
their shared hydrogen bonds in all structures (Figure 9.19). The serine is crucial for activity and 
has been suggested to play an important role in dephosphorylation by balancing negative charge 
on the oxygen bridging the α,β-phosphorous [93,102]. Arginine is a hydrogen bond donor to 
serine and thus aid in balancing negative charge formed on the serine. The ability of arginine to 
function as a hydrogen bond donor to serine is impaired when dTTP is bound because Arg106 
Nη1 is involved in an additional hydrogen bond to O2 of the dTTP pyrimidine moiety. Also, the 
additional hydrogen bond between arginine and dTTP restrains the flexibility of the arginine. The 
more restrained arginine may be less capable of stabilizing negative charge formed on the 
flexible serine side chain. 
A115V:dTTP is unable to attain in the same conformation as WT:dTTP because of the introduced 
valine side chain. The larger size of the valine side chain forces a rearrangement of the flexible 
110-118 residue range (Figure 9.14) to adopt a conformation very similar to the active 
conformation observed in Mj DCD-DUT:dUMPNPP (Figure 9.12B) at the expense of 7 hydrogen 
bonds in the flexible region. The overall structures are generally very similar, and the loss of 7 
hydrogen bonds in the flexible region may explain the much reduced thermal stability of 
A115V:dTTP compared with WT:dTTP (transition temperatures of 67 vs. 87 °C, section 9.3.5). The 
inability of A115V Mt DCD-DUT to exist in the inactive conformation is supported by the 
hyperbolic saturation curve with dUTP at pH 6.8 (Figure 9.2B), which indicates that no structural 
rearrangement is necessary and the enzyme is active.  
WT binds dTTP in an inactive conformation (pdb 2QXX), see Figure 9.12A. WT:dTTP is unable to 
exist in the active conformation observed in Mj DCD-DUT:dUMPNPP unless the backbone of 
Ala115 and Gly116 moves to accommodate the 5-methyl group of dTTP, see Figure 9.21. This 
movement is accompanied by a rearrangement of His112. This conformational change along 
with hydrogen bond patterns of His112 is shown in Figure 9.15. There is no structural hindrance 
for the WT enzyme to be able to bind dTTP in a similar conformation as seen for A115V:dTTP. 
However, the WT:dTTP structure in the inactive conformation has 7 additional hydrogen bonds 
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in the flexible region compared with A115V:dTTP in the active conformation. Therefore, WT 
favors binding dTTP in the inactive conformation. 
 
Figure 9.21: Electrostatic surface 
shown (pdb 2QXX). The backbone structure of 
blue. The arrow points to the clash between Ala131 and Gly132 in 
and Gly116 in Mt) and dTTP in Mt 
APBS plugin [115] to PyMol [5]. 
 
Unexpectedly, the WT enzyme was uninhib
was even uninhibited by dTTP at dCTP concentrations around 
enzyme showed no binding of dT
and inhibition may be explained by looking into the protonation state of a conserved histidine 
near the nucleotide binding site and 
conformations (Mt His112, Figure 
likely to be affected by the protein environment
may be partly protonated at pH 6.8, while it is primarily deprotonated at pH 8.0. Therefore, the 
difference in dTTP inhibition is probably related to the protonation state of His112. WT 
DUT is likely to adopt the same active co
to the conformation seen in A115V:dTTP. Protonation of His112 stabilize
conformation because of the strain caused by the additional proton in the 110
addition, the hydrogen bond between His112 N
protonated histidine can no longer 
                                                          
6 Calculating the pKa value of His112 in WT:dTTP (pdb 2QXX) using PROPKA 
approximately 3. The decrease is attributed to desolvation, however, un
electron density map at the center of the trimer strongly suggest the presence of disordered solvent near 
the histidine. Therefore, the desolvation correction by PROPKA is likely to b
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histidine hydrogen bond pattern and loop conformation for the active conformation of Mj DCD-
DUT). A complete deprotonation of His112 in WT Mt DCD-DUT causes the enzyme to be present 
solely in the active conformation where it is unable to bind dTTP because of the placement of 
Ala115 and Gly116 (Figure 9.21) [85]. This may explain why no dTTP inhibition was observed at 
pH 8.0. The hyperbolic dCTP and dUTP saturation curves at pH 8.0 support that no structural 
rearrangement is needed for the enzyme to be active. Conversely, this structural rearrangement 
is needed at pH 6.8, where His112 is partly protonated and the WT enzyme exhibits cooperative 
substrate saturation [85].  
Unlike the WT enzyme, A115V Mt DCD-DUT was able to bind dTTP at pH above 6.8. Also, dTTP 
inhibition was observed both at pH 6.8 and 8.0 for A115V. Although the structure of A115V:dTTP 
is very similar to Mj DCD-DUT:dUMPNPP, the strained loop in A115V:dTTP is more loose because 
the V115 side chain and the 5-methyl group of dTTP causes movement of the backbone (Figure 
9.13). The additional space at His112 (approximately 1.5 Å movement of His112 Nπ) in 
A115V:dTTP may allow protonated His112 in the active conformation. A115V dTTP inhibition 
was stronger at pH 8.0 compared with pH 6.8 (Figure 9.4B), which can be explained by 
deprotonated His112 leaving more space for dTTP binding than protonated His112.  
The determined KM for the A115V variant was very low for dUTP at pH 8.0 (0.6 ± 0.2 µM). KM 
values in the 0.1-0.5 µM range have been reported for E. coli dUTPase [101,116], but it is unlikely 
that the A115V variant contains a residual amount of the dUTPase subsequent to purification. Ec 
dUTPase is brought to 60 % saturation with ammonium sulfate during purification [117], 
whereas the bifunctional enzyme is only brought to 40-45 % saturation. Also, the pH effect on KM 
and inhibition by dTTP seen for A115V is not seen for E. coli dUTPase [116].  
The WT enzyme shows a slightly higher kcat (1.2 fold) and a slightly lower KM (1.5 fold) for dCTP 
compared with dUTP at pH 8.0, see Table 9.4. This is contrary to the rates determined by Helt et 
al. [85] at pH 6.8, where a lower reaction rate for dCTP was observed compared with dUTP. The 
protonation state of His112 thus seems to have an influence on whether dCTP deamination or 
dUTP dephophorylation appears to be the rate determining reaction.  
Figure 9.22 presents a schematic overview of the discussed conformations of A115V and WT Mt 
DCD-DUT as well as the protonation state of His112 and how it influences the nucleotide 
binding. 
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Figure 9.22: Schematic overview of the protonation/deprotonation of His112 and relation to the 
active/inactive conformations of the protein. A: WT Mt DCD-DUT does not bind dTTP in the 
active conformation and assumes the inactive conformation when His112 is protonated. B: 
A115V Mt DCD-DUT only exists in a slightly wider conformation, very similar to the active 
conformation, where it binds dTTP regardless of the protonation state of His112. 
 
 
 
 
 
9 CHARACTERIZATION OF WT AND TWO VARIANTS OF MT DCD-DUT 
83 
9.4.2 Properties of the A115G variant 
The A115G variant was investigated as a potential enzyme for cleavage of dTTP as discussed in 
section 7.1. However, the enzyme was unable to cleave dTTP and had about 20 fold reduction in 
kcat for dCTP at pH 8.0 as well as for dUTP at pH 8.0 and 6.8. 
Change of Ala115 to a glycine is very likely to introduce additional flexibility to the already 
flexible 110-118 region as judged from available structures of bifunctional enzymes (Figure 9.12 
and Figure 9.15). There is no structural hindrance for the A115G variant to be able to exist in 
both the active and inactive conformations. The similar morphology of the apo crystals of WT 
and A115G suggests that the A115G enzyme adopts the same conformation as the WT enzyme. 
The introduced flexibility is situated very close to the interfaces between the molecules in the 
trimer. The observed A115G dTTP binding curve (Figure 9.6C), where dTTP occupation decreases 
at higher dTTP concentrations, could possibly be explained by the trimer falling apart when dTTP 
attempts to bind to the second or third site of the trimer, thereby releasing dTTP to the solution. 
The increased flexibility may thus result in a destabilization of the trimer when dTTP binds, 
causing a breakdown of the A115G quaternary structure. 
While the dUTP saturation curves for WT are hyperbolic at pH 8.0 and sigmoidal at pH 6.8, dUTP 
saturation curves for A115G are hyperbolic at both pH 8.0 and pH 6.8. Furthermore, the A115G 
variant shows cooperativity for dCTP saturation at pH 8.0, while the WT enzyme shows 
hyperbolic dCTP saturation. The A115G variant thus appears to distinguish between dCTP and 
dUTP as substrates at pH 8.0 (Figure 9.3C). dUTP readily binds and is dephosphorylated, whereas 
a rearrangement is necessary for dCTP deamination to take place. Ala115 is not conserved 
among dUTPases (Chapter 6) and, hence, it may be speculated that changing Ala115 to a glycine 
may have little effect on the conformation of residues important for dUTPase activity. However, 
the glycine may still affect the ability of the enzyme to bind and convert dUTP due to the 
introduced flexibility near the active site. In the WT enzyme, the backbone oxygen of Ala115 
binds to the catalytic water molecule in the deamination reaction and plays an important role for 
dCTP deaminase activity (described in section 6.2). Glycine lacks Cβ and thus has additional 
allowed backbone conformations compared with other residues [72]. This may be related to the 
observed cooperativity for A115G with dCTP at pH 8.0, where an adjustment of the Gly115 
backbone in the flexible loop may be needed for the reaction to take place.  
An opposite pH effect of dTTP inhibition is observed for the A115G variant compared with the 
WT enzyme (Figure 9.4). A115G shows strong dTTP inhibition at pH 8.0 and no significant 
inhibition at pH 6.8. However, the maximal dTTP concentration was 0.1 mM and additional 
experiments are needed to determine whether the enzyme is completely uninhibited at pH 6.8. 
The pH dependence of the A115G dTTP inhibition was contrary to that of the WT enzyme. The 
A115G enzyme was strongly inhibited by dTTP at pH 8.0, whereas the WT enzyme was 
insensitive to dTTP at pH 8.0. The additional space obtained by replacing alanine with glycine 
could be a simple explanation for dTTP binding at pH 8.0. The effect associated with the unusual 
dTTP binding curve at pH 8.0 discussed above is also likely to contribute to the loss of activity 
observed at pH 8.0. Protonation of His112 at pH 6.8 might have a stabilizing effect on the flexible 
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loop through favorable interactions with backbone oxygens thereby reducing the detrimental 
effect of dTTP. For an illustration of the loop, see Figure 9.15A. 
 
9.5 Conclusion 
Substrate saturation and dTTP inhibition studies have been carried out for WT, A115V and 
A115G Mt DCD-DUT, and the structure of A115V in complex with dTTP has been solved.  
The two variant enzymes were constructed to investigate the importance of steric hindrance on 
a water molecule suggested to play a key role in dephosphorylation. However, this water mole-
cule was present in the structure of A115V:dTTP. The A115V variant did not dephosphorylate 
dTTP and the water molecule can therefore not explain the lack of activity with dTTP bound. The 
pyrimidine moiety of dTTP in the structures of WT and A115V is positioned at a different angle 
than the pyrimidine moiety of dUMPNPP in Mj DCD-DUT. This rotation allows a conserved 
arginine to form a hydrogen bond with O2 of the dTTP pymidine moiety. The conserved arginine 
also forms hydrogen bonds with a conserved serine that plays an important role in 
dephosphorylation, possibly by stabilizing negative charge formed on the oxygen bridging the α-
β-phosphorous of the substrate. The additional hydrogen bond between arginine and dTTP 
impairs the ability of the arginine to be a hydrogen bond donor to the serine and thereby also 
impairs the stabilization of negative charge formed on the oxygen bridging the α-β-phosphorous 
in the course of the reaction. The hydrogen bond between the arginine and dTTP is also likely to 
restrain the position of the arginine and affect the ability of the arginine to bond to the flexible 
serine side chain.  
WT enzyme proved insensitive to the presence of dTTP at pH 8.0, while dTTP inhibition at pH 6.8 
was confirmed. This can be explained by the protonation state of His112 situated close to the 
nucleotide binding site. The flexible loop consisting of residues 110-118 can exist in the active or 
the inactive conformation. The active conformation of the WT enzyme is likely to be the same as 
is observed in Mj DCD-DUT:dUMPNPP, in which the WT enzyme is unable to bind dTTP due to 
steric hindrance by Ala115 and Gly116. The WT enzyme is stabilized in the active conformation 
at pH 8.0 because of the completely deprotonated His112. This can explain the insensitivity to 
dTTP at pH 8.0. The hyperbolic substrate saturation of the WT enzyme at pH 8.0 for both dCTP 
and dUTP supports that the enzyme is present solely in the active conformation. In contrast, 
protonation of His112 at pH 6.8 strains the loop in the active conformation and allows the 
enzyme to bind dTTP in the inactive conformation. 
The conformation of the flexible 110-118 region of the A115V:dTTP structure is very similar to 
the active conformation observed in Mj DCD-DUT:dUMPNPP, whereas the WT:dTTP structure is 
clearly in a different inactive conformation. The A115V variant enzyme is unable to exist in the 
inactive conformation due to steric hindrance caused by the introduced valine side chain. The 
flexible loop in the inactive conformation of WT:dTTP has 7 additional hydrogen bonds 
compared with the A115V:dTTP structure, and the WT enzyme thus favors binding dTTP in the 
inactive conformation. The difference in hydrogen bonds can explain the reduced thermal 
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stability of the A115V enzyme compared with the WT enzyme in the presence of dTTP (transition 
temperatures of 67 °C vs. 87 °C, respectively). 
The A115V variant is inhibited by dTTP at both pH 6.8 and 8.0, albeit with a stronger inhibition at 
pH 8.0. The flexible loop in the A115V:dTTP structure is more loose compared with the loop in 
the active structure of Mj DCD-DUT:dUMPNPP. This additional space may account for dTTP 
binding even with protonated His112. The stronger inhibition at pH 8.0 can be explained by 
deprotonated His112 leaving additional space for dTTP binding compared with protonated 
His112.  
The A115G variant was very sensitive to dTTP at pH 8.0, while no substantial inhibition was 
observed at pH 6.8. The pH dependence of the A115G dTTP inhibition was contrary to that of the 
WT enzyme. This can be explained by the additional space for dTTP binding, which is a result of 
replacing alanine with glycine. However, the unusual dTTP binding curve at pH 8.0 suggests that 
dTTP has a detrimental effect on the protein because of the introduced flexibility near the 
nucleotide binding site. This effect appears to be much reduced at pH 6.8, where the A115G 
shows significantly lower sensitivity to dTTP. This could be caused by protonated His112 having a 
stabilizing effect through a hydrogen bond to Gly115 O, thereby introducing a structural restraint 
on the very flexible 110-118 region.  
The A115G variant showed cooperativity with dCTP as substrate and not with dUTP as substrate 
at pH 8.0. This behavior is not seen for the WT enzyme, which shows hyperbolic saturation with 
both substrates at pH 8.0. The difference in substrate saturation for dCTP and dUTP for the 
A115G variant at pH 8.0 may be caused by the additional flexibility introduced by the glycine in 
the already flexible loop. The additional allowed backbone conformations of glycine may have an 
effect on the observed cooperativity with dCTP at pH 8.0. The backbone of Gly115 may have to 
rearrange for the deamination to take place. This rearrangement may be indifferent for the 
dUTPase reaction, as this residue is involved in deamination and not in dephosphorylation. 
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Chapter Ten 
10 CONCLUDING REMARKS 
This thesis presents work on two different projects: the all cysteinyl coordinated D14C variant of 
the hyperthermostable Pyrococcus furiosus ferredoxin as well as WT and two variants of the 
bifunctional dCTP deaminase-dUTPase from Mycobacterium tuberculosis. The ferredoxin work 
includes expression and purification of D14C [Fe4S4] Pf Fd, as well as cluster conversion and 
subsequent purification, crystallization and crystal structure of D14C [Fe3S4] Pf Fd. The work on 
the bifunctional enzyme and variants includes purifications, substrate saturation at pH 8.0 and 
pH 6.8, dTTP inhibition studies, dTTP binding, DSC and crystallization setups with apo enzyme or 
enzyme in complex with dTTP, dUMPNPP or dUMPCPP. The crystal structure of A115V Mt DCD-
DUT with dTTP bound has been solved. To keep track of crystallization trials and results, a 
program named MyCrystals has been developed and used extensively throughout this work. 
MyCrystals combines pictures with crystallization conditions and is able to sort the pictures 
based on selected conditions to give an overview of the crystallization results. 
Changing the cluster coordinating aspartate to cysteine in Pf Fd proved to impair the ease with 
which D14C [Fe4S4] Fd converted to D14C [Fe3S4] Fd. Purification of the [Fe3S4] containing D14C 
Fd was furthermore challenged by the formation of a disulfide bonded dimer when the free 
cysteine was not protonated. Formation of the disulfide bonded dimer was observed at pH 8.0, 
whereas only the monomer was present at pH 5.8. The crystal structure of D14C [Fe3S4] was 
solved to 2.8 Å despite difficulties in crystallization due to inhomogeneity of the protein solution. 
The crystal structure is the first structure with a [Fe3S4] cluster, in which a cysteine from a full 
cysteine binding motif is unprotected and facing away from the cluster. The structure is in close 
resemblance with the WT [Fe3S4] structure. The crystal packing in both D14C and WT [Fe3S4] Fd 
showed extended β-sheet dimers. These dimers were not observed in solution and were 
probably formed as a result of the high protein concentration in the crystals.  
WT, A115V and A115G Mt DCD-DUT have been successfully purified. The A115G variant was 
prone to degradation and in order to obtain intact protein, the purification procedure was 
carried out quickly and with minimal protein precipitation. Precipitation issues were solved by 
changing pH of the buffer from 6.8 to 8.0. Distinct differences in the enzyme kinetics were 
observed at these two pH values, and structural analyses were used as a basis for explaining this 
behavior. The variants were created to investigate the importance of steric hindrance on a water 
molecule suggested to play a key role in dephosphorylation. However, this water molecule was 
present in the structure of A115V:dTTP and the variant did not dephosphorylate dTTP. A rotation 
of the dTTP pyrimidine moiety is observed in the structures of A115V and WT compared with the 
pyrimidine moiety of dUMPNPP in Mj DCD-DUT. This causes changes in the hydrogen bonding 
pattern of conserved residues in the active site and may give rise to less stabilization of the 
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negative charge formed on the oxygen bridging the α-β-phosphorous in the course of the 
dephosphorylation reaction. The structure of A115V Mt DCD-DUT with dTTP bound is in close 
resemblance with DCD-DUT from M. jannaschii with dUMPNPP bound and thus contributes with 
important information on the conformation of conserved residues. The flexible region made up 
of residues 110-118 near the nucleotide binding site rearranges between an active and an 
inactive conformation. dTTP binds to the WT enzyme in the inactive conformation (pdb 2QXX), 
while the active conformation is seen in the structure of Mj DCD-DUT with a substrate analogue 
bound (pdb 2HXD). The flexible region in the solved structure of A115V:dTTP is very similar to 
the active conformation. Unlike the WT enzyme, the A115V variant is unable to bind dTTP in the 
inactive conformation due to steric hindrance caused by the introduced valine side chain. The 
differences seen between A115V:dTTP and Mj DCD-DUT:dUMPNPP are caused by the additional 
methyl group on dTTP and the larger size of the valine side chain. The WT enzyme could exist in 
the same conformation as A115V:dTTP with dTTP bound, but the WT enzyme has 7 additional 
hydrogen bonds in the 110-118 region in the inactive conformation and thus favors binding dTTP 
in the inactive conformation. This difference in hydrogen bonds may also explain the much 
reduced thermal stability of the A115V enzyme compared with the WT enzyme in the presence 
of dTTP (transition temperatures of 67 vs. 87 °C, respectively). 
WT enzyme was inhibited by dTTP at pH 6.8 and unexpectedly proved insensitive to dTTP at pH 
8.0. The protonation state of the conserved His112 in the flexible loop is likely to play an 
important role in the differences in dTTP binding and inhibition observed with varying pH. At pH 
8.0, His112 is completely deprotonated and stabilized in the active conformation, which does 
not allow dTTP binding because of the Ala115 and Gly116 backbones. Protonated His112 strains 
the 110-118 active conformation and allows the WT enzyme to bind dTTP in the inactive 
conformation at pH 6.8. 
The A115V variant was inhibited by dTTP at both pH 6.8 and 8.0 and thus allowed dTTP binding 
even with partly protonated His112. The structure of A115V:dTTP reveals a more loose loop of 
the 110-118 region compared with Mj DCD-DUT:dUMPNPP because of steric hindrance caused 
by the introduced valine side chain and the methyl group of dTTP. This may allow sufficient room 
for protonated histidine even with dTTP bound in a conformation very similar to the active 
conformation.  
The A115G variant was very sensitive to dTTP at pH 8.0, while no substantial inhibition was 
observed at pH 6.8. dTTP binding at pH 8.0 may be explained by the additional flexibility and 
space caused by the introduced glycine. In contrast to both WT and A115V, the protonated 
histidine in A115G may induce stability by binding to the backbone oxygen of Gly115, thereby 
causing a structural restraint on the very flexible loop and reducing dTTP inhibition. The A115G 
variant appeared to distinguish between dCTP and dUTP as substrates at pH 8.0, where 
substrate saturation curves were sigmoidal and hyperbolic, respectively. This may be related to 
Ala115 (for WT) being involved in dCTP deamination. Glycine has additional allowed backbone 
conformations, and A115G may thus require adjustment of the protein chain at Gly115 in order 
for the deamination to take place. In contrast, no dependence on the Gly115 conformation was 
seen for dephosphorylation, emphasizing that this residue is not involved in dephosphorylation.
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11 OUTLOOK 
The successful formation of D14C [Fe3S4] Pf Fd is a preceding step to the formation of 
heterometallic clusters. Subsequent to the developed oxidation procedure presented in this 
thesis, the D14C Fd has been synthesized with two heterometallic clusters. [ZnFe3S4] and 
[AgFe3S4] were produced, purified and characterized by Maja Martic [63]. Additional studies of 
other types of heterometallic clusters as well as studies of the possible catalytic abilities of these 
ferredoxins are among the perspectives. 
Evolution is constantly on-going and studying evolution is of interest to provide substantial, 
fundamental knowledge on how organisms function and evolve. In unraveling the evolution of 
base pairing in DNA, the study of an intermediate step in dTTP synthesis in this work is but a 
small contribution. However, all contributions are important when adding up information across 
molecular families.  
It is difficult to ascertain what kind of mutational study could entail dephosphorylation of dTTP 
by the bifunctional Mt DCD-DUT. Removing side chains introduces additional flexibility and has a 
detrimental effect on the protein nucleotide binding, as was seen for the A115G variant. 
However, the steric hindrance of particularly Ala115 and Gly116 backbones cause dTTP to bind 
with the pyrimidine moiety in a different angle, thereby causing the hydrogen bond pattern and 
the flexibility of conserved residues to change and possibly disrupt activity.  
pH proved to play an important role for activity and inhibition, and further studies of the pH 
effect on the properties of other members of the enzyme family can contribute to the 
understanding of the factors influencing substrate and/or inhibitor binding. 
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Appendix A 
A MYCRYSTALS AND DATABASES 
Enclosed is a DVD with the program MyCrystals, which is described in Chapter 2. The DVD also 
contains three databases with crystallization results and corresponding folders including 
crystallization pictures. The DVD is placed on the last page of the thesis for practical reasons. 
Available databases: 
Ferredoxin.xml Database with 461 entries of crystallization results for D14C [Fe3S4] 
Pyrococcus furiosus ferredoxin (section 5.3.1). 
DCDDUT.xml Database with 379 entries of crystallization results for WT, A115V 
and A115G Mycobacterium tuberculosis dCTP deaminase-dUTPase. 
There is an option to sort database results based on enzyme variant 
(section 9.3.6).  
NDKext.xml Database with 383 entries of crystallization results for an extended 
version of nucleoside diphosphate kinase from Sulfolobus 
solfataricus (Appendix F.3.1). 
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B FERREDOXIN EXPERIMENTAL PROCEDURES 
Subsequent to the oxidation procedure described in detail below, the protein solution was 
exchanged into 20 mM Tris/HCl pH 8.0 by ultrafiltration and then purified by anion exchange at 
pH 8.0 unless otherwise specified. Each solution was loaded onto a 16 mm/10 cm Source 30Q 
column equilibrated with 20 mM Tris/HCl pH 8.0. The column was washed with 2 CV 20 mM 
Tris/HCl pH 8.0 and elution was carried out using a linear salt gradient of 0.15 M to 0.4 M NaCl in 
20 mM Tris/HCl pH 8.0 over 17 CV. 
Ultrafiltration was carried out at 4 °C in a stirred Amicon cell with a PLBC NMWL 3 kDa 
membrane. During the anaerobic experiments, all buffer solutions were flushed with argon to 
remove oxygen (1 hour per 100 mL using the manifold and 1 hour per L using the degassing 
equipment connected to the HPLC). All flasks and tubes were sealed off with Suba-Seal silicon 
rubber septa (Sigma-Aldrich) and filled with argon through teflon tubings fitted with stainless 
steel needles. Syringes used for transfer of protein and solutions were also repeatedly purged 
with argon prior to use. 
B. 15 min, 0.3 M NaCl in 20 mM Tris/HCl pH 8.0  
15x molar excess of K3[Fe(CN)6]Cl3 was used. 5 mL ferricyanide in 20 mM Tris/HCl pH 8.0 was 
added to 10 mg protein in 5 mL 0.3 M NaCl in 20 mM Tris/HCl pH 8.0. The solution was 
incubated at room temperature for 15 minutes with gentle stirring. 
C. 15 min, 100 mM Tris/HCl pH 7.8  
15x molar excess of K3[Fe(CN)6]Cl3 was used. 5 mL ferricyanide solution in 100 mM Tris/HCl pH 
7.8 was added to 10 mg protein in 5 mL 100 mM Tris/HCl pH 7.8. The solution was incubated at 
room temperature for 15 minutes with gentle stirring. 
D/E. 45 min and 3 hrs, 100 mM Tris/HCl pH 7.8  
15x molar excess of K3[Fe(CN)6]Cl3 was used. The ferricyanide solution in 100 mM Tris/HCl pH 7.8 
was added to 17 mg protein solution (also in 100 mM Tris/HCl pH 7.8) and the volume adjusted 
with buffer to 17 mL. 8.5 mL were extracted after an incubation time of 45 minutes and the 
remaining was incubated for a total of 3 hours with gentle stirring. 
F. 15 min, 100 mM BisTrisPropane/HCl pH 6.5, anaerobic purification 
15x molar excess of ferricyanide was used. 5 mL ferricyanide in 100 mM BisTrisPropane/HCl pH 
6.5 was added to 10.2 mg protein in 5 mL 100 mM BisTrisPropane/HCl pH 6.5. The solution was 
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incubated at room temperature for 15 minutes with gentle stirring. Ferricyanide in 5 mL buffer. 
The solution was exchanged into 20 mM Tris/HCl pH 8.0 buffer by ultrafiltration. Anion exchange 
purification was carried out anaerobically using the same purification procedure as described 
above. 
G. 45 min, EDTA, 20 mM Tris/HCl pH 8.0  
15x molar excess of ferricyanide was used. The ferricyanide solution in 20 mM Tris/HCl pH 8.0 
was added to 8 mg protein solution (also in 20 mM Tris/HCl pH 8.0) and 1.5x molar excess EDTA 
was added. The volume adjusted with buffer to 8 mL. The solution was incubated at room 
temperature for 45 minutes with gentle stirring. 
H. 50 min, EDTA, 50 mM Sodium Acetate/Acetic Acid pH 4.5  
15x molar excess of ferricyanide was used. 5 mg protein in 50 mM Sodium Acetate/Acetic Acid 
pH 4.5 was added the ferricyanide solution and 1.5x molar excess of EDTA. The volume was 
adjusted to approximately 5 mL with 50 mM Sodium Acetate/Acetic Acid pH 4.5. Incubated at 
room temperature for 50 minutes with stirring. 
I. 3 hrs and overnight at 4 °C, EDTA, 20 mM BisTris/HCl pH 5.8  
15x molar excess of ferricyanide was used. 4.5 mg protein (in 20 mM BisTris/HCl pH 5.8) was 
added the ferricyanide solution and 1.5x molar excess of EDTA. The volume was adjusted to 4.5 
mL with 20 mM BisTris/HCl pH 5.8. The solution was incubated for 3 hours with stirring and left 
overnight at 4 °C with mild stirring. 
J. Overnight, EDTA, 20 mM BisTris/HCl pH 5.8  
15x molar excess of ferricyanide was used. The ferricyanide solution and 1.5x molar excess of 
EDTA were added to 11.7 mg protein in 20 mM BisTris/HCl pH 5.8. The volume was adjusted to 
13 mL with 20 mM BisTris/HCl pH 5.8. The solution was incubated for overnight with stirring. 
The experiment was repeated; 15x molar excess ferricyanide solution and 1.5x molar excess 
EDTA were added to 16.9 mg protein in 20 mM BisTris/HCl pH 5.8. The volume was adjusted to 
16.9 mL with 20 mM BisTris/HCl pH 5.8 and the solution was incubated for overnight with 
stirring. Purified in two identical anion exchange runs at pH 8.0. 
K. 3 hrs, EDTA, 20 mM BisTris/HCl pH 5.8, anion exchange pH 5.8  
15x molar excess of ferricyanide was used. 4.3 mg protein (in 20 mM BisTris/HCl pH 5.8) was 
added the ferricyanide solution and 1.5x molar excess of EDTA. The volume was adjusted to 4.5 
mL with 20 mM BisTris/HCl pH 5.8. The solution was incubated for 3 hours with stirring. The 
solution was exchanged into 20 mM BisTris/HCl pH 5.8 by ultrafiltration and subsequently 
loaded onto a 16 mm/10 cm Source 30Q column equilibrated with 20 mM BisTris/HCl pH 5.8. 
The column was washed with 2 CV 20 mM Tris/HCl pH 5.8 and elution was carried out using a 
linear salt gradient of 0 M to 0.3 M NaCl in 20 mM Tris/HCl pH 5.8 over 20.4 CV. 
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Additional anion exchange runs were performed on fractions from the initial purification and on 
D14C [Fe4S4] Pf Fd. Column and procedure were identical with the above mentioned 
purifications at either pH 5.8 or 8.0 in 20 mM Tris/HCl. Prior to additional runs, the fractions 
were washed into the respective anion exchange buffer by ultrafiltration. 
L. 3 hrs, EDTA, BisTris/HCl pH 5.8, anion exchange pH 5.8  
15x molar excess of ferricyanide was used. 8.2 mg protein (in 20 mM BisTris/HCl pH 5.8) was 
added the ferricyanide solution and 1.5x molar excess of EDTA. The volume was adjusted to 8.2 
mL with 20 mM BisTris/HCl pH 5.8. The solution was incubated for 3 hours. The solution was 
exchanged into 20 mM BisTris/HCl pH 5.8 by ultrafiltration and subsequently loaded onto a 16 
mm/10 cm Source 30Q column equilibrated with 20 mM BisTris/HCl pH 5.8. The column was 
washed with 2 CV 20 mM Tris/HCl pH 5.8 and elution was carried out using a linear salt gradient 
of 0.05 M to 0.28 M NaCl in 20 mM Tris/HCl pH 5.8 over 15.6 CV. 
Additional anion exchange runs were performed on fractions from the initial purification and on 
a mix of fractions from the initial purification and purified D14C [Fe4S4] Pf Fd. The fractions were 
washed into 20 mM Tris/HCl pH 8.0 by ultrafiltration. Column and procedure were identical with 
the above mentioned purification at pH 8.0 in 20 mM Tris/HCl. 
Also, an anaerobic purification was performed at pH 8.0 on fractions from the initial purification. 
The protein fractions were washed into 20 mM Tris/HCl pH 8.0 by ultrafiltration and 
deoxygenized under argon atmosphere prior to the anion exchange run. 
M. Overnight, EDTA, BisTris/HCl pH 5.8, anion exchange pH 5.8  
15x molar excess of ferricyanide was used. The ferricyanide solution and 1.5x molar excess of 
EDTA were added to 14.5 mg protein in 20 mM BisTris/HCl pH 5.8. The volume was adjusted to 
14.5 mL with 20 mM BisTris/HCl pH 5.8. The solution was incubated overnight with stirring at 
room temperature. The solution was exchanged into 20 mM BisTris/HCl pH 5.8 by ultrafiltration 
and subsequently loaded onto a 16 mm/10 cm Source 30Q column equilibrated with 20 mM 
BisTris/HCl pH 5.8. The column was washed with 2 CV 20 mM Tris/HCl pH 5.8 and elution was 
carried out using a linear salt gradient of 0.05 M to 0.28 M NaCl in 20 mM Tris/HCl pH 5.8 over 
15.6 CV. 
N. 15 min, 100 mM Tris/HCl pH 7.8, anion exchange pH 7.8  
15x molar excess of ferricyanide was used. The ferricyanide solution was added to 14.5 mg 
protein in 100 mM Tris/HCl pH 7.8. The volume was adjusted to 14.5 mL with 100 mM Tris/HCl 
pH 7.8. The solution was incubated at room temperature for 15 minutes with gentle stirring and 
then exchanged into 20 mM Tris/HCl pH 7.8 by ultrafiltration. The protein solution was loaded 
onto a 16 mm/10 cm Source 30Q column equilibrated with 20 mM Tris/HCl pH 7.8. The column 
was washed with 2 CV 20 mM Tris/HCl pH 7.8 and elution was carried out using a linear salt 
gradient of 0.15 M to 0.4 M NaCl in 20 mM Tris/HCl pH 7.8 over 17 CV. 
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O. Attempt to insert Co  
15x molar excess of ferricyaide was used. The ferricyanide solution in 20 mM Tris/HCl pH 8.0 was 
added to 10 mg protein solution (also in 20 mM Tris/HCl pH 8.0) and 10x molar excess CoCl2 was 
added. The volume adjusted with buffer to 10 mL. The solution was incubated at room 
temperature for 45 minutes with gentle stirring. 
P. Attempts with dithionite, conversion suggested by Moura et al. [A1]  
7.5 mg protein (in 1125 µL 20 mM Tris/HCl pH 8.0) was added 750 µL 0.8 M Tris/HCl pH 7.6 and 
then added 100x molar excess of dithionite. The volume was adjusted to 7.5 mL with 0.8 M 
Tris/HCl pH 7.6. 
7.5 mg protein (in 1125 µL 20 mM Tris/HCl pH 8.0) was added 750 µL 0.8 M NaCl in 0.1 M 
Tris/HCl pH 7.6 and then added 100x molar excess of dithionite. The volume was adjusted to 7.5 
mL with 0.1 M Tris/HCl + 0.8 M NaCl pH 7.6. 
Both solutions were incubated 2.5 hours and EDTA in 1.5x molar excess was added prior to 
ultrafiltration. 
Q. Attempt with [Fe(phen)3]
3+  
15x molar excess of [Fe(phen)3]
3+ was used. 3 mL [Fe(phen)3]
3+ solution in water was added to 5 
mg protein (in 2 mL 20 mM Tris/HCl pH 8.0). The solution was incubated for 20 minutes. 
[Fe(phen)3]
2+  was prepared by mixing Fe(NH4)2(SO4)2) with 1,10-phenanthroline monohydrate in 
aqueous solution. The product was oxidized to [Fe(phen)3]
3+ by addition of 
(NH4)2Ce(NO3)6.NaClO4 was added and the solution was cooled on ice, filtered and dried to form 
solid Fe(phen)3(ClO4)3 [A2,3].  
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C FERREDOXIN RESULTS 
General denotations for all figures in this Appendix: chromatogram show elution followed at 
280, 390 and 408 nm (blue, red and pink, respectively) and collected fractions are marked with a 
black line, whereas vertical lines on UV-vis spectra mark 390 nm and/or 408 nm. 
 
Figure C.1: Oxidation of D14C Pf Fd; chromatogram and UV-vis spectra from experiment B.  
 
 
Figure C.2: Oxidation of D14C Pf Fd; chromatogram and UV-vis spectrum from experiment O.  
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Figure C.3: Treatment of D14C Pf Fd; chromatograms and UV-vis spectrum from experiments P. 
Top: treated in 0.8 M Tris/HCl pH 7.6. Bottom: treated in 0.8 M NaCl in 0.1 M Tris/HCl pH 7.6. 
 
 
 
Figure C.4: Oxidation of D14C Pf Fd; chromatogram from experiment Q. 
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Figure C.5: Oxidation of D14C Pf Fd; chromatograms from experiments C, D and E. Incubation 
times are given and the corresponding UV-vis spectra are given to the right of the chromato-
grams.  
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Figure C.6: Oxidation of D14C Pf Fd; chromatogram from experiment F. 
 
  
Figure C.7: Oxidation of D14C Pf Fd; chromatogram and UV-vis spectrum from experiment N. 
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Figure C.8: Oxidation of D14C Pf Fd; chromatogram from experiment G and H.   
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Figure legend on the next page
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Figure C.9: Oxidation of D14C Pf Fd; chromatograms and UV-vis spectra from experiments L. 
Top: chromatogram, purification at pH 5.8. Second to the top: aliquot of collected fractions from 
the top chromatogram re-run at pH 8.0. Second to the bottom: aliquot of collected fraction from 
top chromatogram mixed with D14C [Fe4S4] Pf Fd and re-run at pH 8.0. Bottom: aliquot of 
collected fractions from top chromatogram re-run at pH 8.0 anaerobically.   
 
 
Figure C.10: Mass spectrometric analysis by Alphalyse A/S. Deconvoluted spectrum and original 
spectra of protein in peak a from experiment G. 
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D DCTP DEAMINASE-DUTPASE EXPERIMENTAL 
PROCEDURES 
Centrifugations were at 4 °C in a Sorvall R5C centrifuge with a SS-34 rotor. 
 
D.1 Purification of WT enzyme 
Cell pellet from 250 mL culture was defrosted on ice. 20 mL 50 mM KH2PO4/K2HPO4 pH 6.8 was 
added and the cells resuspended. The cells were lysed by sonication 8 times for 1 minute while 
kept on ice. The suspension was kept on ice for 30 seconds in between sonications. The 
suspension was centrifuged for 20 minutes at 10,000 rpm. The supernatant was decanted off 
and kept on ice. While stirred on ice, 10 (w/w)% streptomycin was slowly added to the solution 
to a final concentration of 1 %. The solution was left for 30 minutes with gentle stirring on ice. 
The solution was centrifuged for 20 minutes at 10,000 rpm. The supernatant was decanted off 
and dialyzed against 500 mL 50 mM KH2PO4/K2HPO4 pH 6.8 at 4 °C overnight. 
The protein solution was loaded onto a 14 mm/30 cm DE52 anion exchange column equilibrated 
with 50 mM KH2PO4/K2HPO4 pH 6.8. The column was washed with 1 CV 50 mM KH2PO4/K2HPO4 
pH 6.8 and eluted using a linear salt gradient of 50 mM KH2PO4/K2HPO4 pH 6.8 to 0.4 M NaCl in 
50 mM KH2PO4/K2HPO4 pH 6.8 over 5 CV. The absorbance at 280 nm and SDS-PAGE were used to 
determine the protein content and purity of the collected fractions. The selected fractions were 
pooled, diluted two times and loaded onto the re-equilibrated column. The anion exchange step 
was then repeated. The selected fractions were pooled and solid (NH4)2SO4 was added to 45 % 
saturation while stirring the solution on ice. The solution was stirred for 5 minutes and then 
centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the pellet was 
dissolved in 2.5 mL 20 mM HEPES/NaOH pH 8.0. The solution was dialyzed twice against 500 mL 
20 mM HEPES/NaOH pH 8.0. The protein content was measured using the absorbance at 280 nm 
and the protein stored at -20 °C in 150 µL aliquots. 
 
D.2 Purification of the A115V variant 
The A115V variant of Mt DCD-DUT was purified using the same techniques as used for the WT 
enzyme described in section D.1. The most significant change was an additional ammonium 
sulfate precipitation prior to the anion exchange. 
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Cell pellet from 250 mL culture was defrosted on ice. 20 mL 50 mM KH2PO4/K2HPO4 pH 6.8 was 
added and the cells resuspended. A 15 µL sample (V1) of the resuspension was drawn for SDS-
PAGE. The cells were lysed by sonication 12 times for 30 seconds while kept on ice. The 
suspension was kept on ice for 30 seconds in between sonications. The suspension was 
centrifuged for 20 minutes at 10,000 rpm. The supernatant was decanted off and kept on ice. A 
15 µL sample of the supernatant (V2) and a sample of the pellet (V3) was drawn for SDS-PAGE. 
While stirred on ice, 10 (w/w)% streptomycin was slowly added to the solution to a final 
concentration of 1 %. The solution was left for 30 minutes with gentle stirring on ice. The 
solution was centrifuged for 20 minutes at 14,000 rpm. The supernatant was decanted off and 
kept on ice. A 15 µL sample of the supernatant (V4) and a sample of the pellet (V5) were drawn 
for SDS-PAGE. The solution was gently stirred on ice and solid (NH4)2SO4 was slowly added to 40 
% saturation. The solution was stirred for 5 minutes on ice and then centrifuged for 20 minutes 
at 14,000 rpm. The supernatant was discarded and the pellet was dissolved in 10 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8. 15 µL samples of the supernatant (V6) and of the dissolved pellet (V7) 
were drawn for SDS-PAGE. Solid (NH4)2SO4 was slowly added to 40 % saturation and the solution 
was gently stirred on ice for 5 minutes.  The solution was stirred for 5 minutes and then 
centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the pellet was 
dissolved in 10 mL 50 mM KH2PO4/K2HPO4 pH 6.8. 15 µL samples of the supernatant (V8) and of 
the dissolved pellet (V9) were drawn for SDS-PAGE. The protein solution was loaded onto a 14 
mm/30 cm DE52 anion exchange column equilibrated with 50 mM KH2PO4/K2HPO4 pH 6.8. The 
column was washed with 2 CV 50 mM KH2PO4/K2HPO4 pH 6.8 and eluted using a linear salt 
gradient of 50 mM KH2PO4/K2HPO4 pH 6.8 to 0.4 M NaCl in 50 mM KH2PO4/K2HPO4 pH 6.8 over 4 
CV. The absorbance at 280 nm and SDS-PAGE were used to determine the protein content and 
purity of the collected fractions. The selected fractions were pooled and solid (NH4)2SO4 was 
added to 40 % saturation while stirring the solution on ice. The solution was stirred for 5 minutes 
and then centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the 
pellet was dissolved in 5 mL 50 mM KH2PO4/K2HPO4 pH 6.8. The solution was dialyzed twice 
against 500 mL 50 mM KH2PO4/K2HPO4 pH 6.8 and centrifuged for 20 minutes at 14,000 rpm. The 
supernatant was decanted off and stored at -20 °C in 200 µL aliquots. 
At this point, the solubility experiments described in section 8.2.4 were carried out. Based on the 
results (section 8.3.5), the A115V protein aliquots were defrosted on ice and pooled. Solid 
(NH4)2SO4 was slowly added to 40 % saturation. The solution was stirred for 5 minutes on ice and 
then centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the pellet 
dissolved in 20 mM HEPES/NaOH pH 8.0. The protein solution was dialyzed against 500 mL 20 
mM HEPES/NaOH pH 8.0 and frozen in aliquots of 150 µL at -20 °C. 
 
D.3 Purification of the A115G variant 
Purification of A115G Mt DCD-DUT was carried out similarly to the purification described in 
section D.4, albeit leaving out dialysis prior to ion exchange in order to save time. 
Two tubes of cell pellet from a total of 250 mL culture were defrosted on ice. 10 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8 was added to each tube and the cells resuspended. The cells were lysed 
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by sonication twelve times for 30 seconds while kept on ice. The suspension was allowed to cool 
down for 30 seconds in between sonications. The suspension was centrifuged for 20 minutes at 
10,000 rpm. The supernatant was decanted off and kept on ice. A 50 µL sample of the 
supernatant (G1) was drawn for SDS-PAGE. While stirred on ice, 10 (w/w)% streptomycin was 
slowly added to the solution to a final concentration of 1 %. The solution was left for 30 minutes 
with gentle stirring on ice. The solution was centrifuged for 20 minutes at 14,000 rpm. The 
supernatant was decanted off and kept on ice.The solution was gently stirred on ice and solid 
(NH4)2SO4 was slowly added to 40 % saturation. The solution was stirred for 5 minutes on ice and 
then centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the pellet 
was dissolved in 20 mL 50 mM KH2PO4/K2HPO4 pH 6.8. A sample of the dissolved pellet (G2) was 
drawn for SDS-PAGE. The protein solution was loaded onto a 14 mm/30 cm DE52 anion 
exchange column equilibrated with 50 mM KH2PO4/K2HPO4 pH 6.8 and eluted using a linear salt 
gradient of 50 mM KH2PO4/K2HPO4 pH 6.8 to 0.4 M NaCl in 50 mM KH2PO4/K2HPO4 pH 6.8 over 4 
CV. The absorbance at 280 nm and SDS-PAGE were used to determine the protein content and 
purity of the collected fractions. The selected fractions were pooled and solid (NH4)2SO4 was 
added to 40 % saturation while stirring the solution on ice. The solution was stirred for 5 minutes 
and then centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and the 
pellet was dissolved in 2 mL 20 mM HEPES/NaOH pH 8.0. The solution was dialyzed against 500 
mL 20 mM HEPES/NaOH pH 8.0 and a sample for SDS-PAGE was drawn. The protein solution was 
stored in 150 µL aliquots at -20 °C. 
 
D.4 Purification 2 of the A115G variant 
Cell pellet from 250 mL culture was defrosted on ice. 20 mL 50 mM KH2PO4/K2HPO4 pH 6.8 was 
added and the cells resuspended. The cells were lysed by sonication twelve times for 30 seconds 
while kept on ice. The suspension was allowed to cool down for 30 seconds in between 
sonications. The suspension was centrifuged for 20 minutes at 10,000 rpm. The supernatant was 
decanted off and kept on ice. While stirred on ice, 10 (w/w)% streptomycin was slowly added to 
the solution to a final concentration of 1 %. The solution was left for 30 minutes with gentle 
stirring on ice. The solution was centrifuged for 20 minutes at 14,000 rpm. The supernatant was 
decanted off and kept on ice. The solution was gently stirred on ice and solid (NH4)2SO4 was 
slowly added to 40 % saturation. The solution was stirred for 5 minutes and then centrifuged for 
20 minutes at 14,000 rpm. The supernatant was discarded and the pellet was dissolved in 10 mL 
50 mM KH2PO4/K2HPO4 pH 6.8. The solution was dialyzed against 500 mL 50 mM KH2PO4/K2HPO4 
pH 6.8. The solution was centrifuged 20 minutes at 14,000 rpm. The supernatant (S) was 
decanted off and the pellet (B) resuspended in 10 mL 50 mM KH2PO4/K2HPO4 pH 6.8. SDS-PAGE 
samples were drawn from both solutions. 
A glass pipette was used to collect the clear protein solution when the pellet of solution B had 
settled. A sample for SDS-PAGE was drawn (B2). The clear solution was added 10 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8. Solid (NH4)2SO4 was slowly added to 40 % saturation and the solution 
was left for 5 minutes with gentle stirring on ice. The solution was centrifuged for 20 minutes at 
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14,000 rpm. The supernatant was discarded and the pellet was dissolved in 5 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8 (B3). 
The supernatant protein solution (S) was loaded onto a 14 mm/30 cm DE52 anion exchange 
column equilibrated with 50 mM KH2PO4/K2HPO4 pH 6.8 and eluted using a linear salt gradient of 
50 mM KH2PO4/K2HPO4 pH 6.8 to 0.4 M NaCl in 50 mM KH2PO4/K2HPO4 pH 6.8 over 4 CV. The 
absorbance at 280 nm and SDS-PAGE were used to determine the protein content and purity of 
the collected fractions. The selected fractions were pooled and solid (NH4)2SO4 was added to 40 
% saturation while gently stirring the solution on ice. The solution was gently stirred for 5 
minutes and then centrifuged for 20 minutes at 14,000 rpm. The supernatant was discarded and 
the pellet was dissolved in 10 mL 50 mM KH2PO4/K2HPO4 pH 6.8 (S2). 
The two protein solutions (B3 and S2) were both dialyzed twice against 500 mL 50 mM 
KH2PO4/K2HPO4 pH 6.8. The solutions were both centrifuged for 20 min at 14,000 rpm. The 
supernatants were decanted off and added 10 % azid to a final concentration of 0.02 % (B4 and 
S3). 
 
D.5 Purification 3 of the A115G variant 
Purification 3 of A115G Mt DCD-DUT was carried out identically with the WT purification 
described in Appendix D.1, except the protein was frozen at -20 °C for approximately 3 weeks 
prior to the final ammonium sulfate precipitation. 
 
D.6 SDS-PAGE gel casting 
SDS-PAGE gels were cast with 12.5 % Acrylamide. A rack designed for gel casting was used and 
the running gel was cast first and allowed to polymerize for a few minutes before the stacking 
gel was cast on top of it. 
SDS-PAGE running gel  
Water 3000 µL 
1.5 M Tris/HCl pH 8.8    2400 µL 
Acrylamid/Bis-acrylamid (30/0.8 w/w %) 4000 µL 
10 % Sodium dodecyl sulfate 2400 µL 
20 % Ammonium persulfate 5 µL 
N,N,N',N'-tetramethylethylene diamine (TEMED) 96 µL 
  
SDS-PAGE stacking gel  
Water 3440 µL 
1 M Tris/HCl pH 6.8 625 µL 
Acrylamid/Bisacrylamid (30/0.8 w/w %) 830 µL 
10 % Sodium dodecyl sulfate 50 µL 
20 % Ammonium persulfate 50 µL 
N,N,N',N'-tetramethylethylene diamine (TEMED) 4 µL 
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D.1 Nucleotide Saturation 
Experimental details for nucleotide saturation assays with WT, A115V and A115G Mt DCD-DUT 
carried out as described in section 9.2.2 are given in Table D.1. 
 
Table D.1: Assay mix contents and corresponding in-assay nucleotide concentrations and 
enzyme dilution factors (in-assay) during nucleotide saturation experiments with WT, A115V and 
A115G Mt DCD-DUT. All given concentrations are in-assay initial concentrations. Labeled 
nucleotide was added in minor amounts; 3H dCTP to dCTP nucleotide mixtures and 3H dUTP to 
dUTP nucleotide mixtures. 
Assay mix Assay components 
[MgCl2] HEPES/NaOH [dCTP] [dUTP]  
Total enzyme 
dilution 
WT     cinitial = 91 µM 
≤ 2 mM 20 mM pH 8.0 9.4-3600 µM - 100-400x 
≤ 2 mM 20 mM pH 8.0 - 9.4-2400 µM 100-400x 
≤ 2 mM 20 mM pH 6.8 - 19-2400 µM 100-200x 
     
A115V    cinitial = 191 µM 
2-5.5 mM 20 mM pH 8.0 0.019-4.8 mM - 30-60x 
2-3 mM 20 mM pH 8.0 - 0.16-2400 µM 30-2000x 
2-3 mM 20 mM pH 6.8 - 5-2400 µM 30-600x 
     
A115G    cinitial = 144 µM 
≤ 2 mM 20 mM pH 8.0 19-3600 µM - 10-40x 
≤ 2 mM 20 mM pH 8.0  9.4-2400 µM 10-80x 
≤ 2 mM 20 mM pH 6.8 - 9.4-2400 µM 10-20x 
 
 
D.2 dTTP Inhibition 
Experimental details for dTTP inhibition assays carried out with WT, A115V and A115G Mt DCD-
DUT as described in section 9.2.3 are given in Table D.2. 
 
D.3 Differential Scanning Calorimetry 
Experimental details for DSC experiments with WT, A115V and A115G Mt DCD-DUT carried out 
as described in section 9.2.6 are given in Table D.3. 
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Table D.2: Assay mix contents and corresponding in-assay dTTP concentration range and enzyme 
dilution factors (in-assay) during dTTP inhibition experiments with WT, A115V and A115G Mt 
DCD-DUT. All given concentrations are in-assay initial concentrations. Labeled nucleotide was 
added in minor amounts; 3H dCTP to dCTP nucleotide mixtures and 3H dUTP to dUTP nucleotide 
mixtures. 
Assay mix   Assay components 
[MgCl2] HEPES/NaOH [dCTP] [dUTP] [dTTP]  
 Total enzyme 
dilution 
WT     cinitial = 91 µM 
2 mM 20 mM pH 8.0 300 µM - 0-1 mM 100x, 200x 
2 mM 20 mM pH 6.8 300 µM - 0-1 mM 100x, 200x 
2 mM 20 mM pH 6.8 - 300 µM 0-1 mM 100x, 200x 
      
A115V     cinitial = 191 µM 
2 mM 20 mM pH 8.0 300 µM - 0-0.1 mM 30x, 60x 
4 mM 20 mM pH 8.0 2.4 mM - 0-1 mM 30x, 60x 
2 mM 20 mM pH 6.8 - 300 µM 0-1 mM 30x, 60x 
      
A115G     cinitial = 144 µM 
2 mM 20 mM pH 8.0 300 µM - 0-0.1 mM 10x, 20x 
2 mM 20 mM pH 8.0 800 µM - 0-0.1 mM 10x, 20x 
2 mM 20 mM pH 6.8 - 300 µM 0-0.1 mM 10x, 20x 
 
 
Table D.3: Enzyme- and dTTP concentrations as well as pH for DSC experiments. 
 
20 mM 
HEPES/NaOH 
[dTTP]  [MgCl2] Enzyme conc. 
WT pH 8.0 - - 20 µM 
 pH 6.8 0.5 mM 1 mM  20 µM 
 pH 6.8 - - 20 µM 
     
A115V pH 8.0 - - 24 µM 
 pH 8.0 0.5 mM 1 mM  24 µM 
     
A115G pH 8.0 - - 12 µM 
 pH 8.0 - - 24 µM 
 pH 8.0 0.5 mM 1 mM  12 µM 
 pH 8.0 0.5 mM 1 mM  24 µM 
 pH 6.8 - - 24 µM 
 
 E DCTP DEAMINASE
E.1 Purification of the A115G variant
An overview of the steps involved in the two purifications of A115G 
protein degradation is shown in 
 
Figure E.1: Diagram of the steps involved in purifications of A115G 
protein degradation. S and B refe
 
Purification 2 of the A115G variant
During this purification of A115G 
encountered. After the first ammonium sulfate precipitation and subsequent centrifugation, the 
pellet did not completely dissolve in 10 mL 50 mM KH
was dialyzed and then centrifuged and split into the supernatant (S) and the pellet was 
resuspended in 10 mL buffer, forming a blurred solution with white precipitat
results of the two samples are shown in 
and sample B contained very pure protein. 
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The supernatant of sample B (B2) contained pure protein and was collected (SDS-PAGE lane B2, 
Figure E.2B) and the remaining precipitate was discarded. Supernatant S was purified by anion 
exchange and Figure E.2B shows SDS-PAGE and the absorbance at 280 nm (fractions 10-12 were 
collected and pooled). Proteins in both solutions (S and B2) were precipitated with ammonium 
sulfate. The pellet from B2 readily dissolved in 5 mL 50 mM KH2PO4/K2HPO4 pH 6.8 (B3), while 
the pellet from S did not completely dissolve in 10 mL 50 mM KH2PO4/K2HPO4 pH 6.8 (S2). 
Samples S2 and B3 were dialyzed twice. Both solutions precipitated and were centrifuged. The 
supernatants were collected and azid was added to a final concentration of 0.02 % (B4 and S3). 
SDS-PAGE results of the samples are shown in Figure E.2C. It is seen that B4 contained little 
protein and protein in S3 had degraded. Both solutions (B4 and S3) were discarded. 
 
 
 
Figure E.2: Purification 2  of A115G Mt DCD-DUT. SDS-PAGE of A: S and B (two solutions after 
first dialysis step).  B: solution B2 and fractions from anion exchange. The collected fractions are 
marked and the absorbance at 280 nm is shown above (the connecting line serves as guide to 
the eye). C: purified samples of the A115G variant protein. See Appendix D.4 for further details 
on samples. 
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Purification 3 of the A115G variant 
Purification 3 of A115G Mt DCD-DUT was carried out identically with the WT purification (for 
details, see Appendix D.5). SDS-PAGE results of fractions from the second anion exchange are 
shown in Figure E.3A. The collected fractions are marked and were pooled for further 
purification. SDS-PAGE of the final product from purification is shown in Figure E.3B. 
Degradation is observed and the protein was discarded. 
 
 
Figure E.3: Purification 3 of A115G Mt DCD-DUT. SDS-PAGE of A: fractions from anion exchange. 
The collected fractions are marked and the absorbance at 280 nm is shown to the right (the 
connecting line serves as guide to the eye). B: purified protein (concentrated protein (1x), 
diluted two times (2x), diluted three times (3x)). See Appendix D.5 for purification details. 
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E.2 Turnover numbers 
Experiments used to calculate turnover numbers (with 1 mM dCTP or dUTP at pH 6.8 or pH 8.0) 
were carried out as described in section 9.2.1 and results for WT, A115V and A115G Mt DCD-
DUT are given in Figure E.4. 
 
 
Figure E.4: Measured reaction rates with 1 mM dCTP or dUTP at pH 6.8 or pH 8.0 plotted against 
the time for A: WT, B: A115V and C: A115G Mt DCD-DUT. Each point was determined twice at 
different enzyme concentrations. 
 
 
 
 
 
 
 
time (s)
tu
rn
ov
er
 
(µ M
 
pr
od
uc
t/µ
M
 
en
zy
m
e)
0 500 1000 1500
0
100
200
300
400
time (s)
tu
rn
ov
er
 
(µ
M
 
pr
od
uc
t/µ
M
 
en
zy
m
e)
0 500 1000 1500
0
10
20
30
40
50
time (s)
tu
rn
ov
er
 
(µ
M
 
pr
od
uc
t/µ
M
 
en
zy
m
e)
0 500 1000 1500
0
5
10
15
20
dCTP pH 8.0
dUTP pH 8.0
dCTP pH 6.8
dUTP pH 6.8
A B
C
APPENDIX E 
127 
E.3 Nucleotide saturation 
Results for dUTP saturation kinetic studies carried out as described in section 9.2.2 are given in 
Figure E.5. 
 
Figure E.5: Data points for nucleotide saturation experiments. A: WT, B: A115V, C: A115G Mt 
DCD-DUT. Each point has been determined for at least twice at different enzyme concentrations. 
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E.4 Differential Scanning Calorimetry 
Results for DSC carried out as described in section 3.2.8 are given in Figure E.6, Figure E.7 and 
Figure E.8 for WT, A115V and A115G Mt DCD-DUT, respectively. Weak signals were observed for 
DSC measurements. 
 
 
Figure E.6: DSC of WT Mt DCD-DUT at pH 6.8 and pH 8.0 in the presence or absence of dTTP. 
Two experiments were made with the apo enzyme. Irreversible transition temperatures are 
given. 
 
 
 
 
Figure E.7: DSC of A115V Mt DCD-DUT at pH 8.0. Irreversible transition temperature for the 
enzyme in the presence of dTTP is given. The experiment failed for the apo enzyme. 
 
Figure E.8: DSC of A115G Mt 
presence or absence of dTTP. Irreversible transition temperatures are given
 
 
E.5 Crystal Structure of A115V 
Pictures related to the crystal structure of A115V 
here. 
 
Figure E.9: Stereo view of Figure 
2QXX). A shift in the backbone causes t
pocket and allows room for dTTP binding. A rearrangement of the backbone at Thr111 and 
His112 prevents the side chain of Thr114 from clashing with Thr111 of a neighboring monomer.
 
DCD-DUT at pH 8.0 at two different enzyme concentrations in the 
.
Mt DCD-DUT:dTTP 
Mt DCD-DUT in complex with dTTP are given 
9.14: Overlay of A115V:dTTP (green) and WT:dTTP (red, pdb 
he valine to take up less space in the nucleotide binding 
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Appendix F 
F CRYSTALLIZATION OF EXTENDED SULFOLOBUS 
SOLFATARICUS NUCLEOSIDE DIPHOSPHATE 
KINASE 
F.1 Introduction 
Nucleoside diphosphate kinase (NDK) catalyzes dephosphorylation of nucleoside triphosphates 
and subsequent phosphorylation of nucleoside diphosphates (see Figure 6.1, page 38). The γ-
phosphate of a nucleoside triphosphate (often ATP) is transferred to an active site histidine and 
a nucleoside diphosphate is released (often ADP). A different nucleoside diphosphate binds to 
the phosphorylated enzyme and the reverse reaction produces nucleoside triphosphate and free 
enzyme. 
Many crystal structures of NDK from different organisms, ranging from bacteria to human, are 
available. The subunit fold of NDK is the same and sequence identity of more than 40 % is 
observed between NDK from different species [A4]. Most quaternary structures of NDK are 
hexameric, but some bacterial NDK are tetrameric, and a halophilic NDK has been identified as a 
dimer [A4,5]. The same dimer is used in the assembly of hexameric and tetrameric structures. 
The subunit fold of NDK is a βαβ βαβ fold, also known as the ferredoxin fold because it was first 
seen in the ferredoxin from Pseudomonas aerogenes. The fold comprises a center of a four-
stranded antiparallel β-sheet and two connecting α-helices. The two β-strands in the center are 
very hydrophobic and the least variable part of the sequence [A4]. Assembly into hexamers is 
likely to play an important role in the stability of NDK because of the increased stability of 
hexamers compared with isolated subunits [A6].  
In general, an extended C-terminal is observed for NDK from mesophilic organisms compared 
with NDK from thermophilic organisms, see Figure F.1. The C-terminal could thus have a 
destabilizing effect on the enzyme. Contrary to this is the finding that increasing the length of 
the C-terminal of NDK from the hexameric thermoacidophilic archaea Sulfolobus solfataricus (Ss) 
has a stabilizing effect by increasing its transition temperature by 2-3 °C7. The C-terminal 
extension consists of 12 residues from NDK from the hexameric mesophilic eukaryote 
Dictyostelium discoideum, see Figure F.1. The crystal structure of WT SS NDK was recently 
                                                           
7 Unpublished results. Martin Willemoës, Department of Biology, University of Copenhagen. 
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solved8, see Figure F.2. The crystal structure of the extended NDK (NDKext) from Ss could explain 
the increased thermostability. This appendix describes NDKext crystallization and attempts to 
solve the crystal structure. 
 
                                    10        20        30        40        50        60            
                           ....|....|....|....|....|....|....|....|....|....|....|....| 
Chloroflexus aurantiacus   -------MERALLILKPDAVQRGLIGAIISRFEQRGLKFQGLKLMQVDEALARRHYAEHE  
Thermus aquaticus          -------MERTFVMVKPDGFRRGLVGEILARFERKGFRIVGLKALRISQELAEKHYAEHR  
Thermus thermophilus       -------MERTFVMIKPDGVRRGLVGEILARFERKGFRIAALKLMQISQELAERHYAEHR  
Oceanithermus profundus    -------MERTFAMIKPDGVRRGLTGKIIQRLEDKGFKIVALKKMRISFDLAEEHYGEHK  
Meiothermus ruber          -------MERTYIMVKPDGVRRGLTGEIINRIERKGFKIVAMKKMVIPRETAETHYGEHR  
Meiothermus silvanus       -------MERTYIMVKPDGVRRGLTGEIISRIERKGFKIVAMKKMLISQQTAETHYGEHK  
Sulfolobus solfataricus    -----MVAQRTFVMIKPDGVKRGLIGEIISRFEKRGLKIVSLKMVKMSRDTAEKLYEEHK  
Dictyostelium discoideum   MSTNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHK  
Saccharomyces cerevisiae   MSS---QTERTFIAVKPDGVQRGLVSQILSRFEKKGYKLVAIKLVKADDKLLEQHYAEHV  
Drosophila melanogaster    MAA---NKERTFIMVKPDGVQRGLVGKIIERFEQKGFKLVALKFTWASKELLEKHYADLS  
Homo sapiens               -MA---NLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQHYIDLK  
Escherichia coli           -----MAIERTFSIIKPNAVAKNVIGNIFARFEAAGFKIVGTKMLHLTVEQARGFYAEHD  
Myxococcus xanthus         -----MAIERTLSIIKPDGLEKGVIGKIISRFEEKGLKPVAIRLQHLSQAQAEGFYAVHK  
Arabidopsis thaliana       -------MEQTFIMIKPDGVQRGLIGEVICRFEKKGFTLKGLKLISVERSFAEKHYEDLS  
 
                                    70        80        90       100       110       120         
                           ....|....|....|....|....|....|....|....|....|....|....|....| 
Chloroflexus aurantiacus   GKSFFNGLVSYITSAPVVVAVVAGKPGTVELVRAMVGATNPAKAAPGTIRGDFGVDIGR-  
Thermus aquaticus          EKPFFPSLVGFITSGPVVAMVLEGPN-AVAEVRKMMGATHPKDALPGTIRGDYATTIDE-  
Thermus thermophilus       EKPFFPGLVRFITSGPVVAMVLEGPG-VVAEVRKMMGATHPKDALPGTIRGDFATTIDE-  
Oceanithermus profundus    EKPFFKPLVEFITSGPVVAMVLEGPG-VIAELRKMMGATNPADALPGTIRGDFATTIDE-  
Meiothermus ruber          GKPFFEGLVNFITSGPVVAMVVEGPG-VIAEMRRLMGATRPWEAAPGTIRADFATTVDE-  
Meiothermus silvanus       GKPFFEGLVRFITSGPVVAMVVEGPQ-AVSEMRRLMGATRPWEAAPGTIRADYATTVDE-  
Sulfolobus solfataricus    GKSFFEELVNYVTSGPVVCMVIEGDD-VVQVIRRMIGNTDPKEAPPGTIRGDYALSKSE-  
Dictyostelium discoideum   ERPFFGGLVSFITSGPVVAMVFEGKG-VVASARLMIGVTNPLASAPGSIRGDFGVDVGR-  
Saccharomyces cerevisiae   GKPFFPKMVSFMKSGPILATVWEGKD-VVRQGRTILGATNPLGSAPGTIRGDFGIDLGR-  
Drosophila melanogaster    ARPFFPGLVNYMNSGPVVPMVWEGLN-VVKTGRQMLGATNPADSLPGTIRGDFCIQVGR-  
Homo sapiens               DRPFFPGLVKYMNSGPVVAMVWEGLN-VVKTGRVMLGETNPADSKPGTIRGDFCIQVGR-  
Escherichia coli           GKPFFDGLVEFMTSGPIVVSVLEGEN-AVQRHRDLLGATNPANALAGTLRADYADSLTE-  
Myxococcus xanthus         ARPFFKDLVQFMISGPVVLMVLEGEN-AVLANRDIMGATNPAQAAEGTIRKDFATSIDK-  
Arabidopsis thaliana       SKSFFSGLVDYIVSGPVVAMIWEGKN-VVLTGRKIIGATNPAASEPGTIRGDFAIDIGR-  
 
                                   130       140       150       160          
                           ....|....|....|....|....|....|....|....|....|.. 
Chloroflexus aurantiacus   --NLIHASDSPESGERETAIFFQPHELIGEWNRALDNWIYE------  
Thermus aquaticus          --NVIHGSATLEDAQREIALFFRPEELL-------------------  
Thermus thermophilus       --NVIHGSATLEDAQREIALFFRPEELL-------------------  
Oceanithermus profundus    --NVIHGSANEADAEREIALFFRPEEFVS------------------  
Meiothermus ruber          --NVIHGSDSPESAQREIGIFFKPEEIIG------------------  
Meiothermus silvanus       --NVIHGSDSPESAAREIGIFFKPEEIIG------------------  
Sulfolobus solfataricus    --NVIHASDSIEKAQREMSLFFDKSDL--------------------  
Dictyostelium discoideum   --NIIHGSDSVESANREIALWFKPEELLT-EVKPNPNLYE-------  
Saccharomyces cerevisiae   --NVCHGSDSVDSAEREINLWFKKEELVDWESNQAKWIYE-------  
Drosophila melanogaster    --NIIHGSDAVESAEKEIALWFNEKELVTWTPAAKDWIYE-------  
Homo sapiens               --NIIHGSDSVKSAEKEISLWFKPEELVDYKSCAHDWVYE-------  
Escherichia coli           --NGTHGSDSVESAAREIAYFFGEGEVC--PRTR-------------  
Myxococcus xanthus         --NTVHGSDSLENAKIEIAYFFRETEIHSYPYQK-------------  
Arabidopsis thaliana       --NVIHGSDSVESARKEIALWF-PDGPVNWQSSVHPWVYET------  
 
Figure F.1: Sequence alignment of NDK from thermophilic organisms (red names) and mesophilic 
organisms (black names), made using ClustalW [A7] and BioEdit [A8] with sequence information 
from UniProt [A9,10]. Highlighted in yellow are the 12 residues of the C-terminal of NDK Dd that 
were attached to NDK Ss to form the extended NDK (NDKext). 
 
                                                           
8 Unpublished structure solved by Maria Blanner, special course at DTU Chemistry 
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Figure F.2: Two views of the unpublished structure of Ss NDK. Three dimers make up the 
hexameric structure. Each dimer is shown in red, blue or green. 
 
F.2 Experimental 
F.2.1 Crystallization 
Crystallization conditions for NDKext were based on initial crystallization screens and 
optimization by Tina Vognsen9. Protein with a concentration of 2.9 mg/mL was kindly supplied 
by Martin Willemoës. Hanging-drop vapor-diffusion in 24 well plates was applied during all 
crystallization experiments. Crystallization conditions were mainly 35-43 % MPD and 0-0.1 M 
CaCl2. A selection of buffers and additives (Hampton Research Additive Screens 1, 2 and 3) were 
used. Crystallization with (NH4)2SO4 with 2-5 % different PEG or MPEG was also tested with 
various buffers. A complete set of all tested conditions is not given, but a variety of 
crystallization conditions are available for picture entries in the enclosed database (Appendix A, 
NDKext.xml, see Chapter 2 for a program description). 
Crystallization conditions on crystals used for data collection were 38-39 % MPD, 0.05-0.07 M 
CaCl2 in 0.1 M sodium acetate pH 4.6. 
 
F.2.2 Data Collection 
Prior to diffraction tests and data collection, crystals were mounted in a loop and cryo-cooled 
directly in liquid nitrogen. Data were collected to 3 Å on a large rod-shaped crystal 
(approximately 60x200 µm): 152 frames with an oscillation angle of 0.5° at MAX-lab (dataset 1). 
At frame 152, diffraction was poor and annealing of the crystal was attempted. Two data sets 
were collected at ESRF on similar large rod-shaped crystals. One dataset was collected to 2.5 Å 
(dataset 2, 240 frames) and the other dataset to 2.7 Å (dataset 3, 250 frames) with oscillation 
angles of 0.5°. 
 
                                                           
9 Tina Vognsen, Master Thesis, Department of Chemistry, Technical University of Denmark, September 
2008 
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F.3 Results and Discussion 
F.3.1 Crystallization  
Several crystals were produced, some of which are shown in Figure F.3. An elaborate summary 
of crystallization results can be found in the enclosed database (Appendix A, NDKext.xml) that 
includes 383 picture entries with matching crystallization conditions. When crystals grew large, 
they had a tendency to form irregular ends. 
 
 
Figure F.3: A: 42 % MPD, 0.04 M CaCl2, 100 mM BisTris pH 5.5 (protein:reservoir ratio 1:1), B: 38 
% MPD, 0.04 M CaCl2, 100 mM BisTris pH 5.5 (protein:reservoir ratio 1:1), C: 38 % MPD, 0.07 M 
CaCl2, 100 mM sodium acetate pH 4.6, (protein:reservoir ratio 3:2 + 0.6 µL 40 % 2,5 hexanediol), 
D: 40 % MPD, 0.04 M CaCl2, 100 mM Tris pH 8.5 (protein:reservoir ratio 3:2), E: 41 % MPD, 0.06 
M CaCl2, 100 mM sodium acetate pH 4.6 (protein:reservoir ratio 3:2), F: 39 % MPD, 0.05 M CaCl2, 
100 mM sodium acetate pH 4.6 (protein:reservoir ratio 3:2). 
 
F.3.2 Data Collection and Processing 
Diffraction of the crystals shown in Figure F.3A-D was very poor or non-existing. Crystals with 
morphology as shown in Figure F.3E-F were used for data collection at MAX-lab and ESRF. A 
tendency is observed where the largest crystals have the best diffraction properties despite their 
cracked appearance. 
Data were collected to 3 Å at MAX-lab (dataset1). The poor diffraction at frame 152 did not 
improve with annealing and data collection was stopped. Two data sets were collected at ESRF, 
one to 2.7 Å and one to 2.5 Å. Merging of the data proved to be a challenging task and several 
attempts were made by Pernille Harris to merge the data in order to solve and refine the 
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structure (difficulties in solving and refining the structure are described in section F.4). Data from 
MAX-lab and from one of the crystals at ESRF merged in hexagonal space group (P6322), whereas 
the other crystal at ESRF only merged in monoclinic (P2) space group.  
Data processing proved very problematic and the difficulties met are best explained by a 
pseudomerohedral twinning of the crystals. In merohedral twinning, a 2-fold axis along a unit 
cell axis relates two parts within the crystal. If the two parts are equally represented within the 
crystal, a higher degree of symmetry will appear as reflections from each ‘subcrystal’ seem 
symmetry related. This is in agreement with a higher degree of symmetry (hexagonal) observed 
for two crystals (dataset 1+2), whereas the third crystal (dataset 3) has lower symmetry 
(monoclinic). The diffraction of the crystals was furthermore observed as a combination of well-
defined and streaky diffraction spots, see Figure F.4.  
Even though the monoclinic crystal could be a single crystal, no reasonable structure solution 
was found likely because of the low quality of the data. Data collection statistics and processing 
used for structure solution attempts are given in Table F.1. 
 
Table F.1: Data collection statistics.a 
 Dataset1 Dataset2 Dataset3 
Beamline MAX-LAB, 911-2 ESRF, ID14-2 ESRF, ID14-2 
Detector  mar165 ADSC Q4 CCD ADSC Q4 CCD 
Wavelength (Å)  1.04 0.933 0.933 
Temperature (K)  100 100 100 
Crystal space group  P6322 P6322 P21 
Unit cell parameters    
a (Å)  71.59 71.662 71.49 
b (Å) 71.59 71.662 198.43 
c (Å)  198.12 199.072 71.47 
β (°)   120.087 
Resolution (Å)  29.6-3.0 (3.07-2.99) 45.3-2.6 (2.81-2.60) 45-2.9 (3.08-2.9) 
No. of reflections 54,592 (3,608) 138,944 (27,095) 94,755 (15,853) 
No. of unique reflections  6,590 (440) 9,977 (1,990) 32,400 (5,519) 
Redundancy 8.3 (8.2) 13.9 (13.6) 2.9 (2.9) 
Mosaicity (°) 0.5-0.8 0.2-0.3 0.4-0.7 
Completeness (%) 99.3 (95.2) 99.8 (99.4) 84.6 (87.5) 
I /σ(I)  8.05 (1.46) 14.45 (2.04) 6.32 (0.95) 
Rmerge 29.3 (181.0) 14.6 (120.6) 14.8 (128.9) 
a Values for the outermost resolution shell are given in parenthesis. 
Rmerge = Σi Ii – 〈Ii〉/ Σi Ii 
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F.4 Attempts to Solve the Structure and Discussion 
The structure of NDKext was attempted solved with dataset 1 (see Table F.1 for statistics) using 
molecular replacement with WT NDK Ss as a search model and two molecules in the asymmetric 
unit. Rfree was 0.396 after a rigid body refinement and a restrained refinement and improved 
slightly to 0.353 when refined to 3.1 Å instead of 3 Å. Any other change; decreasing the 
resolution, refinement of positions in winCoot, addition of any residues to the extended C-
terminal or the use of NCS, resulted in a notable increase in Rfree (Rfree in the range of 0.4-0.45). 
The side chain of Glu97 was removed because it clashed with a symmetry generated molecule, 
however, this also increased Rfree. 
With improved data from ESRF (dataset 2, see Table F.1 for statistics), the structure was 
attempted solved with molecular replacement using MOLREP [A11]. A total of 14 NDK crystal 
structures from different organisms were tested as search models for molecular replacement. 
Solutions were only possible with 2 molecules in the asymmetric unit. The best result with 
hexagonal space groups was achieved with space group P6322 and molecular replacement using 
WT NDK Ss as a search model. Phenix.refine [A12] or REFMAC5 [A13] was used for refinement. 
However, Rfree did not drop below 0.4 at any time during refinement. A range of phenix.refine 
options were tested: Ramachandran restrained refinement, restrained refinement with NCS, 
reference model steering refinement, ordering solvent and simulated annealing. A segment of 
NDKext (residues 108-114) from refinement is shown in Figure F.4, and even though electron 
density appeared sufficient to model the approximate positions of the residues, Rfree had a very 
high value of 0.522. 
 
 
Figure F.4: Left: segment of diffraction image from data collection (Table F.1 dataset 2). Right: 
residues 108-114 shown with 2Fobs – Fcalc = 1.4 (grey) and Fobs – Fcalc = 3.0 (green) during an 
attempt to solve the structure of NDKext with dataset 2 (Rfree was 0.522). 
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F.5 Conclusion 
The crystallization conditions of NDKext have been optimized and several crystals have been 
made. Larger crystals with cracked edges had better diffraction properties than smaller crystals 
with sharp edges. Data were collected on three crystals: one at MAX-lab and two at ESRF. 
However, data processing and refinement did not produce any reasonable structure solution 
likely because of pseudomerohedral twinning of the crystals. New crystallization trials should be 
made in search of a single crystal with improved diffraction properties. 
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Abstract The structure of the all-cysteinyl-coordinated
D14C variant of [4Fe–4S] ferredoxin from the hyper-
thermophilic archaeon Pyrococcus furiosus has been deter-
mined to 1.7 A˚ resolution from a crystal belonging to space
group C2221 with two types of molecules, A and B, in the
asymmetric unit. A and B molecules have different crystal
packing and intramolecular disulfide bond conformation.
The crystal packing reveals a b-sheet interaction between A
molecules in adjacent asymmetric units, whereas B mole-
cules are packed as monomers in a less rigid position next to
the A–A extended b-sheet dimers. The A molecules contain
an intramolecular disulfide bond in a double conformation
with 60% occupancy left-handed and 40% occupancy right-
handed spiral conformation, whereas B molecules have an
intramolecular disulfide bond in a right-handed spiral con-
formation. The cluster in D14C [4Fe–4S] P. furiosus ferre-
doxin was chemically oxidized at pH 5.8 to [3Fe–4S]. For
purification at pH 8.0, two forms of the protein are obtained.
Mass spectrometric analysis shows that the two forms are the
D14C [3Fe–4S] P. furiosus ferredoxin monomer and a
disulfide-bonded dimer of D14C [3Fe–4S] P. furiosus fer-
redoxin. When oxidization and purification are carried out at
pH 5.8, only the monomer is obtained. The crystal structure
of D14C [3Fe–4S] P. furiosus ferredoxin monomer was
determined to 2.8 A˚ resolution from a crystal belonging to
space group P212121 with two molecules in the asymmetric
unit. The molecules resemble molecule A of D14C [4Fe–4S]
P. furiosus ferredoxin and electron density clearly shows the
presence of a [3Fe–4S] cluster.
Keywords Ferredoxin  Crystal structure  Pyrococcus
furiosus  Disulfide bond  Dimer
Abbreviations
BisTris [Bis(2-hydroxyethyl)amino]
tris(hydroxymethyl)methane
CV Column volume
PDB Protein Data Bank
RMS Root mean square
Tris Tris(hydroxymethyl)aminomethane
WT Wild type
Introduction
Iron–sulfur proteins are present in all kinds of organisms
and cellular compartments and assume a range of func-
tions, predominantly electron transfer, but also catalysis
and regulatory and sensing functions. Iron–sulfur proteins
can contain several active site iron–sulfur clusters in a
variety of frameworks: from simple clusters with one to
four irons up to large clusters—some of which are
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heterometallic with nickel or molybdenum as part of or
bound to the cluster [1].
Ferredoxins contain iron–sulfur clusters coordinated
most often by cysteine residues to the protein chain. A
common cluster in bacterial ferredoxins is the cuboidal
[4Fe–4S] cluster bound to the polypeptide chain by cys-
teine ligands with a typical binding motif: –Cys–X2–Cys–
X2–Cys–Xn–Cys–. These [4Fe–4S] clusters can reversibly
interconvert to [3Fe–4S] clusters. Common small ferre-
doxins with only a single cluster often have two additional
cysteines forming an intramolecular disulfide bond, which
replace a second cluster in more ancient ferredoxins [2, 3].
In the binding motif of Pyrococcus furiosus ferredoxin, the
second cysteine is replaced by aspartate and [4Fe–4S] to
[3Fe–4S] cluster conversion is readily observed [4].
Incomplete cysteine coordination is also seen in one of two
[4Fe–4S] clusters in Desulfovibrio africanus ferredoxin III
that readily converts to [3Fe–4S] [5]. Site-directed change
of cluster-coordinating aspartate to cysteine has been
reported to impair the ease with which [4Fe–4S] converts
to [3Fe–4S] [5].
The other reported crystal structures of [3Fe–4S] ferre-
doxins with complete cysteine binding motifs are Desulfo-
vibrio gigas (Protein Data Bank, PDB, entry 1FXD [6]) and
Bacillus thermoproteolyticus (PDB entry 1WTF [7]).
These both have additional chemical groups bound that
protect the free cysteine; hence, the structure of the D14C
[3Fe–4S] P. furiosus ferredoxin is the first crystal structure
in which a cysteine in the binding motif is unmodified and
facing away from the cluster.
The small electron-transfer ferredoxin from the hyper-
thermophilic archaeon P. furiosus [8] consists of 66 amino
acids (7.5 kDa) and contains a single [4Fe–4S]2?,? cluster
and five cysteine residues, two of these forming an intra-
molecular, redox-active disulfide bond [4, 9]. This ferre-
doxin is very thermostable, with no denaturation after 12 h
at 95 C [8]. The protein fold of thermophilic ferredoxins
often shows polypeptide chain extensions [1] and this is
also seen in P. furiosus ferredoxin, which compared with
other ferredoxins has structural extensions in the b-sheet of
the two termini and in a-helix 2 [10]. P. furiosus ferredoxin
is further stabilized by an extensive hydrogen-bonding
network as well as a hydrophobic interaction between Trp2
and Tyr46. The crystal structure of P. furiosus ferredoxin
shows crystal packing as a dimer formed by extended
b-sheet interactions [10]. It has been proposed that
dimerization of wild type (WT) P. furiosus ferredoxin
occurs depending on ionic strength [11, 12]. Although we
have observed crystal packing as extended b-sheet dimers,
these dimers were not observed in solution and could be an
artifact of the high protein concentration in the crystal.
A single exchange of the cluster coordinating Asp14 to
cysteine (D14C) in P. furiosus ferredoxin results in a
complete cysteine binding motif and causes some changes
compared with WT P. furiosus ferredoxin; however, the
thermostability is maintained [13]. An additional Fe–S
charge transfer band in D14C compared with WT
P. furiosus ferredoxin causes an increase in the absorbance
ratio and the extinction coefficient: A390/A280 = 0.73 and
e390 = 20.2 mM
-1 cm-1 for D14C compared with A390/
A280 = 0.56 and e390 = 17 mM
-1 cm-1 for the WT [14,
15]. The reduction potential of the D14C variant is 59 mV
more negative than that of the WT ferredoxin: -427 versus
-368 mV [16]. The electrochemical properties of ferre-
doxins have been reported to be sensitive to changes in the
cluster environment: reduced surface/solvent accessibility,
reduced hydrogen-bonding network, or reduced volume of
the cluster cavity lower the reduction potential and the
conformation of the ligands also has an influence [17–22].
We have expressed and purified D14C [4Fe–4S]2?
P. furiosus ferredoxins in a form suitable for crystallization
and structure determination. D14C [3Fe–4S] P. furiosus
ferredoxin was produced by oxidation. Purification by
anion exchange at pH 5.8 results in a single peak, whereas
for purification at pH 8.0 two peaks are observed. Mass
spectrometric analysis reveals a monomer at pH 5.8,
whereas both a monomer and a disulfide-bonded dimer are
formed at pH 8.0. In this article we report the three-
dimensional crystal structure of D14C [4Fe–4S] P. furiosus
ferredoxin to 1.7 A˚ resolution. D14C [3Fe–4S] P. furiosus
ferredoxin proved difficult to crystallize because of protein
solution inhomogeneity, and the three-dimensional struc-
ture is reported to 2.8 A˚ resolution.
Materials and methods
Expression strain and cultivation
The P. furiosus ferredoxin gene was amplified by PCR and
cloned into the pET3a vector. The D14C mutation was
created by site-directed mutagenesis using a QuikChange
kit (Stratagene). The plasmid encoding the D14C P. furio-
sus ferredoxin was transformed into E. coli BL21(DE3)
cells (Novagen) for expression. The expression strain was
grown in 650 mL cultures.
Purification of D14C [4Fe–4S] P. furiosus ferredoxin
Approximately 30 mL 20 mM tris(hydroxymethyl)amino-
methane (Tris)/HCl pH 8.0 buffer was added to six tubes
each containing cells from 650 mL culture and the cells
were resuspended. Eighty microliters of 1 M sodium
dithionite was added to each tube. Subsequently, the cells
were lysed by sonication three times for 40 s. After soni-
cation, the suspension was incubated for 10 min in a 70 C
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water bath, then centrifuged at 4 C for 20 min at 18,500g,
and the clear supernatant decanted off. The supernatant was
diluted four times with 20 mM Tris/HCl pH 8.0, 2 mM
sodium dithionite. The protein solution was loaded onto a
50 mm/7 cm Q Sepharose Fast Flow column equilibrated
with 20 mM Tris/HCl pH 8.0. The column was washed
with 2 column volumes (CV) 20 mM Tris/HCl pH 8.0 and
2 CV 20 mM Tris/HCl pH 8.0, 0.15 M NaCl. The protein
was eluted isocratically with 20 mM Tris/HCl pH 8.0,
0.4 M NaCl. The volume was reduced to approximately
5 mL by ultrafiltration using a stirred Amicon cell with a
PLBC NMWL 3 kDa membrane. A maximum of 5 mL
protein solution was then loaded onto a HiLoad 16 mm/
60 cm Superdex 75 column equilibrated with 20 mM Tris/
HCl pH 8.0, 0.15 M NaCl and eluted using the same buffer
with a flow rate of 1 mL/min. Fractions containing D14C
P. furiosus [4Fe–4S] ferredoxin were pooled and exchan-
ged into 20 mM Tris/HCl pH 8.0 by ultrafiltration. A
maximum of 15 mg was loaded onto a 16 mm/10 cm
Source 30Q column equilibrated with 20 mM Tris/HCl pH
8.0. The column was washed with 2 CV 20 mM Tris/HCl
pH 8.0 and elution was carried out using a linear salt
gradient of 0.15–0.4 M NaCl in 20 mM Tris/HCl pH 8.0
over 17 CV. The protein was exchanged into 20 mM Tris/
HCl pH 8.0 by ultrafiltration.
Oxidation to and purification of D14C [3Fe–4S]
P. furiosus ferredoxin
Experiments were carried out with buffer A corresponding
to 20 mM Tris/HCl pH 8.0 or 20 mM [bis(2-hydroxyethyl)
amino]tris(hydroxymethyl)methane (BisTris)/HCl pH 5.8.
Fifteen times molar excess ferricyanide and 1.5 times
molar excess EDTA were added to purified D14C
P. furiosus [4Fe–4S] ferredoxin in 20 mM BisTris/HCl pH
5.8 and the mixture was left overnight with stirring at room
temperature. The excess of ferricyanide and EDTA was
removed by ultrafiltration using buffer A. The protein
solution was filtered before being loaded onto a 16 mm/
10 cm Source 30Q column equilibrated with buffer A. The
column was washed with 2 CV buffer A and elution was
carried out using a linear salt gradient of 0.15–0.4 M NaCl
in buffer A over 17 CV. The protein was exchanged into
buffer A by ultrafiltration.
Mass spectrometry
Prior to mass spectrometric analysis all protein samples
were desalted, and the buffer was exchanged into 100 mM
ammonium acetate/acetic acid pH 5.8 using Micro Bio-
Spin P-6 columns (Bio-Rad). Samples were diluted to a
protein concentration of approximately 20 lM. Mass
spectra were obtained with a nano-electrospray ionization
time-of-flight instrument (LCT Premier, Waters). The data
were acquired in negative ion mode. The instrument was
calibrated using 2 mg/mL NaI in 50% 2-propanol solution.
Au/Pd-coated capillaries (Proxeon) were used. The source
temperature was maintained at 50 C during the experi-
ments. The capillary voltage applied was typically between
800 and 900 V, while the cone voltage applied was 50 V.
The MaxEnt1 algorithm provided with MassLynxTM ver-
sion 4.1 (Waters) was used to produce mass spectra from
the observed m/z data.
Crystallization and data collection
For crystallization, the conditions for the WT P. furiosus
ferredoxin [23] were optimized. Platelike crystals of D14C
[4Fe–4S] P. furiosus ferredoxin were obtained at 4 C by
hanging-drop vapor diffusion with a reservoir containing
35% PEG600 and a 0.1 M malonic acid/imidazole/boric
acid buffer system pH 7.5 [24]. The drop contained 2 lL
reservoir solution, 2 lL 6.7 mg/mL D14C [4Fe–4S]
P. furiosus ferredoxin in 20 mM Tris/HCl pH 8.0, and
0.3 lL 0.1 M hexaamminecobalt(III) chloride. The crystals
had grown after 3 days and were cryocooled directly in
liquid nitrogen on the eighth day for subsequent data col-
lection. Diffraction data were collected: 180 frames with an
oscillation angle of 1. Integration and scaling of the data
were performed with XDS/XSCALE [25, 26].
Crystallization of D14C P. furiosus [3Fe–4S] ferredoxin
was much more difficult. Numerous crystallization condi-
tions were tested and at pH below 7 precipitation generally
occurred. This precipitation was most often gray, indicat-
ing that the protein had lost its iron–sulfur cluster. Drops
were generally inhomogeneous, with a mixture of several
combinations of phase separation, precipitation, protein
films, and crystalline clusters with very high mosaicity.
Conditions from crystallization screens were tested; how-
ever; crystals were only obtained with conditions similar to
those for crystallization of the WT [23]. The best crystals
were obtained at room temperature with hanging-drop
vapour diffusion with a reservoir containing 35% PEG1500
and 0.1 M Tris/HCl pH 8.5. The drop contained 2 lL
reservoir solution, 2 lL 6.4 mg/mL D14C [3Fe–4S]
P. furiosus ferredoxin in 20 mM Tris/HCl pH 8.0, and
0.3 lL 0.1 M hexaamminecobalt(III) chloride. Diffraction
data were collected: 360 frames with an oscillation angle of
0.5. Processing and space group determination were dif-
ficult because of anisotropic mosaicity. Processing was
performed with MOSFLM [27] and space group determi-
nation and averaging were achieved with Pointless and
SCALA [28]. The space group determined was in agree-
ment with the findings of previous diffraction experiments.
Data collection statistics for both structures are given in
Table 1.
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Structure determination and refinement of D14C
P. furiosus [4Fe–4S] ferredoxin
The CCP4 [30] suite was used for structure determination
and refinement. MOLREP [31] was used to solve the
structure with molecular replacement. The search model
was the peptide chain of WT [3Fe–4S] P. furiosus ferre-
doxin (PDB entry 1SJ1) [10]. Two molecules, type A and
B, were found in the asymmetric unit. Refinement was
performed with REFMAC5 [32]: first a rigid-body refine-
ment and then restrained refinements with isotropic B fac-
tors and geometric restraints as defined by Engh and Huber
[33] and a limited B value range of 2–200. Inspection of the
2Fobs - Fcalc and the Fobs - Fcalc sigma-A weighted dif-
ference maps was done using winCoot [34, 35]. Electron
density appeared clearly from two [4Fe–4S] clusters and
four [Co(NH3)6]
3?. Two [Co(NH3)6]
3? were added to each
of the two molecules in the asymmetric unit. One cobalt
atom in molecule A was disordered and split into two
cobalt atoms with 50% occupancy. One [Co(NH3)6]
3? in
molecule B was placed on a twofold rotation axis and thus
assigned 50% occupancy. In molecule A, the following
residues were split in alternate conformations (occupancies
were refined manually by inspection of 2Fobs - Fcalc and
Fobs - Fcalc sigma-A weighted difference maps and are
given in parentheses): Thr10 (50/50), Cys17 (95/5), Ser19
(50/50), Cys21 (40/60), Leu45 (50/50), Cys48 (40/60),
Glu54 (50/50), Glu65 (50/50). Molecule B displayed
alternate conformation only at Ser19 (50/50). A total of
155 water molecules were included in the structure in a
combined use of REFMAC5 [32] and manually using
winCoot [34, 35]; all water molecules were inspected
manually. The structure of D14C P. furiosus [4Fe–4S]
ferredoxin is available in the PDB with entry 2Z8Q (see
Table 2 for refinement statistics).
Structure determination and refinement of D14C
P. furiosus [3Fe–4S] ferredoxin
The CCP4 [30] suite was used for structure determination
and refinement. MOLREP [31] was used to solve the struc-
ture with molecular replacement. The search model was the
peptide chain of type A D14C [4Fe–4S] P. furiosus ferre-
doxin. Two molecules were found in the asymmetric unit.
Molecular replacement was also carried out with the search
model of type B D14C [4Fe–4S] P. furiosus ferredoxin. The
R factor and score after molecular replacement were 0.622
and 0.455, compared with 0.592 and 0.534 for type A. An
increase in Rfree was observed during refinement when using
a type B molecule compared with a type A molecule as the
starting model. Molecule A of D14C [4Fe–4S] P. furiosus
ferredoxin is thus a considerably better model for molecular
replacement than molecule B. Refinement was performed
with REFMAC5 [32]: first a rigid-body refinement and then
restrained refinements with isotropic B factors, tight non-
crystallographic symmetry restrains on residues 1–25 and
28–66, and geometric restraints as defined by Engh and
Huber [33] and a limited B value range of 2–200. Inspection
of the 2Fobs - Fcalc and the Fobs - Fcalc sigma-A weighted
difference maps was done using winCoot [34, 35]. Electron
density appeared clearly from two [3Fe–4S] clusters and
four cobalt atoms; electron density was not visible for cobalt
Table 1 Data collection
statistics
Values for the outermost
resolution shell are given in
parentheses.
Rmerge = Ri Ii  Iih ij j=RiIi
D14C Pyrococcus furiosus
[4Fe–4S] ferredoxin
D14C P. furiosus
[3Fe–4S] ferredoxin
Beamline [29] ESRF, ID14-3 ESRF, ID14-4
Detector ADSC Quantum 4 ADSC Quantum Q315r
Wavelength (A˚) 0.931 0.9765
Temperature (K) 100 100
Crystal space group C2221 P212121
Unit cell parameters
a (A˚) 51.4 47.4
b (A˚) 116.8 49.8
c (A˚) 47.7 51.23
Resolution (A˚) 26–1.7 (1.8–1.7) 35.7–2.8 (2.95–2.8)
No. of reflections 113,257 (17,828) 17,078 (2,504)
No. of unique reflections 16,226 (2,509) 3,254 (456)
Redundancy 6.98 (7.11) 5.2 (5.5)
Mosaicity () 0.2–0.4 Fixed 0.8
Completeness (%) 99.9 (100.0) 99.9 (99.9)
I/r(I) 11.41 (4.93) 3.6 (1.9)
Rmerge 0.112 (0.258) 0.252 (0.755)
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ligands. Two cobalt atoms were added to each molecule in
the asymmetric unit. Molecule A displayed alternate con-
formation (occupancies were refined manually by inspection
of 2Fobs - Fcalc and Fobs - Fcalc sigma-A weighted dif-
ference maps and are given in parentheses) at Met27 (50/50)
and molecule B displayed alternate conformation at Cys14
(50/50). The structure of D14C P. furiosus [3Fe–4S] ferre-
doxin is available in the PDB with entry 3PNI (see Table 2
for refinement statistics).
Programs used for the analysis in ‘‘Results
and discussion’’
Structural figures were prepared using PyMOL [37]. Solvent
accessibilities were calculated using AREAIMOL [38, 39].
Root mean square (RMS) deviations were calculated using
the program superpose [40]. The omit map was calculated
using Sfcheck [41]. pKa was estimated using PROPKA [42,
43] Sequence alignment was done using ClustalW [44].
Results and discussion
Purification and cluster conversion
Aerobic purification of D14C P. furiosus ferredoxin pro-
duces the ferredoxin with an intact [4Fe–4S] cluster that is
eluted at 25–26 mS/cm during anion exchange at pH 8.0.
Aerobic purification of WT P. furiosus ferredoxin pro-
duces both [4Fe–4S] and [3Fe–4S] ferredoxins, which are
eluted in the form of two peaks during anion exchange at
pH 8.0.
Oxidation of [4Fe–4S] to [3Fe–4S] D14C P. furiosus
ferredoxin produces a free cysteine, which corresponds to
Asp14 in WT [3Fe–4S] P. furiosus ferredoxin [10]. Oxi-
dation was initially carried out at pH 7.8 as reported in
[45], but multiple peaks were observed during subsequent
anion exchange at pH 8.0 and the pH was therefore chan-
ged. At pH 5.8, a single peak is observed during anion
exchange (see Fig. 1). At pH 8.0, the free Cys14 in D14C
[3Fe–4S] P. furiosus ferredoxin is partly deprotonated and
elution in two peaks is observed (see Fig. 1). This can be
explained by elution of a monomer and a disulfide-bonded
dimer ferredoxin. The dimer is formed when two depro-
tonated monomers form an intermolecular disulfide bond
(see Scheme 1). The pKa of Cys14 was estimated with
PDB entry 1SJ1 (WT [3Fe–4S] P. furiosus ferredoxin
[10]), where Asp14 was mutated to cysteine. The pKa was
estimated to be 8.8, which is an increase compared with the
pKa of 8.3 of normal cysteine as is expected for a cysteine
residue in a negatively charged environment. The calcu-
lated pKa value is consistent with the presence of both
protonated (present as monomers) and deprotonated
(present as dimers) D14C [3Fe–4S] P. furiosus ferredoxin
at pH 8.0 (see Scheme 1).
Mass spectrometry
Mass spectrometric analysis identified the protein purified
at pH 5.8 (see Fig. 1, chromatogram labeled pH 5.8) to be
D14C [3Fe–4S]? P. furiosus ferredoxin. Its m/z spectrum is
shown in Fig. 2 (spectrum A1). Seven protein charge states
are observed—from charge state 9- to charge state 3-.
The m/z range from 800 to 1,300 was used to calculate the
mass spectrum. The apparent mass of the protein, derived
assuming that all negative charge is from proton deficit
[46], is 7,447.6 Da (see Fig. 2, spectrum A2). The calcu-
lated mass is calculated from the sum of average molecular
masses of all amino acids present in the protein sequence
plus the average molecular mass of the iron–sulfur cluster
components [46, 47]. The calculated mass has to be low-
ered by the mass of two protons for each disulfide bond,
and by the mass of protons equal in number to the oxida-
tion state of the metal cluster present [46]. The calculated
mass for the protein with one disulfide bond (C21–C48)
and 1? oxidation state of the metal cluster is 7,447.8 Da,
which perfectly matches the observed apparent mass
(Fig. 2, spectrum A2).
Subsequently, the two observed peaks in protein repuri-
fication at pH 8.0 (see Fig. 1) were analyzed by mass spec-
trometry. Protein from the first peak was identified to be
D14C [3Fe–4S]? P. furiosus ferredoxin, whereas protein
from the second peak was identified to be a disulfide-bonded
Table 2 Refinement statistics for D14C P. furiosus ferredoxin
[4Fe–4S] [3Fe–4S]
R 0.164 0.279
Rfree 0.194 0.318
No. of atoms in model
Protein 988 988
FeS clusters 16 14
Cobalt complexes 24.5a 4
Water oxygens 155 0
Mean temperature (B) factors (A˚2)
Protein chain A/B 7.5/18 39/39
FeS cluster chain A/B 3.9/9.8 34/28
Cobalt complexes chain A/B 13/16 34/34
Water 23 –
Ramachandran plot [36]
No. of residues in favored region 127 116
No. of residues in allowed region 1 12
No. of residues in outlier region 0 0
a One cobalt complex is placed on a twofold rotation axis and
assigned 50% occupancy
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dimer: D14C [3Fe–4S(Cys–S)–(S0–Cys0)3Fe0–4S0]2?
P. furiosus ferredoxin. From its m/z spectrum (Fig. 2, spec-
trum B1), seven protein charge states are observed—from
charge state 12- to charge state 6-. The m/z range from
1,200 to 1,900 was used to calculate the mass spectrum. The
apparent mass of the disulfide-bonded dimer is 14,893.1 Da
(see Fig. 2, spectrum B2). The calculated mass for the pro-
tein with two C21–C48 intramolecular disulfide bonds, a
C14–C140 intermolecular disulfide bond, and two metal
clusters with oxidation state of 1? is 14,893.7 Da, which
matches the observed apparent mass (Fig. 2, spectrum B2).
Description of the structures
The overall structure of D14C P. furiosus [4Fe–4S] ferre-
doxin is illustrated in Fig. 3. The D14C variant [4Fe–4S]
ferredoxin incorporates the same secondary structure ele-
ments as seen in the [3Fe–4S] P. furiosus ferredoxin
structure [10]. The extended b-sheet dimer formation of
P. furiosus ferredoxin seen in the 1.5 A˚-resolution structure
of P. furiosus [3Fe–4S] ferredoxin [10] is also seen in
D14C P. furiosus [4Fe–4S] ferredoxin between adjacent A
molecules (see Fig. 4). The A molecules form an extended
b-sheet by four main-chain intermolecular hydrogen bonds:
Ile63 N–Glu65 O and Glu65 N–Ile63 O in both molecules.
The B molecules do not form this extended b-sheet dimer
and no main-chain intermolecular hydrogen bonds are
observed between B molecules. The hexaammineco-
balt(III) complexes are situated between negatively
charged residues on the ferredoxin surfaces (Table S1) and
thus play an important electrostatic role in the crystal
packing. The overall charge of P. furiosus ferredoxin at
neutral pH is -12 and the cobalt complex is also necessary
during crystallization of WT P. furiosus ferredoxin [23]
and is present in the structure of WT [3Fe–4S] P. furiosus
ferredoxin [13] (see Fig. 5).
The structure of D14C [3Fe–4S] P. furiosus ferredoxin
is similar to that of the A molecules of D14C [4Fe–4S]
P. furiosus ferredoxin (see Fig. 3) and to that of the WT
[3Fe–4S] P. furiosus ferredoxin. The resolution is not
sufficient to make elaborate comparisons; however, elec-
tron density clearly shows the presence of a [3Fe–4S]
cluster in the structure (see Fig. 6). D14C [3Fe–4S]
P. furiosus ferredoxin with an omit map also clearly shows
the presence of a [3Fe–4S] cluster, and when we tried to
model the same structure with a [4Fe–4S] cluster, it was
clear from the Fo - Fc map that the fourth iron does not
belong in the model (Fig. S1). Crystal packing in D14C
[3Fe–4S] ferredoxin is as extended b-sheet dimers of
adjacent molecules, which is the same as in WT [3Fe–4S]
P. furiosus ferredoxin [10] even though the space groups
are different (see Fig. 5). The crystal packing of D14C
[3Fe–4S] emphasizes a strong resemblance to that of WT
[3Fe–4S] P. furiosus ferredoxin and to that of molecule A
of D14C [4Fe–4S] P. furiosus ferredoxin, which is a better
search model for molecular replacement than molecule B,
which does not form this type of extended b-sheet dimer.
Crystals were grown at pH 8.5 and no disulfide-bonded
dimers are observed in the structure. Monomers and
Fig. 1 Purification of D14C [3Fe–4S] Pyrococcus furiosus ferre-
doxin at pH 5.8 (20 mM BisTris/HCl pH 5.8) and a re-run at pH 8.0
(20 mM Tris/HCl pH 8.0)—on a Source 30Q anion exchange column.
Elution was followed at 280, 390, and 408 nm (blue, red, and pink,
respectively). Conductivity (mS/cm) is shown in brown and salt
concentration (% B; buffer with 1 M NaCl) is shown in green. Dimer
refers to a disulfide-bonded dimer of D14C [3Fe–4S] P. furiosus
ferredoxin
Scheme 1 pH-dependent equilibrium of D14C [3Fe–4S] Pyrococcus
furiosus ferredoxin between protonated and deprotonated monomers
and formation of a disulfide-bonded dimer from deprotonated
monomers. Fd ferredoxin
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disulfide-bonded dimers should be present at pH 8.5 (see
Scheme 1); however, the intrinsic crystal properties appear
to favor monomers, likely because of the large flexibility
around the intermolecular disulfide bond. The inhomoge-
neous solution of monomers and disulfide-bonded dimers
used for crystallization can explain the difficulty to grow
crystals and the very high mosaicity of the crystals.
Superposing the A and B molecules of D14C [4Fe–4S]
ferredoxin gives an RMS deviation of 0.8 A˚, whereas
superposing WT [3Fe–4S] ferredoxin onto molecule A and
molecule B, respectively, gives an RMS deviation of 0.3
and 0.8 A˚, respectively. D14C [4Fe–4S] molecule A thus
shows a greater resemblance to WT [3Fe–4S] ferredoxin
than to D14C [4Fe–4S] molecule B. However, the differ-
ences are subtle compared with those obtained from
superposing the structures onto ferredoxins from Thermo-
toga maritima (PBD entry 1VJW) or D. gigas (PDB entry
1FXD), which gives RMS deviations of 6–8 A˚.
Superposing the structure of D14C [3Fe–4S] P. furiosus
ferredoxin onto molecule A and molecule B of D14C
[4Fe–4S] P. furiosus ferredoxin gives an RMS deviation of
0.5 and 0.8 A˚, respectively. Superposing D14C [3Fe–4S]
P. furiosus ferredoxin onto WT [3Fe–4S] P. furiosus
Fig. 2 Mass spectrometric analysis spectra. A1 m/z spectrum and A2 mass spectrum of protein purified at pH 5.8 (Fig. 1, peak at 25.1 mS/cm);
B1 m/z spectrum and B2 mass spectrum of protein purified at pH 8.0 (Fig. 1, peak at 33.5 mS/cm)
Fig. 3 Overall structure of D14C P. furiosus [4Fe–4S] ferredoxin
molecule A represented as ribbons. The two a-helices (1 and 2) and
two b-sheets (A and B) as well as turns A, B, C, and E are marked.
The iron–sulfur cluster is shown as sticks
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ferredoxin (PDB entry 1SJ1) gives an RMS deviation of
0.4 A˚. Fewer differences are thus observed between D14C
[3Fe–4S] P. furiosus ferredoxin and WT [3Fe–4S] ferre-
doxin than with D14C [4Fe–4S] ferredoxin.
Two crystal structures of [3Fe–4S] ferredoxins with
complete cysteine binding motifs –Cys–X2–Cys–X2–Cys–
Xn–Cys– are available: D. gigas [3Fe–4S] ferredoxin (PDB
entry 1FXD) and B. thermoproteolyticus [3Fe–4S] ferredoxin
variant V–II (PDB entry 1WTF). Both of these structures have
an additional chemical group bound to the non-cluster-
coordinating cysteine and thus no free cysteine is seen [6, 7].
The structure of D14C P. furiosus ferredoxin is the first
available structure where a cysteine from a complete cysteine
binding motif is free and facing away from the cluster.
Fig. 4 D14C [4Fe–4S]
P. furiosus ferredoxin A
molecules are shown in blue and
green, whereas B molecules are
shown in red and yellow.
Hexaamminecobalt(III)
complexes are shown in blue
and orange. The extended
b-sheet dimer of A–A
molecules from two different
asymmetric units is shown to
the left and A–A extended
b-sheet dimers forming a layer
with B molecules on each side is
shown to the right
Fig. 5 Crystal packing: side
and top views of a wild-type
[3Fe–4S] P. furiosus ferredoxin
with hexaaminecobalt(III)
complexes shown in blue and
orange (PDB entry 1SJ1 [10])
and b D14C [3Fe–4S]
P. furiosus ferredoxin with
cobalt atoms shown in orange
770 J Biol Inorg Chem (2011) 16:763–775
123
The structure of D14C [4Fe–4S] P. furiosus ferredoxin
A pronounced difference between the A and B molecules in
the asymmetric unit of D14C [4Fe–4S] P. furiosus ferre-
doxin is at the backbone of Asp42, Glu43, and Glu44, where
molecule B is displaced 1–2.6 A˚ from molecule A out-
wards, leading to a-helix 2 being displaced approximately
1 A˚ (see Fig. 7). Superposing molecule A and B and leav-
ing out residues with pronounced differences (38–45 and
63–66) gives an RMS deviation of 0.5 A˚ as compared with
0.8 A˚ for full-length comparison. Some differences are
observed, but generally the molecules are very similar.
Another difference between the two molecules of D14C
[4Fe–4S] P. furiosus ferredoxin is that molecule B shows a
higher mean temperature B factor of 18 A˚2 compared with
molecule A, which has a mean B factor of 7.5 A˚2 (see
Table 2). The difference in mean B factors may be an
intrinsic property of the molecules or it may be explained
by the less restrained position of molecule B compared
with molecule A. This is illustrated in Fig. 4, which shows
the crystal packing of the molecules in layers: A–A
extended b-sheet dimers form a layer, whereas the B
molecules are placed in a less rigid position on each side of
the extended b-sheet dimer layer.
Also, an analysis of hydrogen bonds in the two mole-
cules in the asymmetric unit of D14C [4Fe–4S] P. furiosus
ferredoxin shows that molecule A of D14C [4Fe–4S]
P. furiosus ferredoxin is more similar to WT P. furiosus
[3Fe–4S] ferredoxin [10] than to molecule B. Table 3 lists
the hydrogen bonds that are different between the ferre-
doxin molecules. The hydrogen bond between Val4 N and
Glu38 O is only seen in molecule B and has been suggested
to be present in the native P. furiosus ferredoxin from
NMR analysis [48]. This bond, along with the interactions
between Trp2 and Ile40, links b-sheet A in molecule B to a
third and shorter strand (see Fig. 8). Hydrogen bond Val4
N–Glu38 O is not seen in molecule A and the backbones of
molecules A and B at Glu38 are displaced by 1.5 A˚ (see
Fig. 7). A number of hydrogen-bond differences between
molecules A and B in a-helix 2 are listed in Table 3, and
these are consistent with an approximately 1 A˚ displace-
ment of the a-helix.
The intramolecular disulfide bond between Cys21 and
Cys48 is in a double conformation in D14C [4Fe–4S]
molecule A (40% occupancy of the right-handed and 60%
occupancy of the left-handed spiral conformation), whereas
in molecule B, it is in a single right-handed spiral con-
formation. This disulfide bond is also found in a double
conformation in the WT [3Fe–4S] ferredoxin. Here, how-
ever, the right-handed conformation has 60% occupancy,
whereas the left-handed conformation has 40% occupancy
[10]. Table 4 lists intramolecular distances related to the
disulfide bond. Differences are observed for two of the
shorter steric interactions (emphasized in bold in Table 4):
in the left-handed conformation the Cys48 Sc–Leu20 O
Fig. 6 D14C [3Fe–4S] P. furiosus ferredoxin with 2Fobs - Fcalc
r = 1.3 electron density map clearly showing the presence of a [3Fe–
4S] cluster and Cys14 facing away from the cluster
Fig. 7 Superposed structure of D14C P. furiosus [4Fe–4S] ferredoxin
molecule A (green) and molecule B (orange). The intramolecular
disulfide bonds and the cluster are also shown
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distance is 3.2 A˚ in D14C molecule A compared with
2.8 A˚ in WT ferredoxin and in the right-handed confor-
mation the Cys21 Sc–Val24 Cc2 distance is 3.1 A˚ in
molecule A compared with 3.3 A˚ in WT ferredoxin. It
appears that the conformation is favored when the shorter
distance is more relaxed.
It is also seen in Table 4 that the intramolecular dis-
tances related to the disulfide bond generally are more
relaxed in molecule B, which is possible since a-helix 2 is
shifted approximately 1 A˚. The more favorable single
right-handed disulfide bond thus involves a loss of hydro-
gen bonds in a-helix 2 as mentioned earlier. This is
accompanied by a displacement of the backbone of Asp42,
Glu43, and Glu44 1–2.6 A˚ outwards compared with mol-
ecule A. b-sheet A, which links the A molecules to form an
extended b-sheet dimer, also shows a minor displacement
(see Fig. 7). Whether the disordered intramolecular disul-
fide bond and the more tightly packed a-helix 2 and b-sheet
A is a consequence of the extended b-sheet dimerization is
difficult to judge.
Structure–reduction potential relationship
Sequence alignment of ferredoxins from D14C P. furiosus,
T. maritima, D. africanus I, and B. thermoproteolyticus is
shown in Fig. 9. These ferredoxins all contain a [4Fe–4S]
cluster coordinated to the protein by four cysteine residues
and were selected because of similarity and the availability
of crystal structures with an intact [4Fe–4S] cluster.
The structures of conserved cluster-coordinating
cysteine residues are shown in Fig. 10 for [4Fe–4S] fer-
redoxins from D14C P. furiosus molecule A (this work),
D. africanus I [49], T. maritima [50], and B. thermopro-
teolyticus [51]. Figure 10 shows only minor changes in the
conformation of cluster-coordinating cysteines and even
though residues in between the cysteine residues differ, the
backbones show little displacement.
Sc of the second cysteine in the coordination motif
(Cys14 in P. furiosus ferredoxin) is the least buried atom of
the [4Fe–4S] cluster including ligands [18], and solvent
accessibilities of these atoms are given in Table 5 for
[4Fe–4S] ferredoxins from D14C P. furiosus, T. maritima,
D. africanus I, and B. thermoproteolyticus along with
reduction potentials of the ferredoxins. In agreement with
the literature [17–19], a correlation is seen where less
buried [4Fe–4S] clusters have higher reduction potentials.
Table 5 also lists the N–HS bonds of Sc of cluster-
coordinating cysteines, which has been discussed in the
literature to have an influence on the reduction potential of
[4Fe–4S] clusters [18, 20]. The ferredoxins have equal
numbers of bonds with comparable distances. A shift is
seen in the reduction potential of D14C versus WT
P. furiosus ferredoxin as the D14C ferredoxin has a more
negative reduction potential in its [4Fe–4S] form and a
more positive reduction potential in its [3Fe–4S] form
when it is compared with WT P. furiosus ferredoxin (see
Table 5). Also, in ferredoxin III from D. africanus,
changing a cluster-coordinating aspartate to cysteine
results in a more negative reduction potential in the
Fig. 8 Hydrogen bonds in b-sheet B of D14C P. furiosus [4Fe–4S]
ferredoxin molecule B and the three bonds linking the sheet to the
backbone at residues 38 and 40
Table 3 Possible main-chain hydrogen bonds in D14C [4Fe–4S]
P. furiosus ferredoxin and comparison with those for wild-type (WT)
P. furiosus [3Fe–4S] ferredoxin
Position Residues NO (A˚), this
study
NO (A˚), WT [10]
N O Chain A Chain B Averaged chains
b-sheet A
Val4 Glu38 – 2.8 –
Helix 2
Ala52 Cys48a 3.0 – 3.1
b 2.9 2.9
Leu45 a Asp42 3.2 – 3.2
b 3.2
Asn47 Glu44 – 3.2 –
Lys50 Cys48 a – – –
b 3.2 3.1
Glu51 Cys48 a – – –
b 3.0 2.8
Turn E
Ala60 Val58 (3.5) 3.2 (3.5)
a and b refer to alternate conformations of the residue
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[4Fe–4S] form and a more positive reduction potential in
the [3Fe–4S] form [5]. For the [4Fe–4S] cluster-containing
ferredoxins, this can be explained by aspartate being a
better electron-withdrawing group than cysteine. For the
[3Fe–4S] cluster-containing ferredoxins, it can be
explained by the pKa difference between aspartate and
cysteine: aspartate is completely deprotonated, whereas
cysteine is partly protonated and the increased charge
density of the WT ferredoxin with a free aspartate results in
a lower reduction potential in the [3Fe–4S] form compared
with the D14C ferredoxin with a free (partly protonated)
cysteine near the cluster.
Conclusion
When oxidized to contain a [3Fe–4S] cluster, the D14C
variant of P. furiosus ferredoxin has a free cysteine residue:
Cys14. The [3Fe–4S]-containing ferredoxin shows a
pH-dependent equilibrium between protonated and depro-
tonated monomers and formation of a disulfide-bonded
dimer at pH 8.0. At pH 5.8, only the protonated Cys14–SH
monomer is present as determined by mass spectrometric
analysis. Mass spectrometric analysis also confirmed the
presence of both the monomer and a dimer consisting of
two [3Fe–4S]-containing ferredoxins with an additional
intermolecular disulfide bond at pH 8.0. This inhomoge-
neity is likely to be the reason behind the difficulty in
crystallizing D14C [3Fe–4S] P. furiosus ferredoxin; how-
ever, the structure clearly shows the presence of a [3Fe–4S]
cluster.
Molecules A and B in the D14C variant of [4Fe–4S]
P. furiosus ferredoxin show some distinct differences that
can be related to differences seen in the crystal packing
and conformation of the intramolecular disulfide bond.
Fig. 9 Sequence alignment of ferredoxins from D14C P. furiosus, Thermotoga maritima, Desulfovibrio africanus I, and Bacillus
thermoproteolyticus. Cluster-coordinating cysteines are marked in yellow and conserved residues are marked in blue
Fig. 10 Superposed structures of the –Cys–X2–Cys–X2–Cys– seg-
ment in [4Fe–4S] ferredoxins from D14C P. furiosus molecule
A (green, this work), D. africanus I (blue, PDB entry 1FXR [49]),
T. maritima (red, PDB entry 1VJW [50]), and B. thermoproteolyticus
(yellow, PDB entry 1IQZ [51])
Table 4 Intramolecular distances related to the double conformation of the disulfide bond in D14C [4Fe–4S] ferredoxin molecule A and WT P.
furiosus [3Fe–4S] ferredoxin molecule A and distances in D14C [4Fe–4S] ferredoxin molecule B
60% left
D14C A
40% right
D14C A
40% left
WT A
60% right
WT A
100% right
D14C B
Cys48 O–Cys21 Sc 3.0 3.8 3.1 3.6 3.6
Cys21 Sc–Val24 Cc2 5.2 3.1 5.6 3.3 3.6
Cys48 Sc–Leu20 O 3.2 4.3 2.8 4.1 4.4
Shorter distances relevant for shift in occupancies are shown in bold
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A b-sheet interaction is present between A molecules in
adjacent asymmetric units and these A–A extended b-sheet
dimers form a layer in the crystal packing. The B mole-
cules do not show the same interaction and are packed in a
less rigid position. Molecule B has the intramolecular
disulfide bond in a single right-handed conformation,
whereas molecule A has it in a double conformation. More
relaxed intramolecular distances related to the disulfide
bond in molecule B compared with molecule A are pos-
sible owing to a shift through a-helix 2. The shift of a-helix
2 also causes a shift of b-sheet A to a lesser extent and this
shift could be related to molecule B not forming an
extended b-sheet dimer. Generally, D14C [4Fe–4S] mole-
cule A and WT [3Fe–4S] ferredoxin show a larger
resemblance than the A and B molecules in the D14C
[4Fe–4S] variant. The conformations of the highly con-
served cluster-coordinating cysteine residues in the –Cys–
X2–Cys–X2–Cys– binding motif of ferredoxins from D14C
P. furiosus, T. maritima, D. africanus I, and B. thermo-
proteolyticus are in close resemblance.
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MyCrystals is designed as a user-friendly program to display crystal images and
list crystallization conditions. The crystallization conditions entry ﬁelds can be
customized to suit the experiments.MyCrystals is also able to sort the images by
the entered crystallization conditions, which presents a unique opportunity to
easily assess the effect of, for example, changing pH or concentration and thus
establish the best conditions to be used for optimization.
1. Introduction
Macromolecular structure determination by X-ray diffraction
requires a successful crystallization. This can be a difﬁcult task where
numerous crystallization experiments lead to a large amount of data.
Crystallization projects can be worked on by several people over long
periods of time, and keeping track of, as well as sharing, results can be
made much easier by the use of a database.
There are many available systems and programs that can be used to
store crystallization data. In connection with crystallization robots
there is usually commercial software available to handle the large
amount of data. Some of the free programs are XtalBase (Meining,
2006), XAct (Brodersen et al., 1999), Xtrack (Harris & Jones, 2002),
CLIMS (Fulton et al., 2004) and LISA (Haebel et al., 2001). XtalBase
(Meining, 2006) is a comprehensive system that amongst many other
features can manage and display images of the results, and CLIMS
(Fulton et al., 2004) is able to store visual observations of the drops.
Images combined with scores afford a simple way to assess crystal-
lization results and simplify the optimization procedure because of
the transparency of the results. Laboratory information management
systems like the Protein Information Management System (PiMS;
https://www.compbio.dundee.ac.uk/pims2_0/) are designed to manage
various types of data, such as target, construct and experimental data,
through a web interface. We have developed a program named
MyCrystals with the main purpose of managing and storing images
and crystallization conditions and sorting them to give an overview of
the results.
MyCrystals is simple to use, easy to navigate and requires minimal
time investment by the researcher to utilize the software. The unique
feature of MyCrystals is its ability to display and sort crystallization
images. The images are stored locally or on external media, and the
program creates a database with ﬁle paths to identify the images.
MyCrystals is also able to sort the images by the entered data to view
the effect of, for example, changing the pH or precipitant. This makes
it easier to establish the best conditions and to assess how they can be
optimized. MyCrystals can also be used as a notebook program to
keep track of attempted crystallization conditions without necessarily
using the image-viewing part. Furthermore,MyCrystalsmay be useful
in other experimental optimization procedures, such as puriﬁcation,
where a lot of slightly different procedures are usually tested. These
may be stored in the database and linked to an image ﬁle containing
the resulting chromatogram.
2. Program description and use
MyCrystals is primarily designed for viewing and sorting images in a
simple and intuitive user interface.
The File menu is used for creating new databases and loading or
saving existing databases. Creating a new database in the File menu
will auto-generate a standard set of conditions.
The user interface of MyCrystals is divided into three simple main
tabs: Filter Data, Edit Data and Data Table.
2.1. Data structure
The data consist of two parts. The ﬁrst part is an XML database
that contains all entered conditions including the appropriate image
path for each set of conditions (data entries). The second part is the
images themselves, which are placed in a directory on the hard drive.
MyCrystals recognizes graphics ﬁle formats JPEG, GIF, PNG and TIFF.
The full path to each image consists of two parts, a project directory
and a relative image path. The image path is unique for each data
entry, while the project directory is shared. This arrangement facil-
itates the moving of all images to another location, as only the project
directory needs to be changed.
2.2. Filter Data
The Filter Data tab is used for viewing and sorting images
entered into the database. The sorting options are available in a drop-
down menu and consist of all entered data. First, a condition is
selected, and then a ﬁlter option is applied. Text strings can be sorted
as absolutes, while numerical strings also can be sorted using >, <, ,
 and 6¼. It is possible to apply 15 ﬁlters simultaneously. A list of
entries that match the criteria is generated and displayed in the tab
(see Fig. 1).
The information shown for each data entry in the list can be
customized using the ﬁeld Filter text. Writing [1] will list the data
entered in the ﬁrst ﬁeld in the Data Entry area of the Edit Data tab,
[2] will list the data in the second ﬁeld, and so forth.
Selecting one of the listed entries will display the matching image
to the right of the tab, as shown in Fig. 1.
electronic reprint
2.3. Edit Data
The database can be edited in the Edit Data tab. The tab consists
of three parts: Project Directory, Column Properties and Data
Entry.
The project directory is the path to a directory where all the images
used in the database are placed. The rest of the path is stored as a
property (image path) for each data entry.
Column Properties makes it possible to change the data columns
of the database. It is possible to delete or add columns, change the
names and types, and switch the positions of two columns. An
intuitive user interface renders this possible (see Fig. 2).
The Data Entry area is used to add, change and remove data
entries in the database. The Selected Data Entry area operates on
an existing data entry. To add a new data entry into the database, use
the Add Data Entry button, which creates a new data entry with a
consecutive index number. The data entry
ﬁelds are empty when the ﬁrst data are
typed in, and after Add Data Entry has been
used, the entry ﬁelds will contain the infor-
mation of the latest data entry. Drop-down
menus of previously entered data are avail-
able when entering or correcting database
entries. The Selected Data Entry area can
advantageously be used when entering data,
as an entire set of previously entered
conditions can be loaded by giving the index
number. Minor changes can be applied to
the set of conditions and Add Data Entry
will generate a new entry in the database.
2.4. Data Table
The Data Table tab lists all entered data
to give an overview of the contents of the
database.
3. Platforms and availability
The program is written in C# as a Windows
Form in Microsoft Visual Studio. The
program consists of a single executable ﬁle,
and no installation is needed. MyCrystals
runs under Windows and has no special
hardware requirements.
MyCrystals is available free of charge for
download from http://xray.kemi.dtu.dk/
mycrystals/.
4. Conclusions
The unique main feature of the program
MyCrystals, presented here, is the displaying
and sorting of crystallization images based
on the entered crystallization conditions.
This enables the user to view the effect of
changing conditions, which helps to identify
parameters for optimization.
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Figure 2
A screenshot showing how the Edit Data tab ofMyCrystals can appear. Checking the Lock Properties option
will simplify the Column Properties by only showing the name.
Figure 1
A screenshot showing how the Filter Data tab of MyCrystals can appear. Data with pH > 7.5 and pH 6¼ 9.0 in
35% PEG 600 have been selected. For the displayed image, the conditions are pH = 8.5 and 30 mM NH4H2CO4.
The scalebar is part of the depicted image.
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